{
  "bill_id": "CT2025000S10",
  "source_url": "http://custom.statenet.com/public/resources.cgi?id=ID:bill:CT2025000S10&cuiq=93d84396-c63b-526a-b152-38b7f79b4cfd&client_md=e4f6fea4-27b4-5d41-b7d3-766fe52569f0",
  "versions": [
    {
      "date": "01/08/2025",
      "label": "Introduced",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250108_0_I&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Introduced</td></tr> <tr><td class=\"label\">Version Date:</td> <td>01/08/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">General Assembly</p>\n   <p class=\"center\">\n    <b>Proposed Bill No. 10</b>\n   </p>\n   <p class=\"center\">\n    <b>January Session, 2025</b>\n   </p>\n   <p class=\"center\">LCO No. <b>989</b>\n   </p>\n   <p class=\"center\">*00989*</p>\n   <p class=\"center\">Referred to Committee on INSURANCE AND REAL ESTATE</p>\n   <p class=\"center\">Introduced by:</p>\n   <p class=\"center\">SEN. LOONEY, 11th Dist.</p>\n   <p class=\"center\">SEN. DUFF, 25th Dist.</p>\n   <p class=\"center\">SEN. ANWAR, 3rd Dist.</p>\n   <p class=\"center\">SEN. CABRERA, 17th Dist.</p>\n   <p class=\"center\">SEN. COHEN, 12th Dist.</p>\n   <p class=\"center\">SEN. FLEXER, 29th Dist.</p>\n   <p class=\"center\">SEN. GADKAR-WILCOX, 22nd Dist.</p>\n   <p class=\"center\">SEN. GASTON, 23rd Dist.</p>\n   <p class=\"center\">SEN. HOCHADEL, 13th Dist.</p>\n   <p class=\"center\">SEN. HONIG, 8th Dist.</p>\n   <p class=\"center\">SEN. KUSHNER, 24th Dist.</p>\n   <p class=\"center\">SEN. LESSER, 9th Dist.</p>\n   <p class=\"center\">SEN. LOPES, 6th Dist.</p>\n   <p class=\"center\">SEN. MAHER, 26th Dist.</p>\n   <p class=\"center\">SEN. MARONEY, 14th Dist.</p>\n   <p class=\"center\">SEN. MARX, 20th Dist.</p>\n   <p class=\"center\">SEN. MCCRORY, 2nd Dist.</p>\n   <p class=\"center\">SEN. MILLER P., 27th Dist.</p>\n   <p class=\"center\">SEN. NEEDLEMAN, 33rd Dist.</p>\n   <p class=\"center\">SEN. OSTEN, 19th Dist.</p>\n   <p class=\"center\">SEN. RAHMAN, 4th Dist.</p>\n   <p class=\"center\">SEN. SLAP, 5th Dist.</p>\n   <p class=\"center\">SEN. WINFIELD, 10th Dist.</p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <p class=\"indent\">That the general statutes be amended to address health insurance administrative practices, including utilization review, premium rate filing, downcoding of health insurance claims and other health insurance administrative practices.</p>\n   <p class=\"indent\">\n    <b>Statement of Purpose: </b>\n   </p>\n   <p class=\"indent\">To address health insurance administrative practices, including utilization review, premium rate filing, downcoding of health insurance claims and other health insurance administrative practices.</p>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Introduced  \nVersion Date: | 01/08/2025  \n  \n**STATE OF CONNECTICUT**\n\nGeneral Assembly\n\n**Proposed Bill No. 10**\n\n**January Session, 2025**\n\nLCO No. **989**\n\n*00989*\n\nReferred to Committee on INSURANCE AND REAL ESTATE\n\nIntroduced by:\n\nSEN. LOONEY, 11th Dist.\n\nSEN. DUFF, 25th Dist.\n\nSEN. ANWAR, 3rd Dist.\n\nSEN. CABRERA, 17th Dist.\n\nSEN. COHEN, 12th Dist.\n\nSEN. FLEXER, 29th Dist.\n\nSEN. GADKAR-WILCOX, 22nd Dist.\n\nSEN. GASTON, 23rd Dist.\n\nSEN. HOCHADEL, 13th Dist.\n\nSEN. HONIG, 8th Dist.\n\nSEN. KUSHNER, 24th Dist.\n\nSEN. LESSER, 9th Dist.\n\nSEN. LOPES, 6th Dist.\n\nSEN. MAHER, 26th Dist.\n\nSEN. MARONEY, 14th Dist.\n\nSEN. MARX, 20th Dist.\n\nSEN. MCCRORY, 2nd Dist.\n\nSEN. MILLER P., 27th Dist.\n\nSEN. NEEDLEMAN, 33rd Dist.\n\nSEN. OSTEN, 19th Dist.\n\nSEN. RAHMAN, 4th Dist.\n\nSEN. SLAP, 5th Dist.\n\nSEN. WINFIELD, 10th Dist.\n\nAN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nThat the general statutes be amended to address health insurance\nadministrative practices, including utilization review, premium rate filing,\ndowncoding of health insurance claims and other health insurance\nadministrative practices.\n\n**Statement of Purpose:**\n\nTo address health insurance administrative practices, including utilization\nreview, premium rate filing, downcoding of health insurance claims and other\nhealth insurance administrative practices.\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": false
    },
    {
      "date": "02/25/2025",
      "label": "Drafted by Committee",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250225_0_DBC&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Drafted by Committee</td></tr> <tr><td class=\"label\">Version Date:</td> <td>02/25/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">General Assembly</p>\n   <p class=\"center\">\n    <b>Committee Bill No. 10</b>\n   </p>\n   <p class=\"center\">\n    <b>January Session, 2025</b>\n   </p>\n   <p class=\"center\">LCO No. <b>5342</b>\n   </p>\n   <p class=\"center\">*05342SB00010INS*</p>\n   <p class=\"center\">Referred to Committee on INSURANCE AND REAL ESTATE</p>\n   <p class=\"center\">Introduced by:</p>\n   <p class=\"center\">(INS) </p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <p class=\"indent\">Section 1. (NEW) (Effective October 1, 2025) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;Health carrier&quot; has the same meaning as provided in section 38a-1080 of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Mental health and substance use disorder benefits&quot; has the same meaning as provided in section 38a-477ee of the general statutes, as amended by this act.</p>\n   <p class=\"indent\">(b) (1) Not later than March 1, 2026, and annually thereafter, each health carrier shall file a certification with the Insurance Commissioner for the immediately preceding calendar year, certifying that such health carrier completed a review of such health carrier&#39;s administrative practices for compliance with the state and federal mental health and substance use disorder benefit reporting requirements pursuant to sections 38a-477ee, as amended by this act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510, as amended by this act, and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder. Such certification shall be signed by the chief executive officer and chief medical officer of such health carrier.</p>\n   <p class=\"indent\">(2) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding.</p>\n   <p class=\"indent\">(3) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year fail to comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding and identify (A) each administrative practice of such health carrier not in compliance with such state and federal mental health and substance use disorder benefit reporting requirements, and (B) action that such health carrier will take to bring such health carrier&#39;s administrative practices into compliance with such state and federal mental health and substance use disorder benefit reporting requirements.</p>\n   <p class=\"indent\">Sec. 2. Subsection (c) of section 38a-477ee of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2025):</p>\n   <p class=\"indent\">(c) <strike class=\"amendmentDeletedText\">(1)</strike> Not later than April 15, 2021, and annually thereafter, the Insurance Commissioner shall submit each report that the commissioner received pursuant to subsection (b) of this section for the calendar year immediately preceding to:</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(A)</strike>\n    <u class=\"amendmentInsertedText\">(1)</u> The joint standing committee of the General Assembly having cognizance of matters relating to insurance, in accordance with section 11-4a; and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(B)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> The Attorney General, Healthcare Advocate and Commissioner of Health Strategy.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2) Notwithstanding subdivision (1) of this subsection, the commissioner shall not submit the name or identity of any health carrier or entity that has contracted with such health carrier, and such name or identity shall be given confidential treatment and not be made public by the commissioner.</strike>\n   </p>\n   <p class=\"indent\">Sec. 3. (NEW) (Effective from passage) There is established an account to be known as the &quot;parity advancement account&quot; which shall be a separate, nonlapsing account within the General Fund. The account shall contain any moneys required by law to be deposited in the account and may receive donations from public or private sources. Moneys in the account shall be expended by the Insurance Department, beginning with the fiscal year ending June 30, 2026, for the purposes of enforcing the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act, conducting consumer education and other initiatives that support mental health parity implementation and enforcement on behalf of consumers.</p>\n   <p class=\"indent\">Sec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after providing an opportunity for a hearing in accordance with chapter 54 of the general statutes, may impose a civil penalty on any health carrier of not more than one hundred dollars with respect to each participant or beneficiary covered under a health insurance policy of such health carrier, provided such penalty shall not exceed an aggregate amount of one million dollars annually, for such health carrier&#39;s failure to comply with the certification requirements pursuant to the provisions of section 1 of this act, or the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act.</p>\n   <p class=\"indent\">(2) The commissioner may order the payment of such reasonable expenses as may be necessary to compensate the commissioner in conjunction with any proceedings under this section, which shall be dedicated to the enforcement and implementation of the state and federal mental health parity laws and regulations adopted thereunder.</p>\n   <p class=\"indent\">(b) (1) If any health carrier fails to file any data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, or section 1 of this act, the commissioner shall impose a late fee on such health carrier of one hundred dollars per day from the due date of such filing of data, report, certification or information to the date such health carrier submits such filing to the commissioner.</p>\n   <p class=\"indent\">(2) For any health carrier that files any incomplete data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, and section 1 of this act, the commissioner shall provide notice to such health carrier of such incomplete filing that includes (A) a description of such data, report, certification or other information that is incomplete and any additional data that is needed to consider such filing complete, and (B) the date by which such health carrier is required to provide such data. The commissioner shall impose a late fee on such health carrier of one hundred dollars per day, commencing from the date identified by the commissioner pursuant to subparagraph (B) of this subdivision.</p>\n   <p class=\"indent\">(c) The commissioner may waive any civil penalty imposed pursuant to subsection (a) of this section if the commissioner determines that the violation was due to reasonable cause and was not due to wilful neglect, or if such violation is corrected not more than thirty days after the date that the health carrier filed a certification of noncompliance with the commissioner pursuant to section 1 of this act.</p>\n   <p class=\"indent\">(d) All civil penalties and late fees received by the commissioner pursuant to this section shall be deposited in the General Fund and credited to the parity advancement account established pursuant to section 3 of this act.</p>\n   <p class=\"indent\">Sec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) Each health carrier shall contract with (A) health care professionals to administer such health carrier&#39;s utilization review program, and (B) clinical peers to evaluate the clinical appropriateness of an adverse determination.</p>\n   <p class=\"indent\">(2) (A) Each utilization review program shall use documented clinical review criteria that are based on sound clinical evidence and are evaluated periodically by the health carrier&#39;s organizational mechanism specified in subparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to <strike class=\"amendmentDeletedText\">assure</strike>\n    <u class=\"amendmentInsertedText\">ensure</u> such program&#39;s ongoing effectiveness.</p>\n   <p class=\"indent\">(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a health carrier may develop its own clinical review criteria or it may purchase or license clinical review criteria from qualified vendors approved by the commissioner, provided such clinical review criteria conform to the requirements of subparagraph (A) of this subdivision.</p>\n   <p class=\"indent\">(C) Each health carrier shall (i) post on its Internet web site (I) any clinical review criteria it uses, and (II) links to any rule, guideline, protocol or other similar criterion a health carrier may rely upon to make an adverse determination as described in subparagraph (F) of subdivision (1) of subsection (e) of section 38a-591d, and (ii) make its clinical review criteria available upon request to authorized government agencies.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(D) For each utilization review, there shall be a rebuttable presumption that each health care service under review is medically necessary if such health care service was ordered by a health care professional acting within such health care professional&#39;s scope of practice. Any utilization review company performing such review of a health care service shall have the burden of proving that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">(3) For any utilization review for the treatment of a substance use disorder, as described in section 17a-458, the clinical review criteria used shall be: (A) The most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a substance use disorder, that are not covered in the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(4) For any utilization review for the treatment of a child or adolescent mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a child or adolescent mental disorder, that are not covered in the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(5) For any utilization review for the treatment of an adult mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of an adult mental disorder, that are not covered in the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(b) Each health carrier shall:</p>\n   <p class=\"indent\">(1) Have procedures in place to ensure that (A) the health care professionals administering such health carrier&#39;s utilization review program are applying the clinical review criteria consistently in utilization review determinations, and (B) the appropriate or required individual or individuals are being designated to conduct utilization reviews;</p>\n   <p class=\"indent\">(2) Have data systems sufficient to support utilization review program activities and to generate management reports to enable the health carrier to monitor and manage health care services effectively;</p>\n   <p class=\"indent\">(3) Provide covered persons and participating providers with access to its utilization review staff through a toll-free telephone number or any other free calling option or by electronic means;</p>\n   <p class=\"indent\">(4) Coordinate the utilization review program with other medical management activity conducted by the health carrier, such as quality assurance, credentialing, contracting with health care professionals, data reporting, grievance procedures, processes for assessing member satisfaction and risk management; <strike class=\"amendmentDeletedText\">and</strike>\n   </p>\n   <p class=\"indent\">(5) Routinely assess the effectiveness and efficiency of its utilization review program<u class=\"amendmentInsertedText\">; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(6) Not use any system that employs artificial intelligence, as defined in section 51-10e, or any other algorithm in lieu of a review by a clinical peer to evaluate the clinical appropriateness of an adverse determination pursuant to a contract between such clinical peer and such health carrier</u>.</p>\n   <p class=\"indent\">Sec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(c) (1) (A) When conducting a review of an adverse determination under this section, the health carrier shall ensure that such review is conducted in a manner to ensure the independence and impartiality of the clinical peer or peers involved in making the review decision.</p>\n   <p class=\"indent\">(B) If the adverse determination involves utilization review, the health carrier shall designate an appropriate clinical peer or peers to review such adverse determination. Such clinical peer or peers shall not have been involved in the initial adverse determination.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D) of subdivision (1) of subsection (a) of section 38a-591c, as amended by this act, the health carrier may rebut such presumption by reasonably substantiating to the clinical peer or peers conducting the review pursuant to the provisions of this section that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(C)</strike>\n    <u class=\"amendmentInsertedText\">(ii)</u> The clinical peer or peers conducting a review under this section shall take into consideration all comments, documents, records and other information relevant to the covered person&#39;s benefit request that is the subject of the adverse determination under review, that are submitted by the covered person or the covered person&#39;s authorized representative, regardless of whether such information was submitted or considered in making the initial adverse determination.</p>\n   <p class=\"indent\">(D) Prior to issuing a decision, the health carrier shall provide free of charge, by facsimile, electronic means or any other expeditious method available, to the covered person or the covered person&#39;s authorized representative, as applicable, any new or additional documents, communications, information and evidence relied upon and any new or additional scientific or clinical rationale used by the health carrier in connection with the grievance. Such documents, communications, information, evidence and rationale shall be provided sufficiently in advance of the date the health carrier is required to issue a decision to permit the covered person or the covered person&#39;s authorized representative, as applicable, a reasonable opportunity to respond prior to such date.</p>\n   <p class=\"indent\">(2) If the review under subdivision (1) of this subsection is an expedited review, all necessary information, including the health carrier&#39;s decision, shall be transmitted between the health carrier and the covered person or the covered person&#39;s authorized representative, as applicable, by telephone, facsimile, electronic means or any other expeditious method available.</p>\n   <p class=\"indent\">(3) If the review under subdivision (1) of this subsection is an expedited review of a grievance involving an adverse determination of a concurrent review request, pursuant to 45 CFR 147.136, as amended from time to time, the treatment shall be continued without liability to the covered person until the covered person has been notified of the review decision.</p>\n   <p class=\"indent\">Sec. 7. Section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) <strike class=\"amendmentDeletedText\">for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">for a prescribed drug for the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-492i.</p>\n   <p class=\"indent\">Sec. 8. Section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) <strike class=\"amendmentDeletedText\">for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">for a prescribed drug for the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-518i.</p>\n   <p class=\"indent\">Sec. 9 (NEW) (Effective July 1, 2026) (a) Each insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity that enters into, renews or amends a contract with a health care provider on or after July 1, 2026, to provide covered benefits to insureds or enrollees in this state shall include in such contract:</p>\n   <p class=\"indent\">(1) A provision requiring such insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity to:</p>\n   <p class=\"indent\">(A) Reimburse the contracting health care provider for a covered outpatient benefit that uses a current procedural terminology evaluation and management (CPT E/M) code, current procedural terminology assessment and management (CPT A/M) code or drug infusion code in an amount that does not vary based on the facility where the contracting health care provider provides such benefit; and</p>\n   <p class=\"indent\">(B) Use equal reimbursement rates for all contracting health care providers in the same geographic region, as determined by the Insurance Commissioner, in accordance with the provisions of chapter 54 of the general statutes, and regardless of the employer or affiliation of any contracting health care provider, for each covered outpatient benefit described in subparagraph (A) of this subdivision if the reimbursement for such covered outpatient benefit is made on a fee-for-benefit basis or on the basis of bundled benefits per diagnosis, condition, procedure or another standardized bundle of health care benefits; and</p>\n   <p class=\"indent\">(2) A conspicuous statement that such contract complies with the provisions of subdivision (1) of this subsection.</p>\n   <p class=\"indent\">(b) The Insurance Commissioner shall adopt regulations, in accordance with the provisions of chapter 54 of the general statutes, to implement the provisions of this section, including, but not limited to, the establishment of geographic regions pursuant to the provisions of subparagraph (B) of subdivision (1) of subsection (a) of this section.</p>\n   <p class=\"indent\">Sec. 10. (NEW) (Effective January 1, 2026) (a) For the purposes of this section:</p>\n   <p class=\"indent\">(1) &quot;Actuarial certification&quot; means a written statement by a member of the American Academy of Actuaries or other individual acceptable to the commissioner that the member or individual has (A) examined an insurance company&#39;s books, records, procedures and practices concerning, at a minimum, the company&#39;s actuarial assumptions and methods used to establish attachment points and other terms of a stop loss insurance policy for health care or medical benefits, and (B) determined, on the basis of such examination, that the company is in compliance with this section and all regulations adopted under subsection (f) of this section;</p>\n   <p class=\"indent\">(2) &quot;Affordable Care Act&quot; has the same meaning as provided in section 38a-1080 of the general statutes;</p>\n   <p class=\"indent\">(3) &quot;Attachment point&quot; means the dollar value of claims incurred by a policyholder at which the insurer that issues or delivers a medical stop loss insurance policy to the policyholder incurs liability to such policyholder for payment under such medical stop loss insurance policy;</p>\n   <p class=\"indent\">(4) &quot;Expected claims&quot; means the dollar value of claims that, in the absence of a medical stop loss insurance policy, the policyholder of such medical stop loss insurance policy is projected to incur under such policyholder&#39;s self-funded employee health benefit plan;</p>\n   <p class=\"indent\">(5) &quot;Large employer&quot; has the same meaning as provided in section 1304 of the Affordable Care Act, as amended from time to time; and</p>\n   <p class=\"indent\">(6) &quot;Small employer&quot; has the same meaning as provided in section 1304 of the Affordable Care Act, as amended from time to time.</p>\n   <p class=\"indent\">(b) (1) Except as provided in subdivision (2) of this subsection, on and after January 1, 2026, no insurance company shall deliver, issue for delivery, renew, amend or continue in this state any stop loss insurance policy for health care or medical benefits under any self-funded employee health benefit plan unless such self-funded employee health benefit plan provides coverage for (A) essential health benefits as required by section 38a-492q of the general statutes, and (B) the group state-mandated coverage requirements under chapter 700c of the general statutes.</p>\n   <p class=\"indent\">(2) Notwithstanding the provisions of subdivision (1) of this subsection, on and after January 1, 2026, any insurance company may deliver, issue for delivery, renew, amend or continue in this state a stop loss insurance policy for health care or medical benefits under any self-funded employee health benefit plan, provided such stop loss insurance policy does not:</p>\n   <p class=\"indent\">(A) Have an annual attachment point for claims incurred per covered individual that is less than fifty thousand dollars;</p>\n   <p class=\"indent\">(B) For a small employer, have an annual aggregate attachment point that is less than fifty thousand dollars, ten thousand dollars multiplied by the number of covered individuals or one hundred twenty per cent of expected claims, whichever is greater;</p>\n   <p class=\"indent\">(C) For a large employer, have an annual aggregate attachment point that is less than one hundred ten per cent of expected claims; or</p>\n   <p class=\"indent\">(D) Provide direct coverage for the health care or medical expenses of an individual.</p>\n   <p class=\"indent\">(c) If an insurance company delivers, issues for delivery, renews, amends or continues any employer&#39;s stop loss insurance policy for health care or medical benefits in this state that satisfies the requirements pursuant to subsection (b) of this section, such insurance company shall determine, at least annually, the number of such employer&#39;s employees.</p>\n   <p class=\"indent\">(d) The commissioner shall, not less than biennially, compute the attachment points established pursuant to subparagraphs (A) to (C), inclusive, of subdivision (2) of subsection (b) of this section based on the percentage increase, if any, in the most recent calendar year average in the consumer price index for all urban consumers, and publish on the commissioner&#39;s Internet web site any change in such attachment point not less than six months before the effective date of any such change in attachment point.</p>\n   <p class=\"indent\">(e) Not later than March fifteenth annually, each insurance company that delivers, issues for delivery, renews, amends or continues an employer&#39;s stop loss insurance policy for health care or medical benefits under any self-funded employee health benefit plan that satisfies the provisions of subsection (b) of this section shall submit to the commissioner, in a form and manner prescribed by the commissioner, an actuarial certification. Each such insurance company shall maintain a copy of such actuarial certification at such insurance company&#39;s principal place of business.</p>\n   <p class=\"indent\">(f) The commissioner may adopt regulations, in accordance with chapter 54 of the general statutes, to implement the provisions of this section.</p>\n   <p class=\"indent\">Sec. 11. Subsections (a) to (c), inclusive, of section 38a-481 of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No individual health insurance policy shall be delivered or issued for delivery to any person in this state, nor shall any application, rider or endorsement be used in connection with such policy, until a copy of the form thereof and of the classification of risks and the premium rates have been filed with the commissioner. Rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience<u class=\"amendmentInsertedText\">, the requirements established in section 16 of this act</u>, and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. The commissioner may adopt regulations, in accordance with the provisions of chapter 54, to establish a procedure for reviewing such policies. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such orders. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">(b) <u class=\"amendmentInsertedText\">(1)</u> No rate filed under the provisions of subsection (a) of this section shall be effective until it has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> unfairly discriminatory <strike class=\"amendmentDeletedText\">. The commissioner may disapprove such rate if it fails to comply with such standards, except that no rate filed under the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with section 38a-474</strike>\n    <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 16 of this act</u>.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for health insurance that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 16 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) (1) No rate filed in accordance with the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with the provisions of section 38a-474.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">Sec. 12. Section 38a-513 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) <strike class=\"amendmentDeletedText\">(1)</strike> No group health insurance policy, as defined by the commissioner, or certificate shall be delivered or issued for delivery in this state unless a copy of the form for such policy or certificate has been submitted to and approved by the commissioner under the regulations adopted pursuant to this section. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, concerning the provisions, submission and approval of such policies and certificates and establishing a procedure for reviewing such policies and certificates. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such order.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) (1) No rate filed in accordance with the provisions of subsection (a) of this section shall be effective until such rate has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection or as provided under subdivision (2) of this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate, unfairly discriminatory or unaffordable pursuant to the provisions of section 16 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for a group health insurance policy that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 16 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2)</strike>\n    <u class=\"amendmentInsertedText\">(c)</u> No group health insurance policy or certificate for a small employer, as defined in section 38a-564, shall be delivered or issued for delivery in this state unless the premium rates have been submitted to and approved by the commissioner <u class=\"amendmentInsertedText\">in accordance with the provisions of section 16 of this act</u>. Premium rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience<u class=\"amendmentInsertedText\">, the requirements set forth in section 16 of this act</u>, and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. As used in this subdivision, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(b)</strike>\n    <u class=\"amendmentInsertedText\">(d)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(e)</u> Nothing in this chapter shall preclude the issuance of a group health insurance policy that includes an optional life insurance rider, provided the optional life insurance rider shall be filed with and approved by the Insurance Commissioner pursuant to section 38a-430. Any company offering such policies for sale in this state shall be licensed to sell life insurance in this state pursuant to the provisions of section 38a-41.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(d)</strike>\n    <u class=\"amendmentInsertedText\">(f)</u> Not later than January 1, 2009, the commissioner shall adopt regulations, in accordance with chapter 54, to establish minimum standards for benefits in group specified disease policies, certificates, riders, endorsements and benefits.</p>\n   <p class=\"indent\">Sec. 13. Subdivision (1) of subsection (a) of section 38a-183 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) A health care center governed by sections 38a-175 to 38a-194, inclusive, shall not enter into any agreement with subscribers unless and until <strike class=\"amendmentDeletedText\">it</strike>\n    <u class=\"amendmentInsertedText\">such health care center</u> has filed with the commissioner a full schedule of the amounts to be paid by the subscribers and has obtained the commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 16 of this act</u>. Such filing shall include the information and data required under section 38a-479qqq if the contract or policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract or policy. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such amounts to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant tothe provisions of section 16 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 14. Subsection (a) of section 38a-208 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscribers and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 16 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 16 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 15. Subsection (a) of section 38a-218 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such medical service corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscriber and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 16 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates are</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not be</u> excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 16 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 16. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health insurance policy, agreement or contract that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes, any (A) rate filed for such policy pursuant to section 38a-481 of the general statutes, as amended by this act, (B) rate filed for such policy pursuant to section 38a-513 of the general statutes, as amended by this act, (C) schedule of amounts filed for such agreement pursuant to section 38a-183 of the general statutes, as amended by this act, (D) schedule of rates filed for such contract pursuant to section 38a-208 of the general statutes, as amended by this act, or (E) schedule of rates filed for such contract pursuant to section 38a-218 of the general statutes, as amended by this act, on or after January 1, 2026, shall be filed not later than one hundred twenty calendar days prior to the proposed effective date of such rates or amounts.</p>\n   <p class=\"indent\">(2) Each filer making a rate or amount filing pursuant to this subsection shall, on the date such filer submits such rate or amount filing to the Insurance Commissioner, include with such filer&#39;s rate or amount filing an actuarial memorandum, certified by a qualified actuary, that to the best of such actuary&#39;s knowledge, (A) such rate or amount filing is in compliance with the laws of this state and federal law, as applicable, and (B) the rate or amount filing is not excessive, as described in subdivision (1) of subsection (c) of this section. For the purposes of this subparagraph, &quot;qualified actuary&quot; means a member in good standing of the American Academy of Actuaries who is qualified in accordance with the standards of the American Academy of Actuaries.</p>\n   <p class=\"indent\">(3) (A) Notwithstanding the provisions of section 38a-69a of the general statutes, the Insurance Department shall post on the department&#39;s Internet web site all documents, materials and other information provided to or requested by the department in relation to any such rate or amount filing made pursuant to this subsection, including, but not limited to, financial reports, financial statements, actuarial reports and actuarial memoranda. Such rate or amount filing and such documents, materials and other information shall be posted on such web site not later than three business days after the department receives such filing, and such posting shall be updated to include any correspondence between the department and such filer.</p>\n   <p class=\"indent\">(B) The department shall provide for a written public comment period of not less than thirty calendar days following the posting of such filing. The department shall include in such posting the date such public comment period closes and instructions for the public to submit comments to the department.</p>\n   <p class=\"indent\">(b) (1) The commissioner shall hold a public hearing for each rate or amount filed under the provisions of subdivision (1) of subsection (a) of this section. Not later than five business days after the posting of such rate or amount filing on the department&#39;s Internet web site in accordance with the provisions of subparagraph (A) of subdivision (3) of subsection (a) of this section, the commissioner shall set a public hearing date for such rate or amount filing and shall post the date, place and time of such public hearing in a conspicuous place on the department&#39;s Internet web site.</p>\n   <p class=\"indent\">(2) Such public hearing shall be (A) held after the end of the public comment period specified in subparagraph (B) of subdivision (3) of subsection (a) of this section, but not later than prior to the proposed effective date of such rate or amount, at a place and time that is convenient to the public, and (B) conducted in accordance with the provisions of chapter 54 of the general statutes, this section and section 17 of this act.</p>\n   <p class=\"indent\">(3) Upon setting the date, place and time of the public hearing for such rate or amount filing, the commissioner shall immediately notify the filer of such rate or amount filing of the date, place and time of the public hearing.</p>\n   <p class=\"indent\">(c) The commissioner shall not approve a rate or amount filing submitted in accordance with the provisions of this section if such rate or amount filing is excessive, inadequate, unfairly discriminatory or unaffordable. The commissioner shall conduct an actuarial review to determine if the methodology and assumptions used to develop such rate or amount filing are actuarially sound and in compliance with the Actuarial Standards of Practice issued by the Actuarial Standards Board.</p>\n   <p class=\"indent\">(1) Any rate or amount shall be considered excessive if it is unreasonably high for the insurance provided in relation to the underlying risks and costs after due consideration of: (A) The experience of such filer; (B) such filer&#39;s past and projected costs, including amounts to be paid for commissions; (C) any transfers of funds to the holding or parent company, subsidiary or affiliate of such filer; (D) such filer&#39;s rate of return on assets or profitability, as compared to similar filers; (E) a reasonable margin for profit and contingencies; (F) any public comments received on such filing in accordance with the provisions of subparagraph (B) of subdivision (3) of subsection (a) of this section; and (G) other factors the commissioner deems relevant.</p>\n   <p class=\"indent\">(2) Any rate or amount shall be considered inadequate if such rate or amount is unreasonably low for the insurance provided in relation to the underlying risks and costs and continued use of such rate or amount would endanger solvency of such filer.</p>\n   <p class=\"indent\">(3) Any rate or amount shall be considered unfairly discriminatory if the premium charged for any classification is not reasonably related to the underlying risks and costs, such that different premiums result for insureds with similar risks and costs.</p>\n   <p class=\"indent\">(4) Any rate or amount shall be considered unaffordable if the commissioner determines such rate or amount is inconsistent with the inflation-adjusted Connecticut Health Affordability Index commissioned by the Office of Health Strategy and the Office of the State Comptroller, or another metric jointly designated by the commissioner and the executive director of the Office of Health Strategy.</p>\n   <p class=\"indent\">(d) Not later than thirty days after such public hearing held in accordance with the provisions of subsection (b) of this section, the commissioner shall issue a written decision approving, disapproving or modifying such rate or amount filing. Such decision shall specify all factors used to reach such decision and shall be posted on the department&#39;s Internet web site not later than two business days after the commissioner issues such decision.</p>\n   <p class=\"indent\">Sec. 17. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176 and 4-177a of the general statutes, the Healthcare Advocate or the Attorney General, or both, may be parties to any public hearing held in accordance with the provisions of section 16 of this act.</p>\n   <p class=\"indent\">(b) Subject to the provisions of section 4-181 of the general statutes, (1) the Healthcare Advocate or the Attorney General, or both, shall have access to the records of the Insurance Department regarding any rate or amount filing made in accordance with the provisions of section 16 of this act, and (2) attorneys, actuaries, accountants and other experts who are part of the Insurance Commissioner&#39;s staff and who review or assist in the determination of such filing pursuant to section 16 of this act shall cooperate with the Healthcare Advocate or Attorney General, or both, to carry out the provisions of this section.</p>\n   <p class=\"indent\">(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon and examine under oath such witnesses as the Healthcare Advocate or the Attorney General deems necessary for the review of a rate or amount filing made in accordance with the provisions of section 16 of this act, and (2) require the filer or any holding or parent company or subsidiary of such filer to produce books, vouchers, memoranda, papers, letters, contracts and other documents, regardless of the format in which such materials are stored. Any such books, vouchers, memoranda, papers, letters, contracts or other documents shall be limited to such information or transactions between such filer and the holding or parent company or subsidiary that are reasonably related to the subject matter of the filing.</p>\n   <p class=\"indent\">Sec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <p class=\"indent\">Sec. 19. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <table>\n    <tr>\n     <td colspan=\"3\">This act shall take effect as follows and shall amend the following sections:<br/>\n     </td>\n    </tr>\n    <tr>\n     <td>Section 1</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 2</td>\n     <td>October 1, 2025</td>\n     <td>38a-477ee(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 3</td>\n     <td>from passage</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 4</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 5</td>\n     <td>January 1, 2026</td>\n     <td>38a-591c(a) and (b)</td>\n    </tr>\n    <tr>\n     <td>Sec. 6</td>\n     <td>January 1, 2026</td>\n     <td>38a-591e(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 7</td>\n     <td>January 1, 2026</td>\n     <td>38a-510</td>\n    </tr>\n    <tr>\n     <td>Sec. 8</td>\n     <td>January 1, 2026</td>\n     <td>38a-544</td>\n    </tr>\n    <tr>\n     <td>Sec. 9</td>\n     <td>July 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 10</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 11</td>\n     <td>January 1, 2026</td>\n     <td>38a-481(a) to (c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 12</td>\n     <td>January 1, 2026</td>\n     <td>38a-513</td>\n    </tr>\n    <tr>\n     <td>Sec. 13</td>\n     <td>January 1, 2026</td>\n     <td>38a-183(a)(1)</td>\n    </tr>\n    <tr>\n     <td>Sec. 14</td>\n     <td>January 1, 2026</td>\n     <td>38a-208(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 15</td>\n     <td>January 1, 2026</td>\n     <td>38a-218(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 16</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 17</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 18</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 19</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n   </table>\n   <p class=\"indent\">\n    <b>Statement of Purpose: </b>\n   </p>\n   <p class=\"indent\">To: (1) Establish (A) certain reporting requirements and enforcement provisions concerning compliance with mental health and substance use disorder benefit laws, and (B) the parity advancement account; (2) require health carriers to bear the burden of proving that certain health care services under adverse determination or utilization review are not medically necessary; (3) establish certain prohibitions on the use of step therapy for prescription drugs; (4) require health carriers to include certain provisions in contracts with health care providers regarding reimbursement for certain covered health benefits; (5) establish certain requirements concerning stop loss insurance policies for health care or medical benefits under any self-funded employee health benefit plan; (6) establish certain health insurance rate filing requirements and require that the Insurance Commissioner adopt regulations concerning affordability in rate filing; (7) prohibit the use of artificial intelligence to make an adverse determination based on medical necessity; and (8) prohibit any individual or group health insurance policy from imposing (A) arbitrary time limits on reimbursement for general anesthesia services, or (B) unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <table>\n    <tr>\n     <td>Co-Sponsors:</td>\n     <td>SEN. LOONEY, 11th Dist.; SEN. DUFF, 25th Dist.<br/>SEN. ANWAR, 3rd Dist.; SEN. CABRERA, 17th Dist.<br/>SEN. COHEN, 12th Dist.; SEN. FLEXER, 29th Dist.<br/>SEN. GADKAR-WILCOX, 22nd Dist.; SEN. GASTON, 23rd Dist.<br/>SEN. HOCHADEL, 13th Dist.; SEN. HONIG, 8th Dist.<br/>SEN. KUSHNER, 24th Dist.; SEN. LESSER, 9th Dist.<br/>SEN. LOPES, 6th Dist.; SEN. MAHER, 26th Dist.<br/>SEN. MARONEY, 14th Dist.; SEN. MARX, 20th Dist.<br/>SEN. MCCRORY, 2nd Dist.; SEN. MILLER P., 27th Dist.<br/>SEN. NEEDLEMAN, 33rd Dist.; SEN. OSTEN, 19th Dist.<br/>SEN. RAHMAN, 4th Dist.; SEN. SLAP, 5th Dist.<br/>SEN. WINFIELD, 10th Dist.; REP. ELLIOTT, 88th Dist.</td>\n    </tr>\n   </table>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">S.B. 10 </u>\n   </p>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Drafted by Committee  \nVersion Date: | 02/25/2025  \n  \n**STATE OF CONNECTICUT**\n\nGeneral Assembly\n\n**Committee Bill No. 10**\n\n**January Session, 2025**\n\nLCO No. **5342**\n\n*05342SB00010INS*\n\nReferred to Committee on INSURANCE AND REAL ESTATE\n\nIntroduced by:\n\n(INS)\n\nAN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nSection 1. (NEW) (Effective October 1, 2025) (a) As used in this section:\n\n(1) \"Health carrier\" has the same meaning as provided in section 38a-1080 of\nthe general statutes; and\n\n(2) \"Mental health and substance use disorder benefits\" has the same meaning\nas provided in section 38a-477ee of the general statutes, as amended by this\nact.\n\n(b) (1) Not later than March 1, 2026, and annually thereafter, each health\ncarrier shall file a certification with the Insurance Commissioner for the\nimmediately preceding calendar year, certifying that such health carrier\ncompleted a review of such health carrier's administrative practices for\ncompliance with the state and federal mental health and substance use disorder\nbenefit reporting requirements pursuant to sections 38a-477ee, as amended by\nthis act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510,\nas amended by this act, and 38a-544 of the general statutes, as amended by\nthis act, and the provisions of the federal Paul Wellstone and Pete Domenici\nMental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as\namended from time to time, and regulations adopted thereunder. Such\ncertification shall be signed by the chief executive officer and chief medical\nofficer of such health carrier.\n\n(2) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year comply\nwith the state and federal mental health and substance use disorder benefit\nreporting requirements identified in subdivision (1) of this subsection, such\ncertification filed pursuant to subdivision (1) of this subsection shall state\nsuch finding.\n\n(3) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year fail to\ncomply with the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of this\nsubsection, such certification filed pursuant to subdivision (1) of this\nsubsection shall state such finding and identify (A) each administrative\npractice of such health carrier not in compliance with such state and federal\nmental health and substance use disorder benefit reporting requirements, and\n(B) action that such health carrier will take to bring such health carrier's\nadministrative practices into compliance with such state and federal mental\nhealth and substance use disorder benefit reporting requirements.\n\nSec. 2. Subsection (c) of section 38a-477ee of the general statutes is\nrepealed and the following is substituted in lieu thereof (Effective October\n1, 2025):\n\n(c) ~~(1)~~ Not later than April 15, 2021, and annually thereafter, the\nInsurance Commissioner shall submit each report that the commissioner received\npursuant to subsection (b) of this section for the calendar year immediately\npreceding to:\n\n~~(A)~~ _(1)_ The joint standing committee of the General Assembly having\ncognizance of matters relating to insurance, in accordance with section 11-4a;\nand\n\n~~(B)~~ _(2)_ The Attorney General, Healthcare Advocate and Commissioner of\nHealth Strategy.\n\n~~(2) Notwithstanding subdivision (1) of this subsection, the commissioner\nshall not submit the name or identity of any health carrier or entity that has\ncontracted with such health carrier, and such name or identity shall be given\nconfidential treatment and not be made public by the commissioner.~~\n\nSec. 3. (NEW) (Effective from passage) There is established an account to be\nknown as the \"parity advancement account\" which shall be a separate,\nnonlapsing account within the General Fund. The account shall contain any\nmoneys required by law to be deposited in the account and may receive\ndonations from public or private sources. Moneys in the account shall be\nexpended by the Insurance Department, beginning with the fiscal year ending\nJune 30, 2026, for the purposes of enforcing the state and federal mental\nhealth and substance use disorder benefit reporting requirements identified in\nsubdivision (1) of subsection (b) of section 1 of this act, conducting\nconsumer education and other initiatives that support mental health parity\nimplementation and enforcement on behalf of consumers.\n\nSec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after\nproviding an opportunity for a hearing in accordance with chapter 54 of the\ngeneral statutes, may impose a civil penalty on any health carrier of not more\nthan one hundred dollars with respect to each participant or beneficiary\ncovered under a health insurance policy of such health carrier, provided such\npenalty shall not exceed an aggregate amount of one million dollars annually,\nfor such health carrier's failure to comply with the certification\nrequirements pursuant to the provisions of section 1 of this act, or the state\nand federal mental health and substance use disorder benefit reporting\nrequirements identified in subdivision (1) of subsection (b) of section 1 of\nthis act.\n\n(2) The commissioner may order the payment of such reasonable expenses as may\nbe necessary to compensate the commissioner in conjunction with any\nproceedings under this section, which shall be dedicated to the enforcement\nand implementation of the state and federal mental health parity laws and\nregulations adopted thereunder.\n\n(b) (1) If any health carrier fails to file any data, report, certification or\nother information required by the provisions of section 38a-477ee of the\ngeneral statutes, as amended by this act, or section 1 of this act, the\ncommissioner shall impose a late fee on such health carrier of one hundred\ndollars per day from the due date of such filing of data, report,\ncertification or information to the date such health carrier submits such\nfiling to the commissioner.\n\n(2) For any health carrier that files any incomplete data, report,\ncertification or other information required by the provisions of section\n38a-477ee of the general statutes, as amended by this act, and section 1 of\nthis act, the commissioner shall provide notice to such health carrier of such\nincomplete filing that includes (A) a description of such data, report,\ncertification or other information that is incomplete and any additional data\nthat is needed to consider such filing complete, and (B) the date by which\nsuch health carrier is required to provide such data. The commissioner shall\nimpose a late fee on such health carrier of one hundred dollars per day,\ncommencing from the date identified by the commissioner pursuant to\nsubparagraph (B) of this subdivision.\n\n(c) The commissioner may waive any civil penalty imposed pursuant to\nsubsection (a) of this section if the commissioner determines that the\nviolation was due to reasonable cause and was not due to wilful neglect, or if\nsuch violation is corrected not more than thirty days after the date that the\nhealth carrier filed a certification of noncompliance with the commissioner\npursuant to section 1 of this act.\n\n(d) All civil penalties and late fees received by the commissioner pursuant to\nthis section shall be deposited in the General Fund and credited to the parity\nadvancement account established pursuant to section 3 of this act.\n\nSec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes\nare repealed and the following is substituted in lieu thereof (Effective\nJanuary 1, 2026):\n\n(a) (1) Each health carrier shall contract with (A) health care professionals\nto administer such health carrier's utilization review program, and (B)\nclinical peers to evaluate the clinical appropriateness of an adverse\ndetermination.\n\n(2) (A) Each utilization review program shall use documented clinical review\ncriteria that are based on sound clinical evidence and are evaluated\nperiodically by the health carrier's organizational mechanism specified in\nsubparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to\n~~assure~~ _ensure_ such program's ongoing effectiveness.\n\n(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a\nhealth carrier may develop its own clinical review criteria or it may purchase\nor license clinical review criteria from qualified vendors approved by the\ncommissioner, provided such clinical review criteria conform to the\nrequirements of subparagraph (A) of this subdivision.\n\n(C) Each health carrier shall (i) post on its Internet web site (I) any\nclinical review criteria it uses, and (II) links to any rule, guideline,\nprotocol or other similar criterion a health carrier may rely upon to make an\nadverse determination as described in subparagraph (F) of subdivision (1) of\nsubsection (e) of section 38a-591d, and (ii) make its clinical review criteria\navailable upon request to authorized government agencies.\n\n_(D) For each utilization review, there shall be a rebuttable presumption that\neach health care service under review is medically necessary if such health\ncare service was ordered by a health care professional acting within such\nhealth care professional 's scope of practice. Any utilization review company\nperforming such review of a health care service shall have the burden of\nproving that such health care service is not medically necessary._\n\n(3) For any utilization review for the treatment of a substance use disorder,\nas described in section 17a-458, the clinical review criteria used shall be:\n(A) The most recent edition of the American Society of Addiction Medicine\nTreatment Criteria for Addictive, Substance-Related, and Co-Occurring\nConditions; or (B) clinical review criteria that the health carrier\ndemonstrates to the Insurance Department is consistent with the most recent\nedition of the American Society of Addiction Medicine Treatment Criteria for\nAddictive, Substance-Related, and Co-Occurring Conditions, except that nothing\nin this subdivision shall prohibit a health carrier from developing its own\nclinical review criteria or purchasing or licensing additional clinical review\ncriteria from qualified vendors approved by the commissioner, to address\nadvancements in technology or types of care for the treatment of a substance\nuse disorder, that are not covered in the most recent edition of the American\nSociety of Addiction Medicine Treatment Criteria for Addictive, Substance-\nRelated, and Co-Occurring Conditions. Any such clinical review criteria\ndeveloped by a health carrier or purchased or licensed from a qualified vendor\nshall conform to the requirements of subparagraph (A) of subdivision (2) of\nthis subsection.\n\n(4) For any utilization review for the treatment of a child or adolescent\nmental disorder, the clinical review criteria used shall be: (A) The most\nrecent guidelines of the American Academy of Child and Adolescent Psychiatry's\nChild and Adolescent Service Intensity Instrument; or (B) clinical review\ncriteria that the health carrier demonstrates to the Insurance Department is\nconsistent with the most recent guidelines of the American Academy of Child\nand Adolescent Psychiatry's Child and Adolescent Service Intensity Instrument,\nexcept that nothing in this subdivision shall prohibit a health carrier from\ndeveloping its own clinical review criteria or purchasing or licensing\nadditional clinical review criteria from qualified vendors approved by the\ncommissioner, to address advancements in technology or types of care for the\ntreatment of a child or adolescent mental disorder, that are not covered in\nthe most recent guidelines of the American Academy of Child and Adolescent\nPsychiatry's Child and Adolescent Service Intensity Instrument. Any such\nclinical review criteria developed by a health carrier or purchased or\nlicensed from a qualified vendor shall conform to the requirements of\nsubparagraph (A) of subdivision (2) of this subsection.\n\n(5) For any utilization review for the treatment of an adult mental disorder,\nthe clinical review criteria used shall be: (A) The most recent guidelines of\nthe American Psychiatric Association or the most recent Standards and\nGuidelines of the Association for Ambulatory Behavioral Healthcare; or (B)\nclinical review criteria that the health carrier demonstrates to the Insurance\nDepartment is consistent with the most recent guidelines of the American\nPsychiatric Association or the most recent Standards and Guidelines of the\nAssociation for Ambulatory Behavioral Healthcare, except that nothing in this\nsubdivision shall prohibit a health carrier from developing its own clinical\nreview criteria or purchasing or licensing additional clinical review criteria\nfrom qualified vendors approved by the commissioner, to address advancements\nin technology or types of care for the treatment of an adult mental disorder,\nthat are not covered in the most recent guidelines of the American Psychiatric\nAssociation or the most recent Standards and Guidelines of the Association for\nAmbulatory Behavioral Healthcare. Any such clinical review criteria developed\nby a health carrier or purchased or licensed from a qualified vendor shall\nconform to the requirements of subparagraph (A) of subdivision (2) of this\nsubsection.\n\n(b) Each health carrier shall:\n\n(1) Have procedures in place to ensure that (A) the health care professionals\nadministering such health carrier's utilization review program are applying\nthe clinical review criteria consistently in utilization review\ndeterminations, and (B) the appropriate or required individual or individuals\nare being designated to conduct utilization reviews;\n\n(2) Have data systems sufficient to support utilization review program\nactivities and to generate management reports to enable the health carrier to\nmonitor and manage health care services effectively;\n\n(3) Provide covered persons and participating providers with access to its\nutilization review staff through a toll-free telephone number or any other\nfree calling option or by electronic means;\n\n(4) Coordinate the utilization review program with other medical management\nactivity conducted by the health carrier, such as quality assurance,\ncredentialing, contracting with health care professionals, data reporting,\ngrievance procedures, processes for assessing member satisfaction and risk\nmanagement; ~~and~~\n\n(5) Routinely assess the effectiveness and efficiency of its utilization\nreview program _; and_\n\n_(6) Not use any system that employs artificial intelligence, as defined in\nsection 51-10e, or any other algorithm in lieu of a review by a clinical peer\nto evaluate the clinical appropriateness of an adverse determination pursuant\nto a contract between such clinical peer and such health carrier_.\n\nSec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(c) (1) (A) When conducting a review of an adverse determination under this\nsection, the health carrier shall ensure that such review is conducted in a\nmanner to ensure the independence and impartiality of the clinical peer or\npeers involved in making the review decision.\n\n(B) If the adverse determination involves utilization review, the health\ncarrier shall designate an appropriate clinical peer or peers to review such\nadverse determination. Such clinical peer or peers shall not have been\ninvolved in the initial adverse determination.\n\n_(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D)\nof subdivision (1) of subsection (a) of section 38a-591c, as amended by this\nact, the health carrier may rebut such presumption by reasonably\nsubstantiating to the clinical peer or peers conducting the review pursuant to\nthe provisions of this section that such health care service is not medically\nnecessary._\n\n~~(C)~~ _(ii)_ The clinical peer or peers conducting a review under this\nsection shall take into consideration all comments, documents, records and\nother information relevant to the covered person's benefit request that is the\nsubject of the adverse determination under review, that are submitted by the\ncovered person or the covered person's authorized representative, regardless\nof whether such information was submitted or considered in making the initial\nadverse determination.\n\n(D) Prior to issuing a decision, the health carrier shall provide free of\ncharge, by facsimile, electronic means or any other expeditious method\navailable, to the covered person or the covered person's authorized\nrepresentative, as applicable, any new or additional documents,\ncommunications, information and evidence relied upon and any new or additional\nscientific or clinical rationale used by the health carrier in connection with\nthe grievance. Such documents, communications, information, evidence and\nrationale shall be provided sufficiently in advance of the date the health\ncarrier is required to issue a decision to permit the covered person or the\ncovered person's authorized representative, as applicable, a reasonable\nopportunity to respond prior to such date.\n\n(2) If the review under subdivision (1) of this subsection is an expedited\nreview, all necessary information, including the health carrier's decision,\nshall be transmitted between the health carrier and the covered person or the\ncovered person's authorized representative, as applicable, by telephone,\nfacsimile, electronic means or any other expeditious method available.\n\n(3) If the review under subdivision (1) of this subsection is an expedited\nreview of a grievance involving an adverse determination of a concurrent\nreview request, pursuant to 45 CFR 147.136, as amended from time to time, the\ntreatment shall be continued without liability to the covered person until the\ncovered person has been notified of the review decision.\n\nSec. 7. Section 38a-510 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing an individual health insurance\npolicy or contract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) ~~for a prescribed drug for cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _for a prescribed drug for the treatment of a disabling or life-\nthreatening chronic disease or condition,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications,\n~~or~~ (C) for the period commencing January 1, 2024, and ending January 1,\n2027, inclusive, for the treatment of schizophrenia, major depressive disorder\nor bipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\"_, or (D) for a prescribed drug for the treatment of a mental or\nbehavioral health condition, provided such prescribed drug is in compliance\nwith approved federal Food and Drug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-492i.\n\nSec. 8. Section 38a-544 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing a group health insurance policy or\ncontract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) ~~for a prescribed drug for cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _for a prescribed drug for the treatment of a disabling or life-\nthreatening chronic disease or condition,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications,\n~~or~~ (C) for the period commencing January 1, 2024, and ending January 1,\n2027, inclusive, for the treatment of schizophrenia, major depressive disorder\nor bipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\"_, or (D) for a prescribed drug for the treatment of a mental or\nbehavioral health condition, provided such prescribed drug is in compliance\nwith approved federal Food and Drug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-518i.\n\nSec. 9 (NEW) (Effective July 1, 2026) (a) Each insurer, health care center,\nhospital service corporation, medical service corporation, preferred provider\nnetwork or other entity that enters into, renews or amends a contract with a\nhealth care provider on or after July 1, 2026, to provide covered benefits to\ninsureds or enrollees in this state shall include in such contract:\n\n(1) A provision requiring such insurer, health care center, hospital service\ncorporation, medical service corporation, preferred provider network or other\nentity to:\n\n(A) Reimburse the contracting health care provider for a covered outpatient\nbenefit that uses a current procedural terminology evaluation and management\n(CPT E/M) code, current procedural terminology assessment and management (CPT\nA/M) code or drug infusion code in an amount that does not vary based on the\nfacility where the contracting health care provider provides such benefit; and\n\n(B) Use equal reimbursement rates for all contracting health care providers in\nthe same geographic region, as determined by the Insurance Commissioner, in\naccordance with the provisions of chapter 54 of the general statutes, and\nregardless of the employer or affiliation of any contracting health care\nprovider, for each covered outpatient benefit described in subparagraph (A) of\nthis subdivision if the reimbursement for such covered outpatient benefit is\nmade on a fee-for-benefit basis or on the basis of bundled benefits per\ndiagnosis, condition, procedure or another standardized bundle of health care\nbenefits; and\n\n(2) A conspicuous statement that such contract complies with the provisions of\nsubdivision (1) of this subsection.\n\n(b) The Insurance Commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54 of the general statutes, to implement the provisions\nof this section, including, but not limited to, the establishment of\ngeographic regions pursuant to the provisions of subparagraph (B) of\nsubdivision (1) of subsection (a) of this section.\n\nSec. 10. (NEW) (Effective January 1, 2026) (a) For the purposes of this\nsection:\n\n(1) \"Actuarial certification\" means a written statement by a member of the\nAmerican Academy of Actuaries or other individual acceptable to the\ncommissioner that the member or individual has (A) examined an insurance\ncompany's books, records, procedures and practices concerning, at a minimum,\nthe company's actuarial assumptions and methods used to establish attachment\npoints and other terms of a stop loss insurance policy for health care or\nmedical benefits, and (B) determined, on the basis of such examination, that\nthe company is in compliance with this section and all regulations adopted\nunder subsection (f) of this section;\n\n(2) \"Affordable Care Act\" has the same meaning as provided in section 38a-1080\nof the general statutes;\n\n(3) \"Attachment point\" means the dollar value of claims incurred by a\npolicyholder at which the insurer that issues or delivers a medical stop loss\ninsurance policy to the policyholder incurs liability to such policyholder for\npayment under such medical stop loss insurance policy;\n\n(4) \"Expected claims\" means the dollar value of claims that, in the absence of\na medical stop loss insurance policy, the policyholder of such medical stop\nloss insurance policy is projected to incur under such policyholder's self-\nfunded employee health benefit plan;\n\n(5) \"Large employer\" has the same meaning as provided in section 1304 of the\nAffordable Care Act, as amended from time to time; and\n\n(6) \"Small employer\" has the same meaning as provided in section 1304 of the\nAffordable Care Act, as amended from time to time.\n\n(b) (1) Except as provided in subdivision (2) of this subsection, on and after\nJanuary 1, 2026, no insurance company shall deliver, issue for delivery,\nrenew, amend or continue in this state any stop loss insurance policy for\nhealth care or medical benefits under any self-funded employee health benefit\nplan unless such self-funded employee health benefit plan provides coverage\nfor (A) essential health benefits as required by section 38a-492q of the\ngeneral statutes, and (B) the group state-mandated coverage requirements under\nchapter 700c of the general statutes.\n\n(2) Notwithstanding the provisions of subdivision (1) of this subsection, on\nand after January 1, 2026, any insurance company may deliver, issue for\ndelivery, renew, amend or continue in this state a stop loss insurance policy\nfor health care or medical benefits under any self-funded employee health\nbenefit plan, provided such stop loss insurance policy does not:\n\n(A) Have an annual attachment point for claims incurred per covered individual\nthat is less than fifty thousand dollars;\n\n(B) For a small employer, have an annual aggregate attachment point that is\nless than fifty thousand dollars, ten thousand dollars multiplied by the\nnumber of covered individuals or one hundred twenty per cent of expected\nclaims, whichever is greater;\n\n(C) For a large employer, have an annual aggregate attachment point that is\nless than one hundred ten per cent of expected claims; or\n\n(D) Provide direct coverage for the health care or medical expenses of an\nindividual.\n\n(c) If an insurance company delivers, issues for delivery, renews, amends or\ncontinues any employer's stop loss insurance policy for health care or medical\nbenefits in this state that satisfies the requirements pursuant to subsection\n(b) of this section, such insurance company shall determine, at least\nannually, the number of such employer's employees.\n\n(d) The commissioner shall, not less than biennially, compute the attachment\npoints established pursuant to subparagraphs (A) to (C), inclusive, of\nsubdivision (2) of subsection (b) of this section based on the percentage\nincrease, if any, in the most recent calendar year average in the consumer\nprice index for all urban consumers, and publish on the commissioner's\nInternet web site any change in such attachment point not less than six months\nbefore the effective date of any such change in attachment point.\n\n(e) Not later than March fifteenth annually, each insurance company that\ndelivers, issues for delivery, renews, amends or continues an employer's stop\nloss insurance policy for health care or medical benefits under any self-\nfunded employee health benefit plan that satisfies the provisions of\nsubsection (b) of this section shall submit to the commissioner, in a form and\nmanner prescribed by the commissioner, an actuarial certification. Each such\ninsurance company shall maintain a copy of such actuarial certification at\nsuch insurance company's principal place of business.\n\n(f) The commissioner may adopt regulations, in accordance with chapter 54 of\nthe general statutes, to implement the provisions of this section.\n\nSec. 11. Subsections (a) to (c), inclusive, of section 38a-481 of the general\nstatutes are repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) No individual health insurance policy shall be delivered or issued for\ndelivery to any person in this state, nor shall any application, rider or\nendorsement be used in connection with such policy, until a copy of the form\nthereof and of the classification of risks and the premium rates have been\nfiled with the commissioner. Rate filings shall include the information and\ndata required under section 38a-479qqq if the policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience _, the requirements established in\nsection 16 of this act_ , and premium rates and loss ratios from the inception\nof the policy. Each premium rate filed on or after January 1, 2021, shall, if\nthe insurer intends to account for rebates, as defined in section 38a-479ooo\nin the manner specified in section 38a-479rrr, account for such rebates in\nsuch manner, if the policy is subject to section 38a-479rrr. The commissioner\nmay adopt regulations, in accordance with the provisions of chapter 54, to\nestablish a procedure for reviewing such policies. The commissioner shall\ndisapprove the use of such form at any time if it does not comply with the\nrequirements of law, or if it contains a provision or provisions that are\nunfair or deceptive or that encourage misrepresentation of the policy. The\ncommissioner shall notify, in writing, the insurer that has filed any such\nform of the commissioner's disapproval, specifying the reasons for\ndisapproval, and ordering that no such insurer shall deliver or issue for\ndelivery to any person in this state a policy on or containing such form. The\nprovisions of section 38a-19 shall apply to such orders. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\n(b) _(1)_ No rate filed under the provisions of subsection (a) of this section\nshall be effective until it has been approved by the commissioner in\naccordance with regulations adopted pursuant to this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate _,_ ~~or~~ unfairly discriminatory ~~. The commissioner\nmay disapprove such rate if it fails to comply with such standards, except\nthat no rate filed under the provisions of subsection (a) of this section for\nany Medicare supplement policy shall be effective unless approved in\naccordance with section 38a-474~~ _or unaffordable pursuant to the provisions\nof section 16 of this act_.\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for health insurance that provides coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be\napproved in accordance with the provisions of section 16 of this act._\n\n_(c) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section for any Medicare supplement policy shall be effective unless\napproved in accordance with the provisions of section 38a-474._\n\n~~(c)~~ _(2)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\nSec. 12. Section 38a-513 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) ~~(1)~~ No group health insurance policy, as defined by the commissioner,\nor certificate shall be delivered or issued for delivery in this state unless\na copy of the form for such policy or certificate has been submitted to and\napproved by the commissioner under the regulations adopted pursuant to this\nsection. The commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54, concerning the provisions, submission and approval\nof such policies and certificates and establishing a procedure for reviewing\nsuch policies and certificates. The commissioner shall disapprove the use of\nsuch form at any time if it does not comply with the requirements of law, or\nif it contains a provision or provisions that are unfair or deceptive or that\nencourage misrepresentation of the policy. The commissioner shall notify, in\nwriting, the insurer that has filed any such form of the commissioner's\ndisapproval, specifying the reasons for disapproval, and ordering that no such\ninsurer shall deliver or issue for delivery to any person in this state a\npolicy on or containing such form. The provisions of section 38a-19 shall\napply to such order.\n\n_(b) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section shall be effective until such rate has been approved by the\ncommissioner in accordance with regulations adopted pursuant to this\nsubsection or as provided under subdivision (2) of this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate, unfairly discriminatory or unaffordable pursuant to the\nprovisions of section 16 of this act._\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for a group health insurance policy that provides coverage of the\ntype specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469\nshall be approved in accordance with the provisions of section 16 of this\nact._\n\n~~(2)~~ _(c)_ No group health insurance policy or certificate for a small\nemployer, as defined in section 38a-564, shall be delivered or issued for\ndelivery in this state unless the premium rates have been submitted to and\napproved by the commissioner _in accordance with the provisions of section 16\nof this act_. Premium rate filings shall include the information and data\nrequired under section 38a-479qqq if the policy is subject to said section,\nand an actuarial memorandum that includes, but is not limited to, pricing\nassumptions and claims experience _, the requirements set forth in section 16\nof this act_ , and premium rates and loss ratios from the inception of the\npolicy. Each premium rate filed on or after January 1, 2021, shall, if the\ninsurer intends to account for rebates, as defined in section 38a-479ooo in\nthe manner specified in section 38a-479rrr, account for such rebates in such\nmanner, if the policy is subject to section 38a-479rrr. As used in this\nsubdivision, \"loss ratio\" means the ratio of incurred claims to earned\npremiums by the number of years of policy duration for all combined durations.\n\n~~(b)~~ _(d)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\n~~(c)~~ _(e)_ Nothing in this chapter shall preclude the issuance of a group\nhealth insurance policy that includes an optional life insurance rider,\nprovided the optional life insurance rider shall be filed with and approved by\nthe Insurance Commissioner pursuant to section 38a-430. Any company offering\nsuch policies for sale in this state shall be licensed to sell life insurance\nin this state pursuant to the provisions of section 38a-41.\n\n~~(d)~~ _(f)_ Not later than January 1, 2009, the commissioner shall adopt\nregulations, in accordance with chapter 54, to establish minimum standards for\nbenefits in group specified disease policies, certificates, riders,\nendorsements and benefits.\n\nSec. 13. Subdivision (1) of subsection (a) of section 38a-183 of the general\nstatutes is repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) (1) A health care center governed by sections 38a-175 to 38a-194,\ninclusive, shall not enter into any agreement with subscribers unless and\nuntil ~~it~~ _such health care center_ has filed with the commissioner a full\nschedule of the amounts to be paid by the subscribers and has obtained the\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 16 of this act_. Such filing shall include the information and data\nrequired under section 38a-479qqq if the contract or policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience, and premium rates and loss ratios\nfrom the inception of the contract or policy. The commissioner ~~may refuse\nsuch approval if the commissioner finds such amounts to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant tothe provisions of section 16\nof this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 14. Subsection (a) of section 38a-208 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such corporation shall enter into any contract with subscribers unless\nand until it has filed with the Insurance Commissioner a full schedule of the\nrates to be paid by the subscribers and has obtained said commissioner's\napproval ~~thereof~~ _in accordance with the provisions of section 16 of this\nact_. Such filing shall include an actuarial memorandum that includes, but is\nnot limited to, pricing assumptions and claims experience, and premium rates\nand loss ratios from the inception of the contract. The commissioner ~~may\nrefuse such approval if the commissioner finds such rates to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant to the provisions of section\n16 of this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 15. Subsection (a) of section 38a-218 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such medical service corporation shall enter into any contract with\nsubscribers unless and until it has filed with the Insurance Commissioner a\nfull schedule of the rates to be paid by the subscriber and has obtained said\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 16 of this act_. Such filing shall include an actuarial memorandum\nthat includes, but is not limited to, pricing assumptions and claims\nexperience, and premium rates and loss ratios from the inception of the\ncontract. The commissioner ~~may refuse such approval if the commissioner\nfinds such rates are~~ _shall adopt regulations, in accordance with the\nprovisions of chapter 54, to prescribe standards to ensure that such amounts\nshall not be_ excessive, inadequate _,_ ~~or~~ discriminatory _or unaffordable\npursuant to the provisions of section 16 of this act_. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\nSec. 16. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health\ninsurance policy, agreement or contract that provides coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes, any (A) rate filed for such policy pursuant to section\n38a-481 of the general statutes, as amended by this act, (B) rate filed for\nsuch policy pursuant to section 38a-513 of the general statutes, as amended by\nthis act, (C) schedule of amounts filed for such agreement pursuant to section\n38a-183 of the general statutes, as amended by this act, (D) schedule of rates\nfiled for such contract pursuant to section 38a-208 of the general statutes,\nas amended by this act, or (E) schedule of rates filed for such contract\npursuant to section 38a-218 of the general statutes, as amended by this act,\non or after January 1, 2026, shall be filed not later than one hundred twenty\ncalendar days prior to the proposed effective date of such rates or amounts.\n\n(2) Each filer making a rate or amount filing pursuant to this subsection\nshall, on the date such filer submits such rate or amount filing to the\nInsurance Commissioner, include with such filer's rate or amount filing an\nactuarial memorandum, certified by a qualified actuary, that to the best of\nsuch actuary's knowledge, (A) such rate or amount filing is in compliance with\nthe laws of this state and federal law, as applicable, and (B) the rate or\namount filing is not excessive, as described in subdivision (1) of subsection\n(c) of this section. For the purposes of this subparagraph, \"qualified\nactuary\" means a member in good standing of the American Academy of Actuaries\nwho is qualified in accordance with the standards of the American Academy of\nActuaries.\n\n(3) (A) Notwithstanding the provisions of section 38a-69a of the general\nstatutes, the Insurance Department shall post on the department's Internet web\nsite all documents, materials and other information provided to or requested\nby the department in relation to any such rate or amount filing made pursuant\nto this subsection, including, but not limited to, financial reports,\nfinancial statements, actuarial reports and actuarial memoranda. Such rate or\namount filing and such documents, materials and other information shall be\nposted on such web site not later than three business days after the\ndepartment receives such filing, and such posting shall be updated to include\nany correspondence between the department and such filer.\n\n(B) The department shall provide for a written public comment period of not\nless than thirty calendar days following the posting of such filing. The\ndepartment shall include in such posting the date such public comment period\ncloses and instructions for the public to submit comments to the department.\n\n(b) (1) The commissioner shall hold a public hearing for each rate or amount\nfiled under the provisions of subdivision (1) of subsection (a) of this\nsection. Not later than five business days after the posting of such rate or\namount filing on the department's Internet web site in accordance with the\nprovisions of subparagraph (A) of subdivision (3) of subsection (a) of this\nsection, the commissioner shall set a public hearing date for such rate or\namount filing and shall post the date, place and time of such public hearing\nin a conspicuous place on the department's Internet web site.\n\n(2) Such public hearing shall be (A) held after the end of the public comment\nperiod specified in subparagraph (B) of subdivision (3) of subsection (a) of\nthis section, but not later than prior to the proposed effective date of such\nrate or amount, at a place and time that is convenient to the public, and (B)\nconducted in accordance with the provisions of chapter 54 of the general\nstatutes, this section and section 17 of this act.\n\n(3) Upon setting the date, place and time of the public hearing for such rate\nor amount filing, the commissioner shall immediately notify the filer of such\nrate or amount filing of the date, place and time of the public hearing.\n\n(c) The commissioner shall not approve a rate or amount filing submitted in\naccordance with the provisions of this section if such rate or amount filing\nis excessive, inadequate, unfairly discriminatory or unaffordable. The\ncommissioner shall conduct an actuarial review to determine if the methodology\nand assumptions used to develop such rate or amount filing are actuarially\nsound and in compliance with the Actuarial Standards of Practice issued by the\nActuarial Standards Board.\n\n(1) Any rate or amount shall be considered excessive if it is unreasonably\nhigh for the insurance provided in relation to the underlying risks and costs\nafter due consideration of: (A) The experience of such filer; (B) such filer's\npast and projected costs, including amounts to be paid for commissions; (C)\nany transfers of funds to the holding or parent company, subsidiary or\naffiliate of such filer; (D) such filer's rate of return on assets or\nprofitability, as compared to similar filers; (E) a reasonable margin for\nprofit and contingencies; (F) any public comments received on such filing in\naccordance with the provisions of subparagraph (B) of subdivision (3) of\nsubsection (a) of this section; and (G) other factors the commissioner deems\nrelevant.\n\n(2) Any rate or amount shall be considered inadequate if such rate or amount\nis unreasonably low for the insurance provided in relation to the underlying\nrisks and costs and continued use of such rate or amount would endanger\nsolvency of such filer.\n\n(3) Any rate or amount shall be considered unfairly discriminatory if the\npremium charged for any classification is not reasonably related to the\nunderlying risks and costs, such that different premiums result for insureds\nwith similar risks and costs.\n\n(4) Any rate or amount shall be considered unaffordable if the commissioner\ndetermines such rate or amount is inconsistent with the inflation-adjusted\nConnecticut Health Affordability Index commissioned by the Office of Health\nStrategy and the Office of the State Comptroller, or another metric jointly\ndesignated by the commissioner and the executive director of the Office of\nHealth Strategy.\n\n(d) Not later than thirty days after such public hearing held in accordance\nwith the provisions of subsection (b) of this section, the commissioner shall\nissue a written decision approving, disapproving or modifying such rate or\namount filing. Such decision shall specify all factors used to reach such\ndecision and shall be posted on the department's Internet web site not later\nthan two business days after the commissioner issues such decision.\n\nSec. 17. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176\nand 4-177a of the general statutes, the Healthcare Advocate or the Attorney\nGeneral, or both, may be parties to any public hearing held in accordance with\nthe provisions of section 16 of this act.\n\n(b) Subject to the provisions of section 4-181 of the general statutes, (1)\nthe Healthcare Advocate or the Attorney General, or both, shall have access to\nthe records of the Insurance Department regarding any rate or amount filing\nmade in accordance with the provisions of section 16 of this act, and (2)\nattorneys, actuaries, accountants and other experts who are part of the\nInsurance Commissioner's staff and who review or assist in the determination\nof such filing pursuant to section 16 of this act shall cooperate with the\nHealthcare Advocate or Attorney General, or both, to carry out the provisions\nof this section.\n\n(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon\nand examine under oath such witnesses as the Healthcare Advocate or the\nAttorney General deems necessary for the review of a rate or amount filing\nmade in accordance with the provisions of section 16 of this act, and (2)\nrequire the filer or any holding or parent company or subsidiary of such filer\nto produce books, vouchers, memoranda, papers, letters, contracts and other\ndocuments, regardless of the format in which such materials are stored. Any\nsuch books, vouchers, memoranda, papers, letters, contracts or other documents\nshall be limited to such information or transactions between such filer and\nthe holding or parent company or subsidiary that are reasonably related to the\nsubject matter of the filing.\n\nSec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No individual health insurance policy providing coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes delivered, issued for delivery, renewed, amended or\ncontinued in this state on or after January 1, 2026, shall (1) if such policy\nprovides coverage for general anesthesia, (A) impose an arbitrary time limit\non reimbursement for general anesthesia provided during any medically\nnecessary procedure, or (B) deny, reduce, terminate or fail to provide such\nreimbursement, in whole or in part, for general anesthesia solely because the\nduration of care exceeded a predetermined time limit as determined by the\ninsurer, or (2) impose unilateral arbitrary limitations on reimbursement for\nmedically necessary ancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nSec. 19. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No group health insurance policy providing coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general\nstatutes delivered, issued for delivery, renewed, amended or continued in this\nstate on or after January 1, 2026, shall (1) if such policy provides coverage\nfor general anesthesia, (A) impose an arbitrary time limit on reimbursement\nfor general anesthesia provided during any medically necessary procedure, or\n(B) deny, reduce, terminate or fail to provide such reimbursement, in whole or\nin part, for general anesthesia solely because the duration of care exceeded a\npredetermined time limit as determined by the insurer, or (2) impose\nunilateral arbitrary limitations on reimbursement for medically necessary\nancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nThis act shall take effect as follows and shall amend the following sections:  \n  \n---  \nSection 1 | October 1, 2025 | New section  \nSec. 2 | October 1, 2025 | 38a-477ee(c)  \nSec. 3 | from passage | New section  \nSec. 4 | October 1, 2025 | New section  \nSec. 5 | January 1, 2026 | 38a-591c(a) and (b)  \nSec. 6 | January 1, 2026 | 38a-591e(c)  \nSec. 7 | January 1, 2026 | 38a-510  \nSec. 8 | January 1, 2026 | 38a-544  \nSec. 9 | July 1, 2026 | New section  \nSec. 10 | January 1, 2026 | New section  \nSec. 11 | January 1, 2026 | 38a-481(a) to (c)  \nSec. 12 | January 1, 2026 | 38a-513  \nSec. 13 | January 1, 2026 | 38a-183(a)(1)  \nSec. 14 | January 1, 2026 | 38a-208(a)  \nSec. 15 | January 1, 2026 | 38a-218(a)  \nSec. 16 | January 1, 2026 | New section  \nSec. 17 | January 1, 2026 | New section  \nSec. 18 | January 1, 2026 | New section  \nSec. 19 | January 1, 2026 | New section  \n  \n**Statement of Purpose:**\n\nTo: (1) Establish (A) certain reporting requirements and enforcement\nprovisions concerning compliance with mental health and substance use disorder\nbenefit laws, and (B) the parity advancement account; (2) require health\ncarriers to bear the burden of proving that certain health care services under\nadverse determination or utilization review are not medically necessary; (3)\nestablish certain prohibitions on the use of step therapy for prescription\ndrugs; (4) require health carriers to include certain provisions in contracts\nwith health care providers regarding reimbursement for certain covered health\nbenefits; (5) establish certain requirements concerning stop loss insurance\npolicies for health care or medical benefits under any self-funded employee\nhealth benefit plan; (6) establish certain health insurance rate filing\nrequirements and require that the Insurance Commissioner adopt regulations\nconcerning affordability in rate filing; (7) prohibit the use of artificial\nintelligence to make an adverse determination based on medical necessity; and\n(8) prohibit any individual or group health insurance policy from imposing (A)\narbitrary time limits on reimbursement for general anesthesia services, or (B)\nunilateral arbitrary limitations on reimbursement for medically necessary\nancillary services.\n\nCo-Sponsors: | SEN. LOONEY, 11th Dist.; SEN. DUFF, 25th Dist.  \nSEN. ANWAR, 3rd Dist.; SEN. CABRERA, 17th Dist.  \nSEN. COHEN, 12th Dist.; SEN. FLEXER, 29th Dist.  \nSEN. GADKAR-WILCOX, 22nd Dist.; SEN. GASTON, 23rd Dist.  \nSEN. HOCHADEL, 13th Dist.; SEN. HONIG, 8th Dist.  \nSEN. KUSHNER, 24th Dist.; SEN. LESSER, 9th Dist.  \nSEN. LOPES, 6th Dist.; SEN. MAHER, 26th Dist.  \nSEN. MARONEY, 14th Dist.; SEN. MARX, 20th Dist.  \nSEN. MCCRORY, 2nd Dist.; SEN. MILLER P., 27th Dist.  \nSEN. NEEDLEMAN, 33rd Dist.; SEN. OSTEN, 19th Dist.  \nSEN. RAHMAN, 4th Dist.; SEN. SLAP, 5th Dist.  \nSEN. WINFIELD, 10th Dist.; REP. ELLIOTT, 88th Dist.  \n---|---  \n  \n_S.B. 10_\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": false
    },
    {
      "date": "04/02/2025",
      "label": "Reissued",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250402_0_RI&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Reissued</td></tr> <tr><td class=\"label\">Version Date:</td> <td>04/02/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">General Assembly</p>\n   <p class=\"center\">File No. 419</p>\n   <p class=\"center\">\n    <b>January Session, 2025</b>\n   </p>\n   <p class=\"center\">Substitute Senate Bill No. 10</p>\n   <p class=\"center\">Senate, April 2, 2025</p>\n   <p class=\"center\">The Committee on Insurance and Real Estate reported through SEN. CABRERA of the 17th Dist., Chairperson of the Committee on the part of the Senate, that the substitute bill ought to pass.</p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <p class=\"indent\">Section 1. (NEW) (Effective October 1, 2025) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;Health carrier&quot; has the same meaning as provided in section 38a-1080 of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Mental health and substance use disorder benefits&quot; has the same meaning as provided in section 38a-477ee of the general statutes, as amended by this act.</p>\n   <p class=\"indent\">(b) (1) Not later than March 1, 2026, and annually thereafter, each health carrier shall file a certification with the Insurance Commissioner for the immediately preceding calendar year, certifying that such health carrier completed a review of such health carrier&#39;s administrative practices for compliance with the state and federal mental health and substance use disorder benefit reporting requirements pursuant to sections 38a-477ee, as amended by this act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510, as amended by this act, and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder. Such certification shall be signed by the chief executive officer and chief medical officer of such health carrier.</p>\n   <p class=\"indent\">(2) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding.</p>\n   <p class=\"indent\">(3) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year fail to comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding and identify (A) each administrative practice of such health carrier not in compliance with such state and federal mental health and substance use disorder benefit reporting requirements, and (B) action that such health carrier will take to bring such health carrier&#39;s administrative practices into compliance with such state and federal mental health and substance use disorder benefit reporting requirements.</p>\n   <p class=\"indent\">Sec. 2. Subsection (c) of section 38a-477ee of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2025):</p>\n   <p class=\"indent\">(c) <strike class=\"amendmentDeletedText\">(1)</strike> Not later than April 15, 2021, and annually thereafter, the Insurance Commissioner shall submit each report that the commissioner received pursuant to subsection (b) of this section for the calendar year immediately preceding to:</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(A)</strike>\n    <u class=\"amendmentInsertedText\">(1)</u> The joint standing committee of the General Assembly having cognizance of matters relating to insurance, in accordance with section 11-4a; and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(B)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> The Attorney General, Healthcare Advocate and Commissioner of Health Strategy.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2) Notwithstanding subdivision (1) of this subsection, the commissioner shall not submit the name or identity of any health carrier or entity that has contracted with such health carrier, and such name or identity shall be given confidential treatment and not be made public by the commissioner.</strike>\n   </p>\n   <p class=\"indent\">Sec. 3. (NEW) (Effective from passage) There is established an account to be known as the &quot;parity advancement account&quot; which shall be a separate, nonlapsing account within the General Fund. The account shall contain any moneys required by law to be deposited in the account and may receive donations from public or private sources. Moneys in the account shall be expended by the Insurance Department, beginning with the fiscal year ending June 30, 2026, for the purposes of enforcing the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act, conducting consumer education and other initiatives that support mental health parity implementation and enforcement on behalf of consumers.</p>\n   <p class=\"indent\">Sec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after providing an opportunity for a hearing in accordance with chapter 54 of the general statutes, may impose a civil penalty on any health carrier of not more than one hundred dollars with respect to each participant or beneficiary covered under a health insurance policy of such health carrier, provided such penalty shall not exceed an aggregate amount of one million dollars annually, for such health carrier&#39;s failure to comply with the certification requirements pursuant to the provisions of section 1 of this act, or the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act.</p>\n   <p class=\"indent\">(2) The commissioner may order the payment of such reasonable expenses as may be necessary to compensate the commissioner in conjunction with any proceedings under this section, which shall be dedicated to the enforcement and implementation of the state and federal mental health parity laws and regulations adopted thereunder.</p>\n   <p class=\"indent\">(b) (1) If any health carrier fails to file any data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, or section 1 of this act, the commissioner shall impose a late fee on such health carrier of one hundred dollars per day from the due date of such filing of data, report, certification or information to the date such health carrier submits such filing to the commissioner.</p>\n   <p class=\"indent\">(2) For any health carrier that files any incomplete data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, and section 1 of this act, the commissioner shall provide notice to such health carrier of such incomplete filing that includes (A) a description of such data, report, certification or other information that is incomplete and any additional data that is needed to consider such filing complete, and (B) the date by which such health carrier is required to provide such data. The commissioner shall impose a late fee on such health carrier of one hundred dollars per day, commencing from the date identified by the commissioner pursuant to subparagraph (B) of this subdivision.</p>\n   <p class=\"indent\">(c) The commissioner may waive any civil penalty imposed pursuant to subsection (a) of this section if the commissioner determines that the violation was due to reasonable cause and was not due to wilful neglect, or if such violation is corrected not more than thirty days after the date that the health carrier filed a certification of noncompliance with the commissioner pursuant to section 1 of this act.</p>\n   <p class=\"indent\">(d) All civil penalties and late fees received by the commissioner pursuant to this section shall be deposited in the General Fund and credited to the parity advancement account established pursuant to section 3 of this act.</p>\n   <p class=\"indent\">Sec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) Each health carrier shall contract with (A) health care professionals to administer such health carrier&#39;s utilization review program, and (B) clinical peers to evaluate the clinical appropriateness of an adverse determination.</p>\n   <p class=\"indent\">(2) (A) Each utilization review program shall use documented clinical review criteria that are based on sound clinical evidence and are evaluated periodically by the health carrier&#39;s organizational mechanism specified in subparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to <strike class=\"amendmentDeletedText\">assure</strike>\n    <u class=\"amendmentInsertedText\">ensure</u> such program&#39;s ongoing effectiveness.</p>\n   <p class=\"indent\">(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a health carrier may develop its own clinical review criteria or it may purchase or license clinical review criteria from qualified vendors approved by the commissioner, provided such clinical review criteria conform to the requirements of subparagraph (A) of this subdivision.</p>\n   <p class=\"indent\">(C) Each health carrier shall (i) post on its Internet web site (I) any clinical review criteria it uses, and (II) links to any rule, guideline, protocol or other similar criterion a health carrier may rely upon to make an adverse determination as described in subparagraph (F) of subdivision (1) of subsection (e) of section 38a-591d, and (ii) make its clinical review criteria available upon request to authorized government agencies.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(D) For each utilization review, there shall be a rebuttable presumption that each health care service under review is medically necessary if such health care service was ordered by a health care professional acting within such health care professional&#39;s scope of practice. Any utilization review company performing such review of a health care service shall have the burden of proving that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">(3) For any utilization review for the treatment of a substance use disorder, as described in section 17a-458, the clinical review criteria used shall be: (A) The most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a substance use disorder, that are not covered in the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(4) For any utilization review for the treatment of a child or adolescent mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a child or adolescent mental disorder, that are not covered in the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(5) For any utilization review for the treatment of an adult mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of an adult mental disorder, that are not covered in the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(b) Each health carrier shall:</p>\n   <p class=\"indent\">(1) Have procedures in place to ensure that (A) the health care professionals administering such health carrier&#39;s utilization review program are applying the clinical review criteria consistently in utilization review determinations, and (B) the appropriate or required individual or individuals are being designated to conduct utilization reviews;</p>\n   <p class=\"indent\">(2) Have data systems sufficient to support utilization review program activities and to generate management reports to enable the health carrier to monitor and manage health care services effectively;</p>\n   <p class=\"indent\">(3) Provide covered persons and participating providers with access to its utilization review staff through a toll-free telephone number or any other free calling option or by electronic means;</p>\n   <p class=\"indent\">(4) Coordinate the utilization review program with other medical management activity conducted by the health carrier, such as quality assurance, credentialing, contracting with health care professionals, data reporting, grievance procedures, processes for assessing member satisfaction and risk management; <strike class=\"amendmentDeletedText\">and</strike>\n   </p>\n   <p class=\"indent\">(5) Routinely assess the effectiveness and efficiency of its utilization review program<u class=\"amendmentInsertedText\">; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(6) Not use any system that employs artificial intelligence, as defined in section 51-10e, or any other algorithm in lieu of a review by a clinical peer to evaluate the clinical appropriateness of an adverse determination pursuant to a contract between such clinical peer and such health carrier</u>.</p>\n   <p class=\"indent\">Sec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(c) (1) (A) When conducting a review of an adverse determination under this section, the health carrier shall ensure that such review is conducted in a manner to ensure the independence and impartiality of the clinical peer or peers involved in making the review decision.</p>\n   <p class=\"indent\">(B) If the adverse determination involves utilization review, the health carrier shall designate an appropriate clinical peer or peers to review such adverse determination. Such clinical peer or peers shall not have been involved in the initial adverse determination.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D) of subdivision (2) of subsection (a) of section 38a-591c, as amended by this act, the health carrier may rebut such presumption by reasonably substantiating to the clinical peer or peers conducting the review pursuant to the provisions of this section that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(C)</strike>\n    <u class=\"amendmentInsertedText\">(ii)</u> The clinical peer or peers conducting a review under this section shall take into consideration all comments, documents, records and other information relevant to the covered person&#39;s benefit request that is the subject of the adverse determination under review, that are submitted by the covered person or the covered person&#39;s authorized representative, regardless of whether such information was submitted or considered in making the initial adverse determination.</p>\n   <p class=\"indent\">(D) Prior to issuing a decision, the health carrier shall provide free of charge, by facsimile, electronic means or any other expeditious method available, to the covered person or the covered person&#39;s authorized representative, as applicable, any new or additional documents, communications, information and evidence relied upon and any new or additional scientific or clinical rationale used by the health carrier in connection with the grievance. Such documents, communications, information, evidence and rationale shall be provided sufficiently in advance of the date the health carrier is required to issue a decision to permit the covered person or the covered person&#39;s authorized representative, as applicable, a reasonable opportunity to respond prior to such date.</p>\n   <p class=\"indent\">(2) If the review under subdivision (1) of this subsection is an expedited review, all necessary information, including the health carrier&#39;s decision, shall be transmitted between the health carrier and the covered person or the covered person&#39;s authorized representative, as applicable, by telephone, facsimile, electronic means or any other expeditious method available.</p>\n   <p class=\"indent\">(3) If the review under subdivision (1) of this subsection is an expedited review of a grievance involving an adverse determination of a concurrent review request, pursuant to 45 CFR 147.136, as amended from time to time, the treatment shall be continued without liability to the covered person until the covered person has been notified of the review decision.</p>\n   <p class=\"indent\">Sec. 7. Section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) for a prescribed drug for <strike class=\"amendmentDeletedText\">cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-492i.</p>\n   <p class=\"indent\">Sec. 8. Section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) for a prescribed drug for <strike class=\"amendmentDeletedText\">cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-518i.</p>\n   <p class=\"indent\">Sec. 9. (NEW) (Effective July 1, 2026) (a) Each insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity that enters into, renews or amends a contract with a health care provider on or after July 1, 2026, to provide covered benefits to insureds or enrollees in this state shall include in such contract:</p>\n   <p class=\"indent\">(1) A provision requiring such insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity to:</p>\n   <p class=\"indent\">(A) Reimburse the contracting health care provider for a covered outpatient benefit that uses a current procedural terminology evaluation and management (CPT E/M) code, current procedural terminology assessment and management (CPT A/M) code or drug infusion code in an amount that does not vary based on the facility where the contracting health care provider provides such benefit; and</p>\n   <p class=\"indent\">(B) Use equal reimbursement rates for all contracting health care providers in the same geographic region, as determined by the Insurance Commissioner, in accordance with the provisions of chapter 54 of the general statutes, and regardless of the employer or affiliation of any contracting health care provider, for each covered outpatient benefit described in subparagraph (A) of this subdivision if the reimbursement for such covered outpatient benefit is made on a fee-for-benefit basis or on the basis of bundled benefits per diagnosis, condition, procedure or another standardized bundle of health care benefits; and</p>\n   <p class=\"indent\">(2) A conspicuous statement that such contract complies with the provisions of subdivision (1) of this subsection.</p>\n   <p class=\"indent\">(b) The Insurance Commissioner shall adopt regulations, in accordance with the provisions of chapter 54 of the general statutes, to implement the provisions of this section, including, but not limited to, the establishment of geographic regions pursuant to the provisions of subparagraph (B) of subdivision (1) of subsection (a) of this section.</p>\n   <p class=\"indent\">Sec. 10. Subsections (a) to (c), inclusive, of section 38a-481 of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No individual health insurance policy shall be delivered or issued for delivery to any person in this state, nor shall any application, rider or endorsement be used in connection with such policy, until a copy of the form thereof and of the classification of risks and the premium rates have been filed with the commissioner. Rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, <u class=\"amendmentInsertedText\">the requirements established in section 15 of this act,</u> and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. The commissioner may adopt regulations, in accordance with the provisions of chapter 54, to establish a procedure for reviewing such policies. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such orders. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">(b) <u class=\"amendmentInsertedText\">(1)</u> No rate filed under the provisions of subsection (a) of this section shall be effective until it has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> unfairly discriminatory <strike class=\"amendmentDeletedText\">. The commissioner may disapprove such rate if it fails to comply with such standards, except that no rate filed under the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with section 38a-474</strike>\n    <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for health insurance that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) (1) No rate filed in accordance with the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with the provisions of section 38a-474.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">Sec. 11. Section 38a-513 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) <strike class=\"amendmentDeletedText\">(1)</strike> No group health insurance policy, as defined by the commissioner, or certificate shall be delivered or issued for delivery in this state unless a copy of the form for such policy or certificate has been submitted to and approved by the commissioner under the regulations adopted pursuant to this section. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, concerning the provisions, submission and approval of such policies and certificates and establishing a procedure for reviewing such policies and certificates. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such order.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) (1) No rate filed in accordance with the provisions of subsection (a) of this section shall be effective until such rate has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection or as provided under subdivision (2) of this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate, unfairly discriminatory or unaffordable pursuant to the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for a group health insurance policy that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2)</strike>\n    <u class=\"amendmentInsertedText\">(c)</u> No group health insurance policy or certificate for a small employer, as defined in section 38a-564, shall be delivered or issued for delivery in this state unless the premium rates have been submitted to and approved by the commissioner <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Premium rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, <u class=\"amendmentInsertedText\">the requirements set forth in section 15 of this act,</u> and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. As used in this subdivision, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(b)</strike>\n    <u class=\"amendmentInsertedText\">(d)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(e)</u> Nothing in this chapter shall preclude the issuance of a group health insurance policy that includes an optional life insurance rider, provided the optional life insurance rider shall be filed with and approved by the Insurance Commissioner pursuant to section 38a-430. Any company offering such policies for sale in this state shall be licensed to sell life insurance in this state pursuant to the provisions of section 38a-41.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(d)</strike>\n    <u class=\"amendmentInsertedText\">(f)</u> Not later than January 1, 2009, the commissioner shall adopt regulations, in accordance with chapter 54, to establish minimum standards for benefits in group specified disease policies, certificates, riders, endorsements and benefits.</p>\n   <p class=\"indent\">Sec. 12. Subdivision (1) of subsection (a) of section 38a-183 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) A health care center governed by sections 38a-175 to 38a-194, inclusive, shall not enter into any agreement with subscribers unless and until <strike class=\"amendmentDeletedText\">it</strike>\n    <u class=\"amendmentInsertedText\">such health care center</u> has filed with the commissioner a full schedule of the amounts to be paid by the subscribers and has obtained the commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include the information and data required under section 38a-479qqq if the contract or policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract or policy. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such amounts to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant tothe provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 13. Subsection (a) of section 38a-208 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscribers and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 14. Subsection (a) of section 38a-218 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such medical service corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscriber and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates are</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not be</u> excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 15. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health insurance policy, agreement or contract that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes, any (A) rate filed for such policy pursuant to section 38a-481 of the general statutes, as amended by this act, (B) rate filed for such policy pursuant to section 38a-513 of the general statutes, as amended by this act, (C) schedule of amounts filed for such agreement pursuant to section 38a-183 of the general statutes, as amended by this act, (D) schedule of rates filed for such contract pursuant to section 38a-208 of the general statutes, as amended by this act, or (E) schedule of rates filed for such contract pursuant to section 38a-218 of the general statutes, as amended by this act, on or after January 1, 2026, shall be filed not later than one hundred twenty calendar days prior to the proposed effective date of such rates or amounts.</p>\n   <p class=\"indent\">(2) Each filer making a rate or amount filing pursuant to this subsection shall, on the date such filer submits such rate or amount filing to the Insurance Commissioner, include with such filer&#39;s rate or amount filing an actuarial memorandum, certified by a qualified actuary, that to the best of such actuary&#39;s knowledge, (A) such rate or amount filing is in compliance with the laws of this state and federal law, as applicable, and (B) the rate or amount filing is not excessive, as described in subdivision (1) of subsection (c) of this section. For the purposes of this subparagraph, &quot;qualified actuary&quot; means a member in good standing of the American Academy of Actuaries who is qualified in accordance with the standards of the American Academy of Actuaries.</p>\n   <p class=\"indent\">(3) (A) Notwithstanding the provisions of section 38a-69a of the general statutes, the Insurance Department shall post on the department&#39;s Internet web site all documents, materials and other information provided to or requested by the department in relation to any such rate or amount filing made pursuant to this subsection, including, but not limited to, financial reports, financial statements, actuarial reports and actuarial memoranda. Such rate or amount filing and such documents, materials and other information shall be posted on such web site not later than three business days after the department receives such filing, and such posting shall be updated to include any correspondence between the department and such filer.</p>\n   <p class=\"indent\">(B) The department shall provide for a written public comment period of not less than thirty calendar days following the posting of such filing. The department shall include in such posting the date such public comment period closes and instructions for the public to submit comments to the department.</p>\n   <p class=\"indent\">(b) (1) The commissioner shall hold a public hearing for each rate or amount filed under the provisions of subdivision (1) of subsection (a) of this section. Not later than five business days after the posting of such rate or amount filing on the department&#39;s Internet web site in accordance with the provisions of subparagraph (A) of subdivision (3) of subsection (a) of this section, the commissioner shall set a public hearing date for such rate or amount filing and shall post the date, place and time of such public hearing in a conspicuous place on the department&#39;s Internet web site.</p>\n   <p class=\"indent\">(2) Such public hearing shall be (A) held after the end of the public comment period specified in subparagraph (B) of subdivision (3) of subsection (a) of this section, but not later than prior to the proposed effective date of such rate or amount, at a place and time that is convenient to the public, and (B) conducted in accordance with the provisions of chapter 54 of the general statutes, this section and section 16 of this act.</p>\n   <p class=\"indent\">(3) Upon setting the date, place and time of the public hearing for such rate or amount filing, the commissioner shall immediately notify the filer of such rate or amount filing of the date, place and time of the public hearing.</p>\n   <p class=\"indent\">(c) The commissioner shall not approve a rate or amount filing submitted in accordance with the provisions of this section if such rate or amount filing is excessive, inadequate, unfairly discriminatory or unaffordable. The commissioner shall conduct an actuarial review to determine if the methodology and assumptions used to develop such rate or amount filing are actuarially sound and in compliance with the Actuarial Standards of Practice issued by the Actuarial Standards Board.</p>\n   <p class=\"indent\">(1) Any rate or amount shall be considered excessive if it is unreasonably high for the insurance provided in relation to the underlying risks and costs after due consideration of: (A) The experience of such filer; (B) such filer&#39;s past and projected costs, including amounts to be paid for commissions; (C) any transfers of funds to the holding or parent company, subsidiary or affiliate of such filer; (D) such filer&#39;s rate of return on assets or profitability, as compared to similar filers; (E) a reasonable margin for profit and contingencies; (F) any public comments received on such filing in accordance with the provisions of subparagraph (B) of subdivision (3) of subsection (a) of this section; and (G) other factors the commissioner deems relevant.</p>\n   <p class=\"indent\">(2) Any rate or amount shall be considered inadequate if such rate or amount is unreasonably low for the insurance provided in relation to the underlying risks and costs and continued use of such rate or amount would endanger solvency of such filer.</p>\n   <p class=\"indent\">(3) Any rate or amount shall be considered unfairly discriminatory if the premium charged for any classification is not reasonably related to the underlying risks and costs, such that different premiums result for insureds with similar risks and costs.</p>\n   <p class=\"indent\">(4) Any rate or amount shall be considered unaffordable if the commissioner determines such rate or amount is inconsistent with the inflation-adjusted Connecticut Health Affordability Index commissioned by the Office of Health Strategy and the Office of the State Comptroller, or another metric jointly designated by the commissioner and the Commissioner of Health Strategy.</p>\n   <p class=\"indent\">(d) Not later than thirty days after such public hearing held in accordance with the provisions of subsection (b) of this section, the commissioner shall issue a written decision approving, disapproving or modifying such rate or amount filing. Such decision shall specify all factors used to reach such decision and shall be posted on the department&#39;s Internet web site not later than two business days after the commissioner issues such decision.</p>\n   <p class=\"indent\">Sec. 16. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176 and 4-177a of the general statutes, the Healthcare Advocate or the Attorney General, or both, may be parties to any public hearing held in accordance with the provisions of section 15 of this act.</p>\n   <p class=\"indent\">(b) Subject to the provisions of section 4-181 of the general statutes, (1) the Healthcare Advocate or the Attorney General, or both, shall have access to the records of the Insurance Department regarding any rate or amount filing made in accordance with the provisions of section 15 of this act, and (2) attorneys, actuaries, accountants and other experts who are part of the Insurance Commissioner&#39;s staff and who review or assist in the determination of such filing pursuant to the provisions of section 15 of this act shall cooperate with the Healthcare Advocate or Attorney General, or both, to carry out the provisions of this section.</p>\n   <p class=\"indent\">(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon and examine under oath such witnesses as the Healthcare Advocate or the Attorney General deems necessary for the review of a rate or amount filing made in accordance with the provisions of section 15 of this act, and (2) require the filer or any holding or parent company or subsidiary of such filer to produce books, vouchers, memoranda, papers, letters, contracts and other documents, regardless of the format in which such materials are stored. Any such books, vouchers, memoranda, papers, letters, contracts or other documents shall be limited to such information or transactions between such filer and the holding or parent company or subsidiary that are reasonably related to the subject matter of the filing.</p>\n   <p class=\"indent\">Sec. 17. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <p class=\"indent\">Sec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <table>\n    <tr>\n     <td colspan=\"3\">This act shall take effect as follows and shall amend the following sections:<br/>\n     </td>\n    </tr>\n    <tr>\n     <td>Section 1</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 2</td>\n     <td>October 1, 2025</td>\n     <td>38a-477ee(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 3</td>\n     <td>from passage</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 4</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 5</td>\n     <td>January 1, 2026</td>\n     <td>38a-591c(a) and (b)</td>\n    </tr>\n    <tr>\n     <td>Sec. 6</td>\n     <td>January 1, 2026</td>\n     <td>38a-591e(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 7</td>\n     <td>January 1, 2026</td>\n     <td>38a-510</td>\n    </tr>\n    <tr>\n     <td>Sec. 8</td>\n     <td>January 1, 2026</td>\n     <td>38a-544</td>\n    </tr>\n    <tr>\n     <td>Sec. 9</td>\n     <td>July 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 10</td>\n     <td>January 1, 2026</td>\n     <td>38a-481(a) to (c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 11</td>\n     <td>January 1, 2026</td>\n     <td>38a-513</td>\n    </tr>\n    <tr>\n     <td>Sec. 12</td>\n     <td>January 1, 2026</td>\n     <td>38a-183(a)(1)</td>\n    </tr>\n    <tr>\n     <td>Sec. 13</td>\n     <td>January 1, 2026</td>\n     <td>38a-208(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 14</td>\n     <td>January 1, 2026</td>\n     <td>38a-218(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 15</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 16</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 17</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 18</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n   </table>\n   <p class=\"indent\">\n    <b>Statement of Legislative Commissioners: </b>\n   </p>\n   <p class=\"indent\">In Section 6(c)(1)(C)(i), &quot;<u class=\"amendmentInsertedText\">subdivision (1)</u>&quot; was changed to &quot;<u class=\"amendmentInsertedText\">subdivision (2)</u>&quot; for accuracy, in Section 15(c)(4), &quot;executive director of the Office of Health Strategy&quot; was changed to &quot;Commissioner of Health Strategy&quot; for accuracy, and in Section 16(b)(2), &quot;the provisions of&quot; was added after &quot;pursuant to&quot; for consistency.</p>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Reissued  \nVersion Date: | 04/02/2025  \n  \n**STATE OF CONNECTICUT**\n\nGeneral Assembly\n\nFile No. 419\n\n**January Session, 2025**\n\nSubstitute Senate Bill No. 10\n\nSenate, April 2, 2025\n\nThe Committee on Insurance and Real Estate reported through SEN. CABRERA of\nthe 17th Dist., Chairperson of the Committee on the part of the Senate, that\nthe substitute bill ought to pass.\n\nAN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nSection 1. (NEW) (Effective October 1, 2025) (a) As used in this section:\n\n(1) \"Health carrier\" has the same meaning as provided in section 38a-1080 of\nthe general statutes; and\n\n(2) \"Mental health and substance use disorder benefits\" has the same meaning\nas provided in section 38a-477ee of the general statutes, as amended by this\nact.\n\n(b) (1) Not later than March 1, 2026, and annually thereafter, each health\ncarrier shall file a certification with the Insurance Commissioner for the\nimmediately preceding calendar year, certifying that such health carrier\ncompleted a review of such health carrier's administrative practices for\ncompliance with the state and federal mental health and substance use disorder\nbenefit reporting requirements pursuant to sections 38a-477ee, as amended by\nthis act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510,\nas amended by this act, and 38a-544 of the general statutes, as amended by\nthis act, and the provisions of the federal Paul Wellstone and Pete Domenici\nMental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as\namended from time to time, and regulations adopted thereunder. Such\ncertification shall be signed by the chief executive officer and chief medical\nofficer of such health carrier.\n\n(2) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year comply\nwith the state and federal mental health and substance use disorder benefit\nreporting requirements identified in subdivision (1) of this subsection, such\ncertification filed pursuant to subdivision (1) of this subsection shall state\nsuch finding.\n\n(3) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year fail to\ncomply with the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of this\nsubsection, such certification filed pursuant to subdivision (1) of this\nsubsection shall state such finding and identify (A) each administrative\npractice of such health carrier not in compliance with such state and federal\nmental health and substance use disorder benefit reporting requirements, and\n(B) action that such health carrier will take to bring such health carrier's\nadministrative practices into compliance with such state and federal mental\nhealth and substance use disorder benefit reporting requirements.\n\nSec. 2. Subsection (c) of section 38a-477ee of the general statutes is\nrepealed and the following is substituted in lieu thereof (Effective October\n1, 2025):\n\n(c) ~~(1)~~ Not later than April 15, 2021, and annually thereafter, the\nInsurance Commissioner shall submit each report that the commissioner received\npursuant to subsection (b) of this section for the calendar year immediately\npreceding to:\n\n~~(A)~~ _(1)_ The joint standing committee of the General Assembly having\ncognizance of matters relating to insurance, in accordance with section 11-4a;\nand\n\n~~(B)~~ _(2)_ The Attorney General, Healthcare Advocate and Commissioner of\nHealth Strategy.\n\n~~(2) Notwithstanding subdivision (1) of this subsection, the commissioner\nshall not submit the name or identity of any health carrier or entity that has\ncontracted with such health carrier, and such name or identity shall be given\nconfidential treatment and not be made public by the commissioner.~~\n\nSec. 3. (NEW) (Effective from passage) There is established an account to be\nknown as the \"parity advancement account\" which shall be a separate,\nnonlapsing account within the General Fund. The account shall contain any\nmoneys required by law to be deposited in the account and may receive\ndonations from public or private sources. Moneys in the account shall be\nexpended by the Insurance Department, beginning with the fiscal year ending\nJune 30, 2026, for the purposes of enforcing the state and federal mental\nhealth and substance use disorder benefit reporting requirements identified in\nsubdivision (1) of subsection (b) of section 1 of this act, conducting\nconsumer education and other initiatives that support mental health parity\nimplementation and enforcement on behalf of consumers.\n\nSec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after\nproviding an opportunity for a hearing in accordance with chapter 54 of the\ngeneral statutes, may impose a civil penalty on any health carrier of not more\nthan one hundred dollars with respect to each participant or beneficiary\ncovered under a health insurance policy of such health carrier, provided such\npenalty shall not exceed an aggregate amount of one million dollars annually,\nfor such health carrier's failure to comply with the certification\nrequirements pursuant to the provisions of section 1 of this act, or the state\nand federal mental health and substance use disorder benefit reporting\nrequirements identified in subdivision (1) of subsection (b) of section 1 of\nthis act.\n\n(2) The commissioner may order the payment of such reasonable expenses as may\nbe necessary to compensate the commissioner in conjunction with any\nproceedings under this section, which shall be dedicated to the enforcement\nand implementation of the state and federal mental health parity laws and\nregulations adopted thereunder.\n\n(b) (1) If any health carrier fails to file any data, report, certification or\nother information required by the provisions of section 38a-477ee of the\ngeneral statutes, as amended by this act, or section 1 of this act, the\ncommissioner shall impose a late fee on such health carrier of one hundred\ndollars per day from the due date of such filing of data, report,\ncertification or information to the date such health carrier submits such\nfiling to the commissioner.\n\n(2) For any health carrier that files any incomplete data, report,\ncertification or other information required by the provisions of section\n38a-477ee of the general statutes, as amended by this act, and section 1 of\nthis act, the commissioner shall provide notice to such health carrier of such\nincomplete filing that includes (A) a description of such data, report,\ncertification or other information that is incomplete and any additional data\nthat is needed to consider such filing complete, and (B) the date by which\nsuch health carrier is required to provide such data. The commissioner shall\nimpose a late fee on such health carrier of one hundred dollars per day,\ncommencing from the date identified by the commissioner pursuant to\nsubparagraph (B) of this subdivision.\n\n(c) The commissioner may waive any civil penalty imposed pursuant to\nsubsection (a) of this section if the commissioner determines that the\nviolation was due to reasonable cause and was not due to wilful neglect, or if\nsuch violation is corrected not more than thirty days after the date that the\nhealth carrier filed a certification of noncompliance with the commissioner\npursuant to section 1 of this act.\n\n(d) All civil penalties and late fees received by the commissioner pursuant to\nthis section shall be deposited in the General Fund and credited to the parity\nadvancement account established pursuant to section 3 of this act.\n\nSec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes\nare repealed and the following is substituted in lieu thereof (Effective\nJanuary 1, 2026):\n\n(a) (1) Each health carrier shall contract with (A) health care professionals\nto administer such health carrier's utilization review program, and (B)\nclinical peers to evaluate the clinical appropriateness of an adverse\ndetermination.\n\n(2) (A) Each utilization review program shall use documented clinical review\ncriteria that are based on sound clinical evidence and are evaluated\nperiodically by the health carrier's organizational mechanism specified in\nsubparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to\n~~assure~~ _ensure_ such program's ongoing effectiveness.\n\n(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a\nhealth carrier may develop its own clinical review criteria or it may purchase\nor license clinical review criteria from qualified vendors approved by the\ncommissioner, provided such clinical review criteria conform to the\nrequirements of subparagraph (A) of this subdivision.\n\n(C) Each health carrier shall (i) post on its Internet web site (I) any\nclinical review criteria it uses, and (II) links to any rule, guideline,\nprotocol or other similar criterion a health carrier may rely upon to make an\nadverse determination as described in subparagraph (F) of subdivision (1) of\nsubsection (e) of section 38a-591d, and (ii) make its clinical review criteria\navailable upon request to authorized government agencies.\n\n_(D) For each utilization review, there shall be a rebuttable presumption that\neach health care service under review is medically necessary if such health\ncare service was ordered by a health care professional acting within such\nhealth care professional 's scope of practice. Any utilization review company\nperforming such review of a health care service shall have the burden of\nproving that such health care service is not medically necessary._\n\n(3) For any utilization review for the treatment of a substance use disorder,\nas described in section 17a-458, the clinical review criteria used shall be:\n(A) The most recent edition of the American Society of Addiction Medicine\nTreatment Criteria for Addictive, Substance-Related, and Co-Occurring\nConditions; or (B) clinical review criteria that the health carrier\ndemonstrates to the Insurance Department is consistent with the most recent\nedition of the American Society of Addiction Medicine Treatment Criteria for\nAddictive, Substance-Related, and Co-Occurring Conditions, except that nothing\nin this subdivision shall prohibit a health carrier from developing its own\nclinical review criteria or purchasing or licensing additional clinical review\ncriteria from qualified vendors approved by the commissioner, to address\nadvancements in technology or types of care for the treatment of a substance\nuse disorder, that are not covered in the most recent edition of the American\nSociety of Addiction Medicine Treatment Criteria for Addictive, Substance-\nRelated, and Co-Occurring Conditions. Any such clinical review criteria\ndeveloped by a health carrier or purchased or licensed from a qualified vendor\nshall conform to the requirements of subparagraph (A) of subdivision (2) of\nthis subsection.\n\n(4) For any utilization review for the treatment of a child or adolescent\nmental disorder, the clinical review criteria used shall be: (A) The most\nrecent guidelines of the American Academy of Child and Adolescent Psychiatry's\nChild and Adolescent Service Intensity Instrument; or (B) clinical review\ncriteria that the health carrier demonstrates to the Insurance Department is\nconsistent with the most recent guidelines of the American Academy of Child\nand Adolescent Psychiatry's Child and Adolescent Service Intensity Instrument,\nexcept that nothing in this subdivision shall prohibit a health carrier from\ndeveloping its own clinical review criteria or purchasing or licensing\nadditional clinical review criteria from qualified vendors approved by the\ncommissioner, to address advancements in technology or types of care for the\ntreatment of a child or adolescent mental disorder, that are not covered in\nthe most recent guidelines of the American Academy of Child and Adolescent\nPsychiatry's Child and Adolescent Service Intensity Instrument. Any such\nclinical review criteria developed by a health carrier or purchased or\nlicensed from a qualified vendor shall conform to the requirements of\nsubparagraph (A) of subdivision (2) of this subsection.\n\n(5) For any utilization review for the treatment of an adult mental disorder,\nthe clinical review criteria used shall be: (A) The most recent guidelines of\nthe American Psychiatric Association or the most recent Standards and\nGuidelines of the Association for Ambulatory Behavioral Healthcare; or (B)\nclinical review criteria that the health carrier demonstrates to the Insurance\nDepartment is consistent with the most recent guidelines of the American\nPsychiatric Association or the most recent Standards and Guidelines of the\nAssociation for Ambulatory Behavioral Healthcare, except that nothing in this\nsubdivision shall prohibit a health carrier from developing its own clinical\nreview criteria or purchasing or licensing additional clinical review criteria\nfrom qualified vendors approved by the commissioner, to address advancements\nin technology or types of care for the treatment of an adult mental disorder,\nthat are not covered in the most recent guidelines of the American Psychiatric\nAssociation or the most recent Standards and Guidelines of the Association for\nAmbulatory Behavioral Healthcare. Any such clinical review criteria developed\nby a health carrier or purchased or licensed from a qualified vendor shall\nconform to the requirements of subparagraph (A) of subdivision (2) of this\nsubsection.\n\n(b) Each health carrier shall:\n\n(1) Have procedures in place to ensure that (A) the health care professionals\nadministering such health carrier's utilization review program are applying\nthe clinical review criteria consistently in utilization review\ndeterminations, and (B) the appropriate or required individual or individuals\nare being designated to conduct utilization reviews;\n\n(2) Have data systems sufficient to support utilization review program\nactivities and to generate management reports to enable the health carrier to\nmonitor and manage health care services effectively;\n\n(3) Provide covered persons and participating providers with access to its\nutilization review staff through a toll-free telephone number or any other\nfree calling option or by electronic means;\n\n(4) Coordinate the utilization review program with other medical management\nactivity conducted by the health carrier, such as quality assurance,\ncredentialing, contracting with health care professionals, data reporting,\ngrievance procedures, processes for assessing member satisfaction and risk\nmanagement; ~~and~~\n\n(5) Routinely assess the effectiveness and efficiency of its utilization\nreview program _; and_\n\n_(6) Not use any system that employs artificial intelligence, as defined in\nsection 51-10e, or any other algorithm in lieu of a review by a clinical peer\nto evaluate the clinical appropriateness of an adverse determination pursuant\nto a contract between such clinical peer and such health carrier_.\n\nSec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(c) (1) (A) When conducting a review of an adverse determination under this\nsection, the health carrier shall ensure that such review is conducted in a\nmanner to ensure the independence and impartiality of the clinical peer or\npeers involved in making the review decision.\n\n(B) If the adverse determination involves utilization review, the health\ncarrier shall designate an appropriate clinical peer or peers to review such\nadverse determination. Such clinical peer or peers shall not have been\ninvolved in the initial adverse determination.\n\n_(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D)\nof subdivision (2) of subsection (a) of section 38a-591c, as amended by this\nact, the health carrier may rebut such presumption by reasonably\nsubstantiating to the clinical peer or peers conducting the review pursuant to\nthe provisions of this section that such health care service is not medically\nnecessary._\n\n~~(C)~~ _(ii)_ The clinical peer or peers conducting a review under this\nsection shall take into consideration all comments, documents, records and\nother information relevant to the covered person's benefit request that is the\nsubject of the adverse determination under review, that are submitted by the\ncovered person or the covered person's authorized representative, regardless\nof whether such information was submitted or considered in making the initial\nadverse determination.\n\n(D) Prior to issuing a decision, the health carrier shall provide free of\ncharge, by facsimile, electronic means or any other expeditious method\navailable, to the covered person or the covered person's authorized\nrepresentative, as applicable, any new or additional documents,\ncommunications, information and evidence relied upon and any new or additional\nscientific or clinical rationale used by the health carrier in connection with\nthe grievance. Such documents, communications, information, evidence and\nrationale shall be provided sufficiently in advance of the date the health\ncarrier is required to issue a decision to permit the covered person or the\ncovered person's authorized representative, as applicable, a reasonable\nopportunity to respond prior to such date.\n\n(2) If the review under subdivision (1) of this subsection is an expedited\nreview, all necessary information, including the health carrier's decision,\nshall be transmitted between the health carrier and the covered person or the\ncovered person's authorized representative, as applicable, by telephone,\nfacsimile, electronic means or any other expeditious method available.\n\n(3) If the review under subdivision (1) of this subsection is an expedited\nreview of a grievance involving an adverse determination of a concurrent\nreview request, pursuant to 45 CFR 147.136, as amended from time to time, the\ntreatment shall be continued without liability to the covered person until the\ncovered person has been notified of the review decision.\n\nSec. 7. Section 38a-510 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing an individual health insurance\npolicy or contract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) for a prescribed drug for ~~cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _the treatment of a disabling or life-threatening chronic disease or\ncondition,_ provided such prescribed drug is in compliance with approved\nfederal Food and Drug Administration indications, ~~or~~ (C) for the period\ncommencing January 1, 2024, and ending January 1, 2027, inclusive, for the\ntreatment of schizophrenia, major depressive disorder or bipolar disorder, as\ndefined in the most recent edition of the American Psychiatric Association's\n\"Diagnostic and Statistical Manual of Mental Disorders\"_, or (D) for a\nprescribed drug for the treatment of a mental or behavioral health condition,\nprovided such prescribed drug is in compliance with approved federal Food and\nDrug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-492i.\n\nSec. 8. Section 38a-544 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing a group health insurance policy or\ncontract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) for a prescribed drug for ~~cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _the treatment of a disabling or life-threatening chronic disease or\ncondition,_ provided such prescribed drug is in compliance with approved\nfederal Food and Drug Administration indications, ~~or~~ (C) for the period\ncommencing January 1, 2024, and ending January 1, 2027, inclusive, for the\ntreatment of schizophrenia, major depressive disorder or bipolar disorder, as\ndefined in the most recent edition of the American Psychiatric Association's\n\"Diagnostic and Statistical Manual of Mental Disorders\"_, or (D) for a\nprescribed drug for the treatment of a mental or behavioral health condition,\nprovided such prescribed drug is in compliance with approved federal Food and\nDrug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-518i.\n\nSec. 9. (NEW) (Effective July 1, 2026) (a) Each insurer, health care center,\nhospital service corporation, medical service corporation, preferred provider\nnetwork or other entity that enters into, renews or amends a contract with a\nhealth care provider on or after July 1, 2026, to provide covered benefits to\ninsureds or enrollees in this state shall include in such contract:\n\n(1) A provision requiring such insurer, health care center, hospital service\ncorporation, medical service corporation, preferred provider network or other\nentity to:\n\n(A) Reimburse the contracting health care provider for a covered outpatient\nbenefit that uses a current procedural terminology evaluation and management\n(CPT E/M) code, current procedural terminology assessment and management (CPT\nA/M) code or drug infusion code in an amount that does not vary based on the\nfacility where the contracting health care provider provides such benefit; and\n\n(B) Use equal reimbursement rates for all contracting health care providers in\nthe same geographic region, as determined by the Insurance Commissioner, in\naccordance with the provisions of chapter 54 of the general statutes, and\nregardless of the employer or affiliation of any contracting health care\nprovider, for each covered outpatient benefit described in subparagraph (A) of\nthis subdivision if the reimbursement for such covered outpatient benefit is\nmade on a fee-for-benefit basis or on the basis of bundled benefits per\ndiagnosis, condition, procedure or another standardized bundle of health care\nbenefits; and\n\n(2) A conspicuous statement that such contract complies with the provisions of\nsubdivision (1) of this subsection.\n\n(b) The Insurance Commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54 of the general statutes, to implement the provisions\nof this section, including, but not limited to, the establishment of\ngeographic regions pursuant to the provisions of subparagraph (B) of\nsubdivision (1) of subsection (a) of this section.\n\nSec. 10. Subsections (a) to (c), inclusive, of section 38a-481 of the general\nstatutes are repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) No individual health insurance policy shall be delivered or issued for\ndelivery to any person in this state, nor shall any application, rider or\nendorsement be used in connection with such policy, until a copy of the form\nthereof and of the classification of risks and the premium rates have been\nfiled with the commissioner. Rate filings shall include the information and\ndata required under section 38a-479qqq if the policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience, _the requirements established in\nsection 15 of this act,_ and premium rates and loss ratios from the inception\nof the policy. Each premium rate filed on or after January 1, 2021, shall, if\nthe insurer intends to account for rebates, as defined in section 38a-479ooo\nin the manner specified in section 38a-479rrr, account for such rebates in\nsuch manner, if the policy is subject to section 38a-479rrr. The commissioner\nmay adopt regulations, in accordance with the provisions of chapter 54, to\nestablish a procedure for reviewing such policies. The commissioner shall\ndisapprove the use of such form at any time if it does not comply with the\nrequirements of law, or if it contains a provision or provisions that are\nunfair or deceptive or that encourage misrepresentation of the policy. The\ncommissioner shall notify, in writing, the insurer that has filed any such\nform of the commissioner's disapproval, specifying the reasons for\ndisapproval, and ordering that no such insurer shall deliver or issue for\ndelivery to any person in this state a policy on or containing such form. The\nprovisions of section 38a-19 shall apply to such orders. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\n(b) _(1)_ No rate filed under the provisions of subsection (a) of this section\nshall be effective until it has been approved by the commissioner in\naccordance with regulations adopted pursuant to this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate _,_ ~~or~~ unfairly discriminatory ~~. The commissioner\nmay disapprove such rate if it fails to comply with such standards, except\nthat no rate filed under the provisions of subsection (a) of this section for\nany Medicare supplement policy shall be effective unless approved in\naccordance with section 38a-474~~ _or unaffordable pursuant to the provisions\nof section 15 of this act_.\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for health insurance that provides coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be\napproved in accordance with the provisions of section 15 of this act._\n\n_(c) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section for any Medicare supplement policy shall be effective unless\napproved in accordance with the provisions of section 38a-474._\n\n~~(c)~~ _(2)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\nSec. 11. Section 38a-513 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) ~~(1)~~ No group health insurance policy, as defined by the commissioner,\nor certificate shall be delivered or issued for delivery in this state unless\na copy of the form for such policy or certificate has been submitted to and\napproved by the commissioner under the regulations adopted pursuant to this\nsection. The commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54, concerning the provisions, submission and approval\nof such policies and certificates and establishing a procedure for reviewing\nsuch policies and certificates. The commissioner shall disapprove the use of\nsuch form at any time if it does not comply with the requirements of law, or\nif it contains a provision or provisions that are unfair or deceptive or that\nencourage misrepresentation of the policy. The commissioner shall notify, in\nwriting, the insurer that has filed any such form of the commissioner's\ndisapproval, specifying the reasons for disapproval, and ordering that no such\ninsurer shall deliver or issue for delivery to any person in this state a\npolicy on or containing such form. The provisions of section 38a-19 shall\napply to such order.\n\n_(b) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section shall be effective until such rate has been approved by the\ncommissioner in accordance with regulations adopted pursuant to this\nsubsection or as provided under subdivision (2) of this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate, unfairly discriminatory or unaffordable pursuant to the\nprovisions of section 15 of this act._\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for a group health insurance policy that provides coverage of the\ntype specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469\nshall be approved in accordance with the provisions of section 15 of this\nact._\n\n~~(2)~~ _(c)_ No group health insurance policy or certificate for a small\nemployer, as defined in section 38a-564, shall be delivered or issued for\ndelivery in this state unless the premium rates have been submitted to and\napproved by the commissioner _in accordance with the provisions of section 15\nof this act_. Premium rate filings shall include the information and data\nrequired under section 38a-479qqq if the policy is subject to said section,\nand an actuarial memorandum that includes, but is not limited to, pricing\nassumptions and claims experience, _the requirements set forth in section 15\nof this act,_ and premium rates and loss ratios from the inception of the\npolicy. Each premium rate filed on or after January 1, 2021, shall, if the\ninsurer intends to account for rebates, as defined in section 38a-479ooo in\nthe manner specified in section 38a-479rrr, account for such rebates in such\nmanner, if the policy is subject to section 38a-479rrr. As used in this\nsubdivision, \"loss ratio\" means the ratio of incurred claims to earned\npremiums by the number of years of policy duration for all combined durations.\n\n~~(b)~~ _(d)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\n~~(c)~~ _(e)_ Nothing in this chapter shall preclude the issuance of a group\nhealth insurance policy that includes an optional life insurance rider,\nprovided the optional life insurance rider shall be filed with and approved by\nthe Insurance Commissioner pursuant to section 38a-430. Any company offering\nsuch policies for sale in this state shall be licensed to sell life insurance\nin this state pursuant to the provisions of section 38a-41.\n\n~~(d)~~ _(f)_ Not later than January 1, 2009, the commissioner shall adopt\nregulations, in accordance with chapter 54, to establish minimum standards for\nbenefits in group specified disease policies, certificates, riders,\nendorsements and benefits.\n\nSec. 12. Subdivision (1) of subsection (a) of section 38a-183 of the general\nstatutes is repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) (1) A health care center governed by sections 38a-175 to 38a-194,\ninclusive, shall not enter into any agreement with subscribers unless and\nuntil ~~it~~ _such health care center_ has filed with the commissioner a full\nschedule of the amounts to be paid by the subscribers and has obtained the\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 15 of this act_. Such filing shall include the information and data\nrequired under section 38a-479qqq if the contract or policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience, and premium rates and loss ratios\nfrom the inception of the contract or policy. The commissioner ~~may refuse\nsuch approval if the commissioner finds such amounts to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant tothe provisions of section 15\nof this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 13. Subsection (a) of section 38a-208 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such corporation shall enter into any contract with subscribers unless\nand until it has filed with the Insurance Commissioner a full schedule of the\nrates to be paid by the subscribers and has obtained said commissioner's\napproval ~~thereof~~ _in accordance with the provisions of section 15 of this\nact_. Such filing shall include an actuarial memorandum that includes, but is\nnot limited to, pricing assumptions and claims experience, and premium rates\nand loss ratios from the inception of the contract. The commissioner ~~may\nrefuse such approval if the commissioner finds such rates to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant to the provisions of section\n15 of this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 14. Subsection (a) of section 38a-218 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such medical service corporation shall enter into any contract with\nsubscribers unless and until it has filed with the Insurance Commissioner a\nfull schedule of the rates to be paid by the subscriber and has obtained said\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 15 of this act_. Such filing shall include an actuarial memorandum\nthat includes, but is not limited to, pricing assumptions and claims\nexperience, and premium rates and loss ratios from the inception of the\ncontract. The commissioner ~~may refuse such approval if the commissioner\nfinds such rates are~~ _shall adopt regulations, in accordance with the\nprovisions of chapter 54, to prescribe standards to ensure that such amounts\nshall not be_ excessive, inadequate _,_ ~~or~~ discriminatory _or unaffordable\npursuant to the provisions of section 15 of this act_. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\nSec. 15. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health\ninsurance policy, agreement or contract that provides coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes, any (A) rate filed for such policy pursuant to section\n38a-481 of the general statutes, as amended by this act, (B) rate filed for\nsuch policy pursuant to section 38a-513 of the general statutes, as amended by\nthis act, (C) schedule of amounts filed for such agreement pursuant to section\n38a-183 of the general statutes, as amended by this act, (D) schedule of rates\nfiled for such contract pursuant to section 38a-208 of the general statutes,\nas amended by this act, or (E) schedule of rates filed for such contract\npursuant to section 38a-218 of the general statutes, as amended by this act,\non or after January 1, 2026, shall be filed not later than one hundred twenty\ncalendar days prior to the proposed effective date of such rates or amounts.\n\n(2) Each filer making a rate or amount filing pursuant to this subsection\nshall, on the date such filer submits such rate or amount filing to the\nInsurance Commissioner, include with such filer's rate or amount filing an\nactuarial memorandum, certified by a qualified actuary, that to the best of\nsuch actuary's knowledge, (A) such rate or amount filing is in compliance with\nthe laws of this state and federal law, as applicable, and (B) the rate or\namount filing is not excessive, as described in subdivision (1) of subsection\n(c) of this section. For the purposes of this subparagraph, \"qualified\nactuary\" means a member in good standing of the American Academy of Actuaries\nwho is qualified in accordance with the standards of the American Academy of\nActuaries.\n\n(3) (A) Notwithstanding the provisions of section 38a-69a of the general\nstatutes, the Insurance Department shall post on the department's Internet web\nsite all documents, materials and other information provided to or requested\nby the department in relation to any such rate or amount filing made pursuant\nto this subsection, including, but not limited to, financial reports,\nfinancial statements, actuarial reports and actuarial memoranda. Such rate or\namount filing and such documents, materials and other information shall be\nposted on such web site not later than three business days after the\ndepartment receives such filing, and such posting shall be updated to include\nany correspondence between the department and such filer.\n\n(B) The department shall provide for a written public comment period of not\nless than thirty calendar days following the posting of such filing. The\ndepartment shall include in such posting the date such public comment period\ncloses and instructions for the public to submit comments to the department.\n\n(b) (1) The commissioner shall hold a public hearing for each rate or amount\nfiled under the provisions of subdivision (1) of subsection (a) of this\nsection. Not later than five business days after the posting of such rate or\namount filing on the department's Internet web site in accordance with the\nprovisions of subparagraph (A) of subdivision (3) of subsection (a) of this\nsection, the commissioner shall set a public hearing date for such rate or\namount filing and shall post the date, place and time of such public hearing\nin a conspicuous place on the department's Internet web site.\n\n(2) Such public hearing shall be (A) held after the end of the public comment\nperiod specified in subparagraph (B) of subdivision (3) of subsection (a) of\nthis section, but not later than prior to the proposed effective date of such\nrate or amount, at a place and time that is convenient to the public, and (B)\nconducted in accordance with the provisions of chapter 54 of the general\nstatutes, this section and section 16 of this act.\n\n(3) Upon setting the date, place and time of the public hearing for such rate\nor amount filing, the commissioner shall immediately notify the filer of such\nrate or amount filing of the date, place and time of the public hearing.\n\n(c) The commissioner shall not approve a rate or amount filing submitted in\naccordance with the provisions of this section if such rate or amount filing\nis excessive, inadequate, unfairly discriminatory or unaffordable. The\ncommissioner shall conduct an actuarial review to determine if the methodology\nand assumptions used to develop such rate or amount filing are actuarially\nsound and in compliance with the Actuarial Standards of Practice issued by the\nActuarial Standards Board.\n\n(1) Any rate or amount shall be considered excessive if it is unreasonably\nhigh for the insurance provided in relation to the underlying risks and costs\nafter due consideration of: (A) The experience of such filer; (B) such filer's\npast and projected costs, including amounts to be paid for commissions; (C)\nany transfers of funds to the holding or parent company, subsidiary or\naffiliate of such filer; (D) such filer's rate of return on assets or\nprofitability, as compared to similar filers; (E) a reasonable margin for\nprofit and contingencies; (F) any public comments received on such filing in\naccordance with the provisions of subparagraph (B) of subdivision (3) of\nsubsection (a) of this section; and (G) other factors the commissioner deems\nrelevant.\n\n(2) Any rate or amount shall be considered inadequate if such rate or amount\nis unreasonably low for the insurance provided in relation to the underlying\nrisks and costs and continued use of such rate or amount would endanger\nsolvency of such filer.\n\n(3) Any rate or amount shall be considered unfairly discriminatory if the\npremium charged for any classification is not reasonably related to the\nunderlying risks and costs, such that different premiums result for insureds\nwith similar risks and costs.\n\n(4) Any rate or amount shall be considered unaffordable if the commissioner\ndetermines such rate or amount is inconsistent with the inflation-adjusted\nConnecticut Health Affordability Index commissioned by the Office of Health\nStrategy and the Office of the State Comptroller, or another metric jointly\ndesignated by the commissioner and the Commissioner of Health Strategy.\n\n(d) Not later than thirty days after such public hearing held in accordance\nwith the provisions of subsection (b) of this section, the commissioner shall\nissue a written decision approving, disapproving or modifying such rate or\namount filing. Such decision shall specify all factors used to reach such\ndecision and shall be posted on the department's Internet web site not later\nthan two business days after the commissioner issues such decision.\n\nSec. 16. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176\nand 4-177a of the general statutes, the Healthcare Advocate or the Attorney\nGeneral, or both, may be parties to any public hearing held in accordance with\nthe provisions of section 15 of this act.\n\n(b) Subject to the provisions of section 4-181 of the general statutes, (1)\nthe Healthcare Advocate or the Attorney General, or both, shall have access to\nthe records of the Insurance Department regarding any rate or amount filing\nmade in accordance with the provisions of section 15 of this act, and (2)\nattorneys, actuaries, accountants and other experts who are part of the\nInsurance Commissioner's staff and who review or assist in the determination\nof such filing pursuant to the provisions of section 15 of this act shall\ncooperate with the Healthcare Advocate or Attorney General, or both, to carry\nout the provisions of this section.\n\n(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon\nand examine under oath such witnesses as the Healthcare Advocate or the\nAttorney General deems necessary for the review of a rate or amount filing\nmade in accordance with the provisions of section 15 of this act, and (2)\nrequire the filer or any holding or parent company or subsidiary of such filer\nto produce books, vouchers, memoranda, papers, letters, contracts and other\ndocuments, regardless of the format in which such materials are stored. Any\nsuch books, vouchers, memoranda, papers, letters, contracts or other documents\nshall be limited to such information or transactions between such filer and\nthe holding or parent company or subsidiary that are reasonably related to the\nsubject matter of the filing.\n\nSec. 17. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No individual health insurance policy providing coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes delivered, issued for delivery, renewed, amended or\ncontinued in this state on or after January 1, 2026, shall (1) if such policy\nprovides coverage for general anesthesia, (A) impose an arbitrary time limit\non reimbursement for general anesthesia provided during any medically\nnecessary procedure, or (B) deny, reduce, terminate or fail to provide such\nreimbursement, in whole or in part, for general anesthesia solely because the\nduration of care exceeded a predetermined time limit as determined by the\ninsurer, or (2) impose unilateral arbitrary limitations on reimbursement for\nmedically necessary ancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nSec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No group health insurance policy providing coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general\nstatutes delivered, issued for delivery, renewed, amended or continued in this\nstate on or after January 1, 2026, shall (1) if such policy provides coverage\nfor general anesthesia, (A) impose an arbitrary time limit on reimbursement\nfor general anesthesia provided during any medically necessary procedure, or\n(B) deny, reduce, terminate or fail to provide such reimbursement, in whole or\nin part, for general anesthesia solely because the duration of care exceeded a\npredetermined time limit as determined by the insurer, or (2) impose\nunilateral arbitrary limitations on reimbursement for medically necessary\nancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nThis act shall take effect as follows and shall amend the following sections:  \n  \n---  \nSection 1 | October 1, 2025 | New section  \nSec. 2 | October 1, 2025 | 38a-477ee(c)  \nSec. 3 | from passage | New section  \nSec. 4 | October 1, 2025 | New section  \nSec. 5 | January 1, 2026 | 38a-591c(a) and (b)  \nSec. 6 | January 1, 2026 | 38a-591e(c)  \nSec. 7 | January 1, 2026 | 38a-510  \nSec. 8 | January 1, 2026 | 38a-544  \nSec. 9 | July 1, 2026 | New section  \nSec. 10 | January 1, 2026 | 38a-481(a) to (c)  \nSec. 11 | January 1, 2026 | 38a-513  \nSec. 12 | January 1, 2026 | 38a-183(a)(1)  \nSec. 13 | January 1, 2026 | 38a-208(a)  \nSec. 14 | January 1, 2026 | 38a-218(a)  \nSec. 15 | January 1, 2026 | New section  \nSec. 16 | January 1, 2026 | New section  \nSec. 17 | January 1, 2026 | New section  \nSec. 18 | January 1, 2026 | New section  \n  \n**Statement of Legislative Commissioners:**\n\nIn Section 6(c)(1)(C)(i), \"_subdivision (1)_ \" was changed to \"_subdivision\n(2)_ \" for accuracy, in Section 15(c)(4), \"executive director of the Office of\nHealth Strategy\" was changed to \"Commissioner of Health Strategy\" for\naccuracy, and in Section 16(b)(2), \"the provisions of\" was added after\n\"pursuant to\" for consistency.\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": false
    },
    {
      "date": "04/02/2025",
      "label": "Substituted",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250402_0_S&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Substituted</td></tr> <tr><td class=\"label\">Version Date:</td> <td>04/02/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">\n    <b>General Assembly</b>\n   </p>\n   <p class=\"center\">\n    <b>Substitute Bill No. 10</b>\n   </p>\n   <p class=\"center\">\n    <b>January Session, 2025</b>\n   </p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <p class=\"indent\">Section 1. (NEW) (Effective October 1, 2025) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;Health carrier&quot; has the same meaning as provided in section 38a-1080 of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Mental health and substance use disorder benefits&quot; has the same meaning as provided in section 38a-477ee of the general statutes, as amended by this act.</p>\n   <p class=\"indent\">(b) (1) Not later than March 1, 2026, and annually thereafter, each health carrier shall file a certification with the Insurance Commissioner for the immediately preceding calendar year, certifying that such health carrier completed a review of such health carrier&#39;s administrative practices for compliance with the state and federal mental health and substance use disorder benefit reporting requirements pursuant to sections 38a-477ee, as amended by this act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510, as amended by this act, and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder. Such certification shall be signed by the chief executive officer and chief medical officer of such health carrier.</p>\n   <p class=\"indent\">(2) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding.</p>\n   <p class=\"indent\">(3) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year fail to comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding and identify (A) each administrative practice of such health carrier not in compliance with such state and federal mental health and substance use disorder benefit reporting requirements, and (B) action that such health carrier will take to bring such health carrier&#39;s administrative practices into compliance with such state and federal mental health and substance use disorder benefit reporting requirements.</p>\n   <p class=\"indent\">Sec. 2. Subsection (c) of section 38a-477ee of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2025):</p>\n   <p class=\"indent\">(c) <strike class=\"amendmentDeletedText\">(1)</strike> Not later than April 15, 2021, and annually thereafter, the Insurance Commissioner shall submit each report that the commissioner received pursuant to subsection (b) of this section for the calendar year immediately preceding to:</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(A)</strike>\n    <u class=\"amendmentInsertedText\">(1)</u> The joint standing committee of the General Assembly having cognizance of matters relating to insurance, in accordance with section 11-4a; and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(B)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> The Attorney General, Healthcare Advocate and Commissioner of Health Strategy.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2) Notwithstanding subdivision (1) of this subsection, the commissioner shall not submit the name or identity of any health carrier or entity that has contracted with such health carrier, and such name or identity shall be given confidential treatment and not be made public by the commissioner.</strike>\n   </p>\n   <p class=\"indent\">Sec. 3. (NEW) (Effective from passage) There is established an account to be known as the &quot;parity advancement account&quot; which shall be a separate, nonlapsing account within the General Fund. The account shall contain any moneys required by law to be deposited in the account and may receive donations from public or private sources. Moneys in the account shall be expended by the Insurance Department, beginning with the fiscal year ending June 30, 2026, for the purposes of enforcing the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act, conducting consumer education and other initiatives that support mental health parity implementation and enforcement on behalf of consumers.</p>\n   <p class=\"indent\">Sec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after providing an opportunity for a hearing in accordance with chapter 54 of the general statutes, may impose a civil penalty on any health carrier of not more than one hundred dollars with respect to each participant or beneficiary covered under a health insurance policy of such health carrier, provided such penalty shall not exceed an aggregate amount of one million dollars annually, for such health carrier&#39;s failure to comply with the certification requirements pursuant to the provisions of section 1 of this act, or the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act.</p>\n   <p class=\"indent\">(2) The commissioner may order the payment of such reasonable expenses as may be necessary to compensate the commissioner in conjunction with any proceedings under this section, which shall be dedicated to the enforcement and implementation of the state and federal mental health parity laws and regulations adopted thereunder.</p>\n   <p class=\"indent\">(b) (1) If any health carrier fails to file any data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, or section 1 of this act, the commissioner shall impose a late fee on such health carrier of one hundred dollars per day from the due date of such filing of data, report, certification or information to the date such health carrier submits such filing to the commissioner.</p>\n   <p class=\"indent\">(2) For any health carrier that files any incomplete data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, and section 1 of this act, the commissioner shall provide notice to such health carrier of such incomplete filing that includes (A) a description of such data, report, certification or other information that is incomplete and any additional data that is needed to consider such filing complete, and (B) the date by which such health carrier is required to provide such data. The commissioner shall impose a late fee on such health carrier of one hundred dollars per day, commencing from the date identified by the commissioner pursuant to subparagraph (B) of this subdivision.</p>\n   <p class=\"indent\">(c) The commissioner may waive any civil penalty imposed pursuant to subsection (a) of this section if the commissioner determines that the violation was due to reasonable cause and was not due to wilful neglect, or if such violation is corrected not more than thirty days after the date that the health carrier filed a certification of noncompliance with the commissioner pursuant to section 1 of this act.</p>\n   <p class=\"indent\">(d) All civil penalties and late fees received by the commissioner pursuant to this section shall be deposited in the General Fund and credited to the parity advancement account established pursuant to section 3 of this act.</p>\n   <p class=\"indent\">Sec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) Each health carrier shall contract with (A) health care professionals to administer such health carrier&#39;s utilization review program, and (B) clinical peers to evaluate the clinical appropriateness of an adverse determination.</p>\n   <p class=\"indent\">(2) (A) Each utilization review program shall use documented clinical review criteria that are based on sound clinical evidence and are evaluated periodically by the health carrier&#39;s organizational mechanism specified in subparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to <strike class=\"amendmentDeletedText\">assure</strike>\n    <u class=\"amendmentInsertedText\">ensure</u> such program&#39;s ongoing effectiveness.</p>\n   <p class=\"indent\">(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a health carrier may develop its own clinical review criteria or it may purchase or license clinical review criteria from qualified vendors approved by the commissioner, provided such clinical review criteria conform to the requirements of subparagraph (A) of this subdivision.</p>\n   <p class=\"indent\">(C) Each health carrier shall (i) post on its Internet web site (I) any clinical review criteria it uses, and (II) links to any rule, guideline, protocol or other similar criterion a health carrier may rely upon to make an adverse determination as described in subparagraph (F) of subdivision (1) of subsection (e) of section 38a-591d, and (ii) make its clinical review criteria available upon request to authorized government agencies.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(D) For each utilization review, there shall be a rebuttable presumption that each health care service under review is medically necessary if such health care service was ordered by a health care professional acting within such health care professional&#39;s scope of practice. Any utilization review company performing such review of a health care service shall have the burden of proving that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">(3) For any utilization review for the treatment of a substance use disorder, as described in section 17a-458, the clinical review criteria used shall be: (A) The most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a substance use disorder, that are not covered in the most recent edition of the American Society of Addiction Medicine Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(4) For any utilization review for the treatment of a child or adolescent mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of a child or adolescent mental disorder, that are not covered in the most recent guidelines of the American Academy of Child and Adolescent Psychiatry&#39;s Child and Adolescent Service Intensity Instrument. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(5) For any utilization review for the treatment of an adult mental disorder, the clinical review criteria used shall be: (A) The most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare; or (B) clinical review criteria that the health carrier demonstrates to the Insurance Department is consistent with the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare, except that nothing in this subdivision shall prohibit a health carrier from developing its own clinical review criteria or purchasing or licensing additional clinical review criteria from qualified vendors approved by the commissioner, to address advancements in technology or types of care for the treatment of an adult mental disorder, that are not covered in the most recent guidelines of the American Psychiatric Association or the most recent Standards and Guidelines of the Association for Ambulatory Behavioral Healthcare. Any such clinical review criteria developed by a health carrier or purchased or licensed from a qualified vendor shall conform to the requirements of subparagraph (A) of subdivision (2) of this subsection.</p>\n   <p class=\"indent\">(b) Each health carrier shall:</p>\n   <p class=\"indent\">(1) Have procedures in place to ensure that (A) the health care professionals administering such health carrier&#39;s utilization review program are applying the clinical review criteria consistently in utilization review determinations, and (B) the appropriate or required individual or individuals are being designated to conduct utilization reviews;</p>\n   <p class=\"indent\">(2) Have data systems sufficient to support utilization review program activities and to generate management reports to enable the health carrier to monitor and manage health care services effectively;</p>\n   <p class=\"indent\">(3) Provide covered persons and participating providers with access to its utilization review staff through a toll-free telephone number or any other free calling option or by electronic means;</p>\n   <p class=\"indent\">(4) Coordinate the utilization review program with other medical management activity conducted by the health carrier, such as quality assurance, credentialing, contracting with health care professionals, data reporting, grievance procedures, processes for assessing member satisfaction and risk management; <strike class=\"amendmentDeletedText\">and</strike>\n   </p>\n   <p class=\"indent\">(5) Routinely assess the effectiveness and efficiency of its utilization review program<u class=\"amendmentInsertedText\">; and</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(6) Not use any system that employs artificial intelligence, as defined in section 51-10e, or any other algorithm in lieu of a review by a clinical peer to evaluate the clinical appropriateness of an adverse determination pursuant to a contract between such clinical peer and such health carrier</u>.</p>\n   <p class=\"indent\">Sec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(c) (1) (A) When conducting a review of an adverse determination under this section, the health carrier shall ensure that such review is conducted in a manner to ensure the independence and impartiality of the clinical peer or peers involved in making the review decision.</p>\n   <p class=\"indent\">(B) If the adverse determination involves utilization review, the health carrier shall designate an appropriate clinical peer or peers to review such adverse determination. Such clinical peer or peers shall not have been involved in the initial adverse determination.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D) of subdivision (2) of subsection (a) of section 38a-591c, as amended by this act, the health carrier may rebut such presumption by reasonably substantiating to the clinical peer or peers conducting the review pursuant to the provisions of this section that such health care service is not medically necessary.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(C)</strike>\n    <u class=\"amendmentInsertedText\">(ii)</u> The clinical peer or peers conducting a review under this section shall take into consideration all comments, documents, records and other information relevant to the covered person&#39;s benefit request that is the subject of the adverse determination under review, that are submitted by the covered person or the covered person&#39;s authorized representative, regardless of whether such information was submitted or considered in making the initial adverse determination.</p>\n   <p class=\"indent\">(D) Prior to issuing a decision, the health carrier shall provide free of charge, by facsimile, electronic means or any other expeditious method available, to the covered person or the covered person&#39;s authorized representative, as applicable, any new or additional documents, communications, information and evidence relied upon and any new or additional scientific or clinical rationale used by the health carrier in connection with the grievance. Such documents, communications, information, evidence and rationale shall be provided sufficiently in advance of the date the health carrier is required to issue a decision to permit the covered person or the covered person&#39;s authorized representative, as applicable, a reasonable opportunity to respond prior to such date.</p>\n   <p class=\"indent\">(2) If the review under subdivision (1) of this subsection is an expedited review, all necessary information, including the health carrier&#39;s decision, shall be transmitted between the health carrier and the covered person or the covered person&#39;s authorized representative, as applicable, by telephone, facsimile, electronic means or any other expeditious method available.</p>\n   <p class=\"indent\">(3) If the review under subdivision (1) of this subsection is an expedited review of a grievance involving an adverse determination of a concurrent review request, pursuant to 45 CFR 147.136, as amended from time to time, the treatment shall be continued without liability to the covered person until the covered person has been notified of the review decision.</p>\n   <p class=\"indent\">Sec. 7. Section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) for a prescribed drug for <strike class=\"amendmentDeletedText\">cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-492i.</p>\n   <p class=\"indent\">Sec. 8. Section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than <strike class=\"amendmentDeletedText\">thirty</strike>\n    <u class=\"amendmentInsertedText\">twenty</u> days, (B) for a prescribed drug for <strike class=\"amendmentDeletedText\">cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer</strike>\n    <u class=\"amendmentInsertedText\">the treatment of a disabling or life-threatening chronic disease or condition,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, <strike class=\"amendmentDeletedText\">or</strike> (C) for the period commencing January 1, 2024, and ending January 1, 2027, inclusive, for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;<u class=\"amendmentInsertedText\">, or (D) for a prescribed drug for the treatment of a mental or behavioral health condition, provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications</u>.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in <strike class=\"amendmentDeletedText\">subparagraph (B) or (C)</strike>\n    <u class=\"amendmentInsertedText\">subparagraphs (B) to (D), inclusive,</u> of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">twenty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive<u class=\"amendmentInsertedText\">, as amended by this act</u>, or (2) affect the provisions of section 38a-518i.</p>\n   <p class=\"indent\">Sec. 9 (NEW) (Effective July 1, 2026) (a) Each insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity that enters into, renews or amends a contract with a health care provider on or after July 1, 2026, to provide covered benefits to insureds or enrollees in this state shall include in such contract:</p>\n   <p class=\"indent\">(1) A provision requiring such insurer, health care center, hospital service corporation, medical service corporation, preferred provider network or other entity to:</p>\n   <p class=\"indent\">(A) Reimburse the contracting health care provider for a covered outpatient benefit that uses a current procedural terminology evaluation and management (CPT E/M) code, current procedural terminology assessment and management (CPT A/M) code or drug infusion code in an amount that does not vary based on the facility where the contracting health care provider provides such benefit; and</p>\n   <p class=\"indent\">(B) Use equal reimbursement rates for all contracting health care providers in the same geographic region, as determined by the Insurance Commissioner, in accordance with the provisions of chapter 54 of the general statutes, and regardless of the employer or affiliation of any contracting health care provider, for each covered outpatient benefit described in subparagraph (A) of this subdivision if the reimbursement for such covered outpatient benefit is made on a fee-for-benefit basis or on the basis of bundled benefits per diagnosis, condition, procedure or another standardized bundle of health care benefits; and</p>\n   <p class=\"indent\">(2) A conspicuous statement that such contract complies with the provisions of subdivision (1) of this subsection.</p>\n   <p class=\"indent\">(b) The Insurance Commissioner shall adopt regulations, in accordance with the provisions of chapter 54 of the general statutes, to implement the provisions of this section, including, but not limited to, the establishment of geographic regions pursuant to the provisions of subparagraph (B) of subdivision (1) of subsection (a) of this section.</p>\n   <p class=\"indent\">Sec. 10. Subsections (a) to (c), inclusive, of section 38a-481 of the general statutes are repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No individual health insurance policy shall be delivered or issued for delivery to any person in this state, nor shall any application, rider or endorsement be used in connection with such policy, until a copy of the form thereof and of the classification of risks and the premium rates have been filed with the commissioner. Rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, <u class=\"amendmentInsertedText\">the requirements established in section 15 of this act,</u> and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. The commissioner may adopt regulations, in accordance with the provisions of chapter 54, to establish a procedure for reviewing such policies. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such orders. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">(b) <u class=\"amendmentInsertedText\">(1)</u> No rate filed under the provisions of subsection (a) of this section shall be effective until it has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> unfairly discriminatory <strike class=\"amendmentDeletedText\">. The commissioner may disapprove such rate if it fails to comply with such standards, except that no rate filed under the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with section 38a-474</strike>\n    <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for health insurance that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(c) (1) No rate filed in accordance with the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with the provisions of section 38a-474.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">Sec. 11. Section 38a-513 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) <strike class=\"amendmentDeletedText\">(1)</strike> No group health insurance policy, as defined by the commissioner, or certificate shall be delivered or issued for delivery in this state unless a copy of the form for such policy or certificate has been submitted to and approved by the commissioner under the regulations adopted pursuant to this section. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, concerning the provisions, submission and approval of such policies and certificates and establishing a procedure for reviewing such policies and certificates. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such order.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(b) (1) No rate filed in accordance with the provisions of subsection (a) of this section shall be effective until such rate has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection or as provided under subdivision (2) of this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate, unfairly discriminatory or unaffordable pursuant to the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(2) Any rate filed in accordance with the provisions of subsection (a) of this section for a group health insurance policy that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be approved in accordance with the provisions of section 15 of this act.</u>\n   </p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2)</strike>\n    <u class=\"amendmentInsertedText\">(c)</u> No group health insurance policy or certificate for a small employer, as defined in section 38a-564, shall be delivered or issued for delivery in this state unless the premium rates have been submitted to and approved by the commissioner <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Premium rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, <u class=\"amendmentInsertedText\">the requirements set forth in section 15 of this act,</u> and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. As used in this subdivision, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(b)</strike>\n    <u class=\"amendmentInsertedText\">(d)</u> No insurance company, fraternal benefit society, hospital service corporation, medical service corporation, health care center or other entity that delivers or issues for delivery in this state any Medicare supplement policies or certificates shall incorporate in its rates or determinations to grant coverage for Medicare supplement insurance policies or certificates any factors or values based on the age, gender, previous claims history or the medical condition of any person covered by such policy or certificate.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(c)</strike>\n    <u class=\"amendmentInsertedText\">(e)</u> Nothing in this chapter shall preclude the issuance of a group health insurance policy that includes an optional life insurance rider, provided the optional life insurance rider shall be filed with and approved by the Insurance Commissioner pursuant to section 38a-430. Any company offering such policies for sale in this state shall be licensed to sell life insurance in this state pursuant to the provisions of section 38a-41.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(d)</strike>\n    <u class=\"amendmentInsertedText\">(f)</u> Not later than January 1, 2009, the commissioner shall adopt regulations, in accordance with chapter 54, to establish minimum standards for benefits in group specified disease policies, certificates, riders, endorsements and benefits.</p>\n   <p class=\"indent\">Sec. 12. Subdivision (1) of subsection (a) of section 38a-183 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) (1) A health care center governed by sections 38a-175 to 38a-194, inclusive, shall not enter into any agreement with subscribers unless and until <strike class=\"amendmentDeletedText\">it</strike>\n    <u class=\"amendmentInsertedText\">such health care center</u> has filed with the commissioner a full schedule of the amounts to be paid by the subscribers and has obtained the commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include the information and data required under section 38a-479qqq if the contract or policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract or policy. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such amounts to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant tothe provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 13. Subsection (a) of section 38a-208 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscribers and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates to</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not</u> be excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 14. Subsection (a) of section 38a-218 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No such medical service corporation shall enter into any contract with subscribers unless and until it has filed with the Insurance Commissioner a full schedule of the rates to be paid by the subscriber and has obtained said commissioner&#39;s approval <strike class=\"amendmentDeletedText\">thereof</strike>\n    <u class=\"amendmentInsertedText\">in accordance with the provisions of section 15 of this act</u>. Such filing shall include an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the contract. The commissioner <strike class=\"amendmentDeletedText\">may refuse such approval if the commissioner finds such rates are</strike>\n    <u class=\"amendmentInsertedText\">shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such amounts shall not be</u> excessive, inadequate<u class=\"amendmentInsertedText\">,</u>\n    <strike class=\"amendmentDeletedText\">or</strike> discriminatory <u class=\"amendmentInsertedText\">or unaffordable pursuant to the provisions of section 15 of this act</u>. As used in this subsection, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 15. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health insurance policy, agreement or contract that provides coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes, any (A) rate filed for such policy pursuant to section 38a-481 of the general statutes, as amended by this act, (B) rate filed for such policy pursuant to section 38a-513 of the general statutes, as amended by this act, (C) schedule of amounts filed for such agreement pursuant to section 38a-183 of the general statutes, as amended by this act, (D) schedule of rates filed for such contract pursuant to section 38a-208 of the general statutes, as amended by this act, or (E) schedule of rates filed for such contract pursuant to section 38a-218 of the general statutes, as amended by this act, on or after January 1, 2026, shall be filed not later than one hundred twenty calendar days prior to the proposed effective date of such rates or amounts.</p>\n   <p class=\"indent\">(2) Each filer making a rate or amount filing pursuant to this subsection shall, on the date such filer submits such rate or amount filing to the Insurance Commissioner, include with such filer&#39;s rate or amount filing an actuarial memorandum, certified by a qualified actuary, that to the best of such actuary&#39;s knowledge, (A) such rate or amount filing is in compliance with the laws of this state and federal law, as applicable, and (B) the rate or amount filing is not excessive, as described in subdivision (1) of subsection (c) of this section. For the purposes of this subparagraph, &quot;qualified actuary&quot; means a member in good standing of the American Academy of Actuaries who is qualified in accordance with the standards of the American Academy of Actuaries.</p>\n   <p class=\"indent\">(3) (A) Notwithstanding the provisions of section 38a-69a of the general statutes, the Insurance Department shall post on the department&#39;s Internet web site all documents, materials and other information provided to or requested by the department in relation to any such rate or amount filing made pursuant to this subsection, including, but not limited to, financial reports, financial statements, actuarial reports and actuarial memoranda. Such rate or amount filing and such documents, materials and other information shall be posted on such web site not later than three business days after the department receives such filing, and such posting shall be updated to include any correspondence between the department and such filer.</p>\n   <p class=\"indent\">(B) The department shall provide for a written public comment period of not less than thirty calendar days following the posting of such filing. The department shall include in such posting the date such public comment period closes and instructions for the public to submit comments to the department.</p>\n   <p class=\"indent\">(b) (1) The commissioner shall hold a public hearing for each rate or amount filed under the provisions of subdivision (1) of subsection (a) of this section. Not later than five business days after the posting of such rate or amount filing on the department&#39;s Internet web site in accordance with the provisions of subparagraph (A) of subdivision (3) of subsection (a) of this section, the commissioner shall set a public hearing date for such rate or amount filing and shall post the date, place and time of such public hearing in a conspicuous place on the department&#39;s Internet web site.</p>\n   <p class=\"indent\">(2) Such public hearing shall be (A) held after the end of the public comment period specified in subparagraph (B) of subdivision (3) of subsection (a) of this section, but not later than prior to the proposed effective date of such rate or amount, at a place and time that is convenient to the public, and (B) conducted in accordance with the provisions of chapter 54 of the general statutes, this section and section 16 of this act.</p>\n   <p class=\"indent\">(3) Upon setting the date, place and time of the public hearing for such rate or amount filing, the commissioner shall immediately notify the filer of such rate or amount filing of the date, place and time of the public hearing.</p>\n   <p class=\"indent\">(c) The commissioner shall not approve a rate or amount filing submitted in accordance with the provisions of this section if such rate or amount filing is excessive, inadequate, unfairly discriminatory or unaffordable. The commissioner shall conduct an actuarial review to determine if the methodology and assumptions used to develop such rate or amount filing are actuarially sound and in compliance with the Actuarial Standards of Practice issued by the Actuarial Standards Board.</p>\n   <p class=\"indent\">(1) Any rate or amount shall be considered excessive if it is unreasonably high for the insurance provided in relation to the underlying risks and costs after due consideration of: (A) The experience of such filer; (B) such filer&#39;s past and projected costs, including amounts to be paid for commissions; (C) any transfers of funds to the holding or parent company, subsidiary or affiliate of such filer; (D) such filer&#39;s rate of return on assets or profitability, as compared to similar filers; (E) a reasonable margin for profit and contingencies; (F) any public comments received on such filing in accordance with the provisions of subparagraph (B) of subdivision (3) of subsection (a) of this section; and (G) other factors the commissioner deems relevant.</p>\n   <p class=\"indent\">(2) Any rate or amount shall be considered inadequate if such rate or amount is unreasonably low for the insurance provided in relation to the underlying risks and costs and continued use of such rate or amount would endanger solvency of such filer.</p>\n   <p class=\"indent\">(3) Any rate or amount shall be considered unfairly discriminatory if the premium charged for any classification is not reasonably related to the underlying risks and costs, such that different premiums result for insureds with similar risks and costs.</p>\n   <p class=\"indent\">(4) Any rate or amount shall be considered unaffordable if the commissioner determines such rate or amount is inconsistent with the inflation-adjusted Connecticut Health Affordability Index commissioned by the Office of Health Strategy and the Office of the State Comptroller, or another metric jointly designated by the commissioner and the Commissioner of Health Strategy.</p>\n   <p class=\"indent\">(d) Not later than thirty days after such public hearing held in accordance with the provisions of subsection (b) of this section, the commissioner shall issue a written decision approving, disapproving or modifying such rate or amount filing. Such decision shall specify all factors used to reach such decision and shall be posted on the department&#39;s Internet web site not later than two business days after the commissioner issues such decision.</p>\n   <p class=\"indent\">Sec. 16. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176 and 4-177a of the general statutes, the Healthcare Advocate or the Attorney General, or both, may be parties to any public hearing held in accordance with the provisions of section 15 of this act.</p>\n   <p class=\"indent\">(b) Subject to the provisions of section 4-181 of the general statutes, (1) the Healthcare Advocate or the Attorney General, or both, shall have access to the records of the Insurance Department regarding any rate or amount filing made in accordance with the provisions of section 15 of this act, and (2) attorneys, actuaries, accountants and other experts who are part of the Insurance Commissioner&#39;s staff and who review or assist in the determination of such filing pursuant to the provisions of section 15 of this act shall cooperate with the Healthcare Advocate or Attorney General, or both, to carry out the provisions of this section.</p>\n   <p class=\"indent\">(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon and examine under oath such witnesses as the Healthcare Advocate or the Attorney General deems necessary for the review of a rate or amount filing made in accordance with the provisions of section 15 of this act, and (2) require the filer or any holding or parent company or subsidiary of such filer to produce books, vouchers, memoranda, papers, letters, contracts and other documents, regardless of the format in which such materials are stored. Any such books, vouchers, memoranda, papers, letters, contracts or other documents shall be limited to such information or transactions between such filer and the holding or parent company or subsidiary that are reasonably related to the subject matter of the filing.</p>\n   <p class=\"indent\">Sec. 17. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <p class=\"indent\">Sec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medical necessity&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall (1) if such policy provides coverage for general anesthesia, (A) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (B) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer, or (2) impose unilateral arbitrary limitations on reimbursement for medically necessary ancillary services.</p>\n   <p class=\"indent\">(c) The medical necessity for administering general anesthesia during any medical procedure shall be determined by the attending board-certified anesthesiologist during such medical procedure.</p>\n   <table>\n    <tr>\n     <td colspan=\"3\">This act shall take effect as follows and shall amend the following sections:<br/>\n     </td>\n    </tr>\n    <tr>\n     <td>Section 1</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 2</td>\n     <td>October 1, 2025</td>\n     <td>38a-477ee(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 3</td>\n     <td>from passage</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 4</td>\n     <td>October 1, 2025</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 5</td>\n     <td>January 1, 2026</td>\n     <td>38a-591c(a) and (b)</td>\n    </tr>\n    <tr>\n     <td>Sec. 6</td>\n     <td>January 1, 2026</td>\n     <td>38a-591e(c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 7</td>\n     <td>January 1, 2026</td>\n     <td>38a-510</td>\n    </tr>\n    <tr>\n     <td>Sec. 8</td>\n     <td>January 1, 2026</td>\n     <td>38a-544</td>\n    </tr>\n    <tr>\n     <td>Sec. 9</td>\n     <td>July 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 10</td>\n     <td>January 1, 2026</td>\n     <td>38a-481(a) to (c)</td>\n    </tr>\n    <tr>\n     <td>Sec. 11</td>\n     <td>January 1, 2026</td>\n     <td>38a-513</td>\n    </tr>\n    <tr>\n     <td>Sec. 12</td>\n     <td>January 1, 2026</td>\n     <td>38a-183(a)(1)</td>\n    </tr>\n    <tr>\n     <td>Sec. 13</td>\n     <td>January 1, 2026</td>\n     <td>38a-208(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 14</td>\n     <td>January 1, 2026</td>\n     <td>38a-218(a)</td>\n    </tr>\n    <tr>\n     <td>Sec. 15</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 16</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 17</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n    <tr>\n     <td>Sec. 18</td>\n     <td>January 1, 2026</td>\n     <td>New section</td>\n    </tr>\n   </table>\n   <p class=\"indent\">\n    <b>Statement of Legislative Commissioners: </b>\n   </p>\n   <p class=\"indent\">In Section 6(c)(1)(C)(i), &quot;<u class=\"amendmentInsertedText\">subdivision (1)</u>&quot; was changed to &quot;<u class=\"amendmentInsertedText\">subdivision (2)</u>&quot; for accuracy, in Section 15(c)(4), &quot;executive director of the Office of Health Strategy&quot; was changed to &quot;Commissioner of Health Strategy&quot; for accuracy, and in Section 16(b)(2), &quot;the provisions of&quot; was added after &quot;pursuant to&quot; for consistency.</p>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Substituted  \nVersion Date: | 04/02/2025  \n  \n**STATE OF CONNECTICUT**\n\n**General Assembly**\n\n**Substitute Bill No. 10**\n\n**January Session, 2025**\n\nAN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nSection 1. (NEW) (Effective October 1, 2025) (a) As used in this section:\n\n(1) \"Health carrier\" has the same meaning as provided in section 38a-1080 of\nthe general statutes; and\n\n(2) \"Mental health and substance use disorder benefits\" has the same meaning\nas provided in section 38a-477ee of the general statutes, as amended by this\nact.\n\n(b) (1) Not later than March 1, 2026, and annually thereafter, each health\ncarrier shall file a certification with the Insurance Commissioner for the\nimmediately preceding calendar year, certifying that such health carrier\ncompleted a review of such health carrier's administrative practices for\ncompliance with the state and federal mental health and substance use disorder\nbenefit reporting requirements pursuant to sections 38a-477ee, as amended by\nthis act, 38a-488c, 38a-488d, 38a-514c, 38a-514d, 38a-488a, 38a-514, 38a-510,\nas amended by this act, and 38a-544 of the general statutes, as amended by\nthis act, and the provisions of the federal Paul Wellstone and Pete Domenici\nMental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as\namended from time to time, and regulations adopted thereunder. Such\ncertification shall be signed by the chief executive officer and chief medical\nofficer of such health carrier.\n\n(2) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year comply\nwith the state and federal mental health and substance use disorder benefit\nreporting requirements identified in subdivision (1) of this subsection, such\ncertification filed pursuant to subdivision (1) of this subsection shall state\nsuch finding.\n\n(3) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year fail to\ncomply with the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of this\nsubsection, such certification filed pursuant to subdivision (1) of this\nsubsection shall state such finding and identify (A) each administrative\npractice of such health carrier not in compliance with such state and federal\nmental health and substance use disorder benefit reporting requirements, and\n(B) action that such health carrier will take to bring such health carrier's\nadministrative practices into compliance with such state and federal mental\nhealth and substance use disorder benefit reporting requirements.\n\nSec. 2. Subsection (c) of section 38a-477ee of the general statutes is\nrepealed and the following is substituted in lieu thereof (Effective October\n1, 2025):\n\n(c) ~~(1)~~ Not later than April 15, 2021, and annually thereafter, the\nInsurance Commissioner shall submit each report that the commissioner received\npursuant to subsection (b) of this section for the calendar year immediately\npreceding to:\n\n~~(A)~~ _(1)_ The joint standing committee of the General Assembly having\ncognizance of matters relating to insurance, in accordance with section 11-4a;\nand\n\n~~(B)~~ _(2)_ The Attorney General, Healthcare Advocate and Commissioner of\nHealth Strategy.\n\n~~(2) Notwithstanding subdivision (1) of this subsection, the commissioner\nshall not submit the name or identity of any health carrier or entity that has\ncontracted with such health carrier, and such name or identity shall be given\nconfidential treatment and not be made public by the commissioner.~~\n\nSec. 3. (NEW) (Effective from passage) There is established an account to be\nknown as the \"parity advancement account\" which shall be a separate,\nnonlapsing account within the General Fund. The account shall contain any\nmoneys required by law to be deposited in the account and may receive\ndonations from public or private sources. Moneys in the account shall be\nexpended by the Insurance Department, beginning with the fiscal year ending\nJune 30, 2026, for the purposes of enforcing the state and federal mental\nhealth and substance use disorder benefit reporting requirements identified in\nsubdivision (1) of subsection (b) of section 1 of this act, conducting\nconsumer education and other initiatives that support mental health parity\nimplementation and enforcement on behalf of consumers.\n\nSec. 4. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after\nproviding an opportunity for a hearing in accordance with chapter 54 of the\ngeneral statutes, may impose a civil penalty on any health carrier of not more\nthan one hundred dollars with respect to each participant or beneficiary\ncovered under a health insurance policy of such health carrier, provided such\npenalty shall not exceed an aggregate amount of one million dollars annually,\nfor such health carrier's failure to comply with the certification\nrequirements pursuant to the provisions of section 1 of this act, or the state\nand federal mental health and substance use disorder benefit reporting\nrequirements identified in subdivision (1) of subsection (b) of section 1 of\nthis act.\n\n(2) The commissioner may order the payment of such reasonable expenses as may\nbe necessary to compensate the commissioner in conjunction with any\nproceedings under this section, which shall be dedicated to the enforcement\nand implementation of the state and federal mental health parity laws and\nregulations adopted thereunder.\n\n(b) (1) If any health carrier fails to file any data, report, certification or\nother information required by the provisions of section 38a-477ee of the\ngeneral statutes, as amended by this act, or section 1 of this act, the\ncommissioner shall impose a late fee on such health carrier of one hundred\ndollars per day from the due date of such filing of data, report,\ncertification or information to the date such health carrier submits such\nfiling to the commissioner.\n\n(2) For any health carrier that files any incomplete data, report,\ncertification or other information required by the provisions of section\n38a-477ee of the general statutes, as amended by this act, and section 1 of\nthis act, the commissioner shall provide notice to such health carrier of such\nincomplete filing that includes (A) a description of such data, report,\ncertification or other information that is incomplete and any additional data\nthat is needed to consider such filing complete, and (B) the date by which\nsuch health carrier is required to provide such data. The commissioner shall\nimpose a late fee on such health carrier of one hundred dollars per day,\ncommencing from the date identified by the commissioner pursuant to\nsubparagraph (B) of this subdivision.\n\n(c) The commissioner may waive any civil penalty imposed pursuant to\nsubsection (a) of this section if the commissioner determines that the\nviolation was due to reasonable cause and was not due to wilful neglect, or if\nsuch violation is corrected not more than thirty days after the date that the\nhealth carrier filed a certification of noncompliance with the commissioner\npursuant to section 1 of this act.\n\n(d) All civil penalties and late fees received by the commissioner pursuant to\nthis section shall be deposited in the General Fund and credited to the parity\nadvancement account established pursuant to section 3 of this act.\n\nSec. 5. Subsections (a) and (b) of section 38a-591c of the general statutes\nare repealed and the following is substituted in lieu thereof (Effective\nJanuary 1, 2026):\n\n(a) (1) Each health carrier shall contract with (A) health care professionals\nto administer such health carrier's utilization review program, and (B)\nclinical peers to evaluate the clinical appropriateness of an adverse\ndetermination.\n\n(2) (A) Each utilization review program shall use documented clinical review\ncriteria that are based on sound clinical evidence and are evaluated\nperiodically by the health carrier's organizational mechanism specified in\nsubparagraph (F) of subdivision (2) of subsection (c) of section 38a-591b to\n~~assure~~ _ensure_ such program's ongoing effectiveness.\n\n(B) Except as provided in subdivisions (3), (4) and (5) of this subsection, a\nhealth carrier may develop its own clinical review criteria or it may purchase\nor license clinical review criteria from qualified vendors approved by the\ncommissioner, provided such clinical review criteria conform to the\nrequirements of subparagraph (A) of this subdivision.\n\n(C) Each health carrier shall (i) post on its Internet web site (I) any\nclinical review criteria it uses, and (II) links to any rule, guideline,\nprotocol or other similar criterion a health carrier may rely upon to make an\nadverse determination as described in subparagraph (F) of subdivision (1) of\nsubsection (e) of section 38a-591d, and (ii) make its clinical review criteria\navailable upon request to authorized government agencies.\n\n_(D) For each utilization review, there shall be a rebuttable presumption that\neach health care service under review is medically necessary if such health\ncare service was ordered by a health care professional acting within such\nhealth care professional 's scope of practice. Any utilization review company\nperforming such review of a health care service shall have the burden of\nproving that such health care service is not medically necessary._\n\n(3) For any utilization review for the treatment of a substance use disorder,\nas described in section 17a-458, the clinical review criteria used shall be:\n(A) The most recent edition of the American Society of Addiction Medicine\nTreatment Criteria for Addictive, Substance-Related, and Co-Occurring\nConditions; or (B) clinical review criteria that the health carrier\ndemonstrates to the Insurance Department is consistent with the most recent\nedition of the American Society of Addiction Medicine Treatment Criteria for\nAddictive, Substance-Related, and Co-Occurring Conditions, except that nothing\nin this subdivision shall prohibit a health carrier from developing its own\nclinical review criteria or purchasing or licensing additional clinical review\ncriteria from qualified vendors approved by the commissioner, to address\nadvancements in technology or types of care for the treatment of a substance\nuse disorder, that are not covered in the most recent edition of the American\nSociety of Addiction Medicine Treatment Criteria for Addictive, Substance-\nRelated, and Co-Occurring Conditions. Any such clinical review criteria\ndeveloped by a health carrier or purchased or licensed from a qualified vendor\nshall conform to the requirements of subparagraph (A) of subdivision (2) of\nthis subsection.\n\n(4) For any utilization review for the treatment of a child or adolescent\nmental disorder, the clinical review criteria used shall be: (A) The most\nrecent guidelines of the American Academy of Child and Adolescent Psychiatry's\nChild and Adolescent Service Intensity Instrument; or (B) clinical review\ncriteria that the health carrier demonstrates to the Insurance Department is\nconsistent with the most recent guidelines of the American Academy of Child\nand Adolescent Psychiatry's Child and Adolescent Service Intensity Instrument,\nexcept that nothing in this subdivision shall prohibit a health carrier from\ndeveloping its own clinical review criteria or purchasing or licensing\nadditional clinical review criteria from qualified vendors approved by the\ncommissioner, to address advancements in technology or types of care for the\ntreatment of a child or adolescent mental disorder, that are not covered in\nthe most recent guidelines of the American Academy of Child and Adolescent\nPsychiatry's Child and Adolescent Service Intensity Instrument. Any such\nclinical review criteria developed by a health carrier or purchased or\nlicensed from a qualified vendor shall conform to the requirements of\nsubparagraph (A) of subdivision (2) of this subsection.\n\n(5) For any utilization review for the treatment of an adult mental disorder,\nthe clinical review criteria used shall be: (A) The most recent guidelines of\nthe American Psychiatric Association or the most recent Standards and\nGuidelines of the Association for Ambulatory Behavioral Healthcare; or (B)\nclinical review criteria that the health carrier demonstrates to the Insurance\nDepartment is consistent with the most recent guidelines of the American\nPsychiatric Association or the most recent Standards and Guidelines of the\nAssociation for Ambulatory Behavioral Healthcare, except that nothing in this\nsubdivision shall prohibit a health carrier from developing its own clinical\nreview criteria or purchasing or licensing additional clinical review criteria\nfrom qualified vendors approved by the commissioner, to address advancements\nin technology or types of care for the treatment of an adult mental disorder,\nthat are not covered in the most recent guidelines of the American Psychiatric\nAssociation or the most recent Standards and Guidelines of the Association for\nAmbulatory Behavioral Healthcare. Any such clinical review criteria developed\nby a health carrier or purchased or licensed from a qualified vendor shall\nconform to the requirements of subparagraph (A) of subdivision (2) of this\nsubsection.\n\n(b) Each health carrier shall:\n\n(1) Have procedures in place to ensure that (A) the health care professionals\nadministering such health carrier's utilization review program are applying\nthe clinical review criteria consistently in utilization review\ndeterminations, and (B) the appropriate or required individual or individuals\nare being designated to conduct utilization reviews;\n\n(2) Have data systems sufficient to support utilization review program\nactivities and to generate management reports to enable the health carrier to\nmonitor and manage health care services effectively;\n\n(3) Provide covered persons and participating providers with access to its\nutilization review staff through a toll-free telephone number or any other\nfree calling option or by electronic means;\n\n(4) Coordinate the utilization review program with other medical management\nactivity conducted by the health carrier, such as quality assurance,\ncredentialing, contracting with health care professionals, data reporting,\ngrievance procedures, processes for assessing member satisfaction and risk\nmanagement; ~~and~~\n\n(5) Routinely assess the effectiveness and efficiency of its utilization\nreview program _; and_\n\n_(6) Not use any system that employs artificial intelligence, as defined in\nsection 51-10e, or any other algorithm in lieu of a review by a clinical peer\nto evaluate the clinical appropriateness of an adverse determination pursuant\nto a contract between such clinical peer and such health carrier_.\n\nSec. 6. Subsection (c) of section 38a-591e of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(c) (1) (A) When conducting a review of an adverse determination under this\nsection, the health carrier shall ensure that such review is conducted in a\nmanner to ensure the independence and impartiality of the clinical peer or\npeers involved in making the review decision.\n\n(B) If the adverse determination involves utilization review, the health\ncarrier shall designate an appropriate clinical peer or peers to review such\nadverse determination. Such clinical peer or peers shall not have been\ninvolved in the initial adverse determination.\n\n_(C)(i) To effectuate the rebuttable presumption pursuant to subparagraph (D)\nof subdivision (2) of subsection (a) of section 38a-591c, as amended by this\nact, the health carrier may rebut such presumption by reasonably\nsubstantiating to the clinical peer or peers conducting the review pursuant to\nthe provisions of this section that such health care service is not medically\nnecessary._\n\n~~(C)~~ _(ii)_ The clinical peer or peers conducting a review under this\nsection shall take into consideration all comments, documents, records and\nother information relevant to the covered person's benefit request that is the\nsubject of the adverse determination under review, that are submitted by the\ncovered person or the covered person's authorized representative, regardless\nof whether such information was submitted or considered in making the initial\nadverse determination.\n\n(D) Prior to issuing a decision, the health carrier shall provide free of\ncharge, by facsimile, electronic means or any other expeditious method\navailable, to the covered person or the covered person's authorized\nrepresentative, as applicable, any new or additional documents,\ncommunications, information and evidence relied upon and any new or additional\nscientific or clinical rationale used by the health carrier in connection with\nthe grievance. Such documents, communications, information, evidence and\nrationale shall be provided sufficiently in advance of the date the health\ncarrier is required to issue a decision to permit the covered person or the\ncovered person's authorized representative, as applicable, a reasonable\nopportunity to respond prior to such date.\n\n(2) If the review under subdivision (1) of this subsection is an expedited\nreview, all necessary information, including the health carrier's decision,\nshall be transmitted between the health carrier and the covered person or the\ncovered person's authorized representative, as applicable, by telephone,\nfacsimile, electronic means or any other expeditious method available.\n\n(3) If the review under subdivision (1) of this subsection is an expedited\nreview of a grievance involving an adverse determination of a concurrent\nreview request, pursuant to 45 CFR 147.136, as amended from time to time, the\ntreatment shall be continued without liability to the covered person until the\ncovered person has been notified of the review decision.\n\nSec. 7. Section 38a-510 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing an individual health insurance\npolicy or contract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) for a prescribed drug for ~~cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _the treatment of a disabling or life-threatening chronic disease or\ncondition,_ provided such prescribed drug is in compliance with approved\nfederal Food and Drug Administration indications, ~~or~~ (C) for the period\ncommencing January 1, 2024, and ending January 1, 2027, inclusive, for the\ntreatment of schizophrenia, major depressive disorder or bipolar disorder, as\ndefined in the most recent edition of the American Psychiatric Association's\n\"Diagnostic and Statistical Manual of Mental Disorders\"_, or (D) for a\nprescribed drug for the treatment of a mental or behavioral health condition,\nprovided such prescribed drug is in compliance with approved federal Food and\nDrug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-492i.\n\nSec. 8. Section 38a-544 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing a group health insurance policy or\ncontract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan ~~thirty~~ _twenty_ days, (B) for a prescribed drug for ~~cancer\ntreatment for an insured who has been diagnosed with stage IV metastatic\ncancer~~ _the treatment of a disabling or life-threatening chronic disease or\ncondition,_ provided such prescribed drug is in compliance with approved\nfederal Food and Drug Administration indications, ~~or~~ (C) for the period\ncommencing January 1, 2024, and ending January 1, 2027, inclusive, for the\ntreatment of schizophrenia, major depressive disorder or bipolar disorder, as\ndefined in the most recent edition of the American Psychiatric Association's\n\"Diagnostic and Statistical Manual of Mental Disorders\"_, or (D) for a\nprescribed drug for the treatment of a mental or behavioral health condition,\nprovided such prescribed drug is in compliance with approved federal Food and\nDrug Administration indications_.\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\n~~subparagraph (B) or (C)~~ _subparagraphs (B) to (D), inclusive,_ of\nsubdivision (2) of this subsection, an insured's treating health care provider\nmay deem such step therapy drug regimen clinically ineffective for the\ninsured, at which time the insurance company, hospital service corporation,\nmedical service corporation, health care center or other entity shall\nauthorize dispensation of and coverage for the drug prescribed by the\ninsured's treating health care provider, provided such drug is a covered drug\nunder such policy or contract. If such provider does not deem such step\ntherapy drug regimen clinically ineffective or has not requested an override\npursuant to subdivision (1) of subsection (b) of this section, such drug\nregimen may be continued. For purposes of this section, \"step therapy\" means a\nprotocol or program that establishes the specific sequence in which\nprescription drugs for a specified medical condition are to be prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _twenty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive _, as amended by this act_ , or (2) affect the\nprovisions of section 38a-518i.\n\nSec. 9 (NEW) (Effective July 1, 2026) (a) Each insurer, health care center,\nhospital service corporation, medical service corporation, preferred provider\nnetwork or other entity that enters into, renews or amends a contract with a\nhealth care provider on or after July 1, 2026, to provide covered benefits to\ninsureds or enrollees in this state shall include in such contract:\n\n(1) A provision requiring such insurer, health care center, hospital service\ncorporation, medical service corporation, preferred provider network or other\nentity to:\n\n(A) Reimburse the contracting health care provider for a covered outpatient\nbenefit that uses a current procedural terminology evaluation and management\n(CPT E/M) code, current procedural terminology assessment and management (CPT\nA/M) code or drug infusion code in an amount that does not vary based on the\nfacility where the contracting health care provider provides such benefit; and\n\n(B) Use equal reimbursement rates for all contracting health care providers in\nthe same geographic region, as determined by the Insurance Commissioner, in\naccordance with the provisions of chapter 54 of the general statutes, and\nregardless of the employer or affiliation of any contracting health care\nprovider, for each covered outpatient benefit described in subparagraph (A) of\nthis subdivision if the reimbursement for such covered outpatient benefit is\nmade on a fee-for-benefit basis or on the basis of bundled benefits per\ndiagnosis, condition, procedure or another standardized bundle of health care\nbenefits; and\n\n(2) A conspicuous statement that such contract complies with the provisions of\nsubdivision (1) of this subsection.\n\n(b) The Insurance Commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54 of the general statutes, to implement the provisions\nof this section, including, but not limited to, the establishment of\ngeographic regions pursuant to the provisions of subparagraph (B) of\nsubdivision (1) of subsection (a) of this section.\n\nSec. 10. Subsections (a) to (c), inclusive, of section 38a-481 of the general\nstatutes are repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) No individual health insurance policy shall be delivered or issued for\ndelivery to any person in this state, nor shall any application, rider or\nendorsement be used in connection with such policy, until a copy of the form\nthereof and of the classification of risks and the premium rates have been\nfiled with the commissioner. Rate filings shall include the information and\ndata required under section 38a-479qqq if the policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience, _the requirements established in\nsection 15 of this act,_ and premium rates and loss ratios from the inception\nof the policy. Each premium rate filed on or after January 1, 2021, shall, if\nthe insurer intends to account for rebates, as defined in section 38a-479ooo\nin the manner specified in section 38a-479rrr, account for such rebates in\nsuch manner, if the policy is subject to section 38a-479rrr. The commissioner\nmay adopt regulations, in accordance with the provisions of chapter 54, to\nestablish a procedure for reviewing such policies. The commissioner shall\ndisapprove the use of such form at any time if it does not comply with the\nrequirements of law, or if it contains a provision or provisions that are\nunfair or deceptive or that encourage misrepresentation of the policy. The\ncommissioner shall notify, in writing, the insurer that has filed any such\nform of the commissioner's disapproval, specifying the reasons for\ndisapproval, and ordering that no such insurer shall deliver or issue for\ndelivery to any person in this state a policy on or containing such form. The\nprovisions of section 38a-19 shall apply to such orders. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\n(b) _(1)_ No rate filed under the provisions of subsection (a) of this section\nshall be effective until it has been approved by the commissioner in\naccordance with regulations adopted pursuant to this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate _,_ ~~or~~ unfairly discriminatory ~~. The commissioner\nmay disapprove such rate if it fails to comply with such standards, except\nthat no rate filed under the provisions of subsection (a) of this section for\nany Medicare supplement policy shall be effective unless approved in\naccordance with section 38a-474~~ _or unaffordable pursuant to the provisions\nof section 15 of this act_.\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for health insurance that provides coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 shall be\napproved in accordance with the provisions of section 15 of this act._\n\n_(c) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section for any Medicare supplement policy shall be effective unless\napproved in accordance with the provisions of section 38a-474._\n\n~~(c)~~ _(2)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\nSec. 11. Section 38a-513 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) ~~(1)~~ No group health insurance policy, as defined by the commissioner,\nor certificate shall be delivered or issued for delivery in this state unless\na copy of the form for such policy or certificate has been submitted to and\napproved by the commissioner under the regulations adopted pursuant to this\nsection. The commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54, concerning the provisions, submission and approval\nof such policies and certificates and establishing a procedure for reviewing\nsuch policies and certificates. The commissioner shall disapprove the use of\nsuch form at any time if it does not comply with the requirements of law, or\nif it contains a provision or provisions that are unfair or deceptive or that\nencourage misrepresentation of the policy. The commissioner shall notify, in\nwriting, the insurer that has filed any such form of the commissioner's\ndisapproval, specifying the reasons for disapproval, and ordering that no such\ninsurer shall deliver or issue for delivery to any person in this state a\npolicy on or containing such form. The provisions of section 38a-19 shall\napply to such order.\n\n_(b) (1) No rate filed in accordance with the provisions of subsection (a) of\nthis section shall be effective until such rate has been approved by the\ncommissioner in accordance with regulations adopted pursuant to this\nsubsection or as provided under subdivision (2) of this subsection. The\ncommissioner shall adopt regulations, in accordance with the provisions of\nchapter 54, to prescribe standards to ensure that such rates shall not be\nexcessive, inadequate, unfairly discriminatory or unaffordable pursuant to the\nprovisions of section 15 of this act._\n\n_(2) Any rate filed in accordance with the provisions of subsection (a) of\nthis section for a group health insurance policy that provides coverage of the\ntype specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469\nshall be approved in accordance with the provisions of section 15 of this\nact._\n\n~~(2)~~ _(c)_ No group health insurance policy or certificate for a small\nemployer, as defined in section 38a-564, shall be delivered or issued for\ndelivery in this state unless the premium rates have been submitted to and\napproved by the commissioner _in accordance with the provisions of section 15\nof this act_. Premium rate filings shall include the information and data\nrequired under section 38a-479qqq if the policy is subject to said section,\nand an actuarial memorandum that includes, but is not limited to, pricing\nassumptions and claims experience, _the requirements set forth in section 15\nof this act,_ and premium rates and loss ratios from the inception of the\npolicy. Each premium rate filed on or after January 1, 2021, shall, if the\ninsurer intends to account for rebates, as defined in section 38a-479ooo in\nthe manner specified in section 38a-479rrr, account for such rebates in such\nmanner, if the policy is subject to section 38a-479rrr. As used in this\nsubdivision, \"loss ratio\" means the ratio of incurred claims to earned\npremiums by the number of years of policy duration for all combined durations.\n\n~~(b)~~ _(d)_ No insurance company, fraternal benefit society, hospital\nservice corporation, medical service corporation, health care center or other\nentity that delivers or issues for delivery in this state any Medicare\nsupplement policies or certificates shall incorporate in its rates or\ndeterminations to grant coverage for Medicare supplement insurance policies or\ncertificates any factors or values based on the age, gender, previous claims\nhistory or the medical condition of any person covered by such policy or\ncertificate.\n\n~~(c)~~ _(e)_ Nothing in this chapter shall preclude the issuance of a group\nhealth insurance policy that includes an optional life insurance rider,\nprovided the optional life insurance rider shall be filed with and approved by\nthe Insurance Commissioner pursuant to section 38a-430. Any company offering\nsuch policies for sale in this state shall be licensed to sell life insurance\nin this state pursuant to the provisions of section 38a-41.\n\n~~(d)~~ _(f)_ Not later than January 1, 2009, the commissioner shall adopt\nregulations, in accordance with chapter 54, to establish minimum standards for\nbenefits in group specified disease policies, certificates, riders,\nendorsements and benefits.\n\nSec. 12. Subdivision (1) of subsection (a) of section 38a-183 of the general\nstatutes is repealed and the following is substituted in lieu thereof\n(Effective January 1, 2026):\n\n(a) (1) A health care center governed by sections 38a-175 to 38a-194,\ninclusive, shall not enter into any agreement with subscribers unless and\nuntil ~~it~~ _such health care center_ has filed with the commissioner a full\nschedule of the amounts to be paid by the subscribers and has obtained the\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 15 of this act_. Such filing shall include the information and data\nrequired under section 38a-479qqq if the contract or policy is subject to said\nsection, and an actuarial memorandum that includes, but is not limited to,\npricing assumptions and claims experience, and premium rates and loss ratios\nfrom the inception of the contract or policy. The commissioner ~~may refuse\nsuch approval if the commissioner finds such amounts to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant tothe provisions of section 15\nof this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 13. Subsection (a) of section 38a-208 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such corporation shall enter into any contract with subscribers unless\nand until it has filed with the Insurance Commissioner a full schedule of the\nrates to be paid by the subscribers and has obtained said commissioner's\napproval ~~thereof~~ _in accordance with the provisions of section 15 of this\nact_. Such filing shall include an actuarial memorandum that includes, but is\nnot limited to, pricing assumptions and claims experience, and premium rates\nand loss ratios from the inception of the contract. The commissioner ~~may\nrefuse such approval if the commissioner finds such rates to~~ _shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such amounts shall not_ be excessive, inadequate _,_\n~~or~~ discriminatory _or unaffordable pursuant to the provisions of section\n15 of this act_. As used in this subsection, \"loss ratio\" means the ratio of\nincurred claims to earned premiums by the number of years of policy duration\nfor all combined durations.\n\nSec. 14. Subsection (a) of section 38a-218 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No such medical service corporation shall enter into any contract with\nsubscribers unless and until it has filed with the Insurance Commissioner a\nfull schedule of the rates to be paid by the subscriber and has obtained said\ncommissioner's approval ~~thereof~~ _in accordance with the provisions of\nsection 15 of this act_. Such filing shall include an actuarial memorandum\nthat includes, but is not limited to, pricing assumptions and claims\nexperience, and premium rates and loss ratios from the inception of the\ncontract. The commissioner ~~may refuse such approval if the commissioner\nfinds such rates are~~ _shall adopt regulations, in accordance with the\nprovisions of chapter 54, to prescribe standards to ensure that such amounts\nshall not be_ excessive, inadequate _,_ ~~or~~ discriminatory _or unaffordable\npursuant to the provisions of section 15 of this act_. As used in this\nsubsection, \"loss ratio\" means the ratio of incurred claims to earned premiums\nby the number of years of policy duration for all combined durations.\n\nSec. 15. (NEW) (Effective January 1, 2026) (a) (1) With respect to a health\ninsurance policy, agreement or contract that provides coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes, any (A) rate filed for such policy pursuant to section\n38a-481 of the general statutes, as amended by this act, (B) rate filed for\nsuch policy pursuant to section 38a-513 of the general statutes, as amended by\nthis act, (C) schedule of amounts filed for such agreement pursuant to section\n38a-183 of the general statutes, as amended by this act, (D) schedule of rates\nfiled for such contract pursuant to section 38a-208 of the general statutes,\nas amended by this act, or (E) schedule of rates filed for such contract\npursuant to section 38a-218 of the general statutes, as amended by this act,\non or after January 1, 2026, shall be filed not later than one hundred twenty\ncalendar days prior to the proposed effective date of such rates or amounts.\n\n(2) Each filer making a rate or amount filing pursuant to this subsection\nshall, on the date such filer submits such rate or amount filing to the\nInsurance Commissioner, include with such filer's rate or amount filing an\nactuarial memorandum, certified by a qualified actuary, that to the best of\nsuch actuary's knowledge, (A) such rate or amount filing is in compliance with\nthe laws of this state and federal law, as applicable, and (B) the rate or\namount filing is not excessive, as described in subdivision (1) of subsection\n(c) of this section. For the purposes of this subparagraph, \"qualified\nactuary\" means a member in good standing of the American Academy of Actuaries\nwho is qualified in accordance with the standards of the American Academy of\nActuaries.\n\n(3) (A) Notwithstanding the provisions of section 38a-69a of the general\nstatutes, the Insurance Department shall post on the department's Internet web\nsite all documents, materials and other information provided to or requested\nby the department in relation to any such rate or amount filing made pursuant\nto this subsection, including, but not limited to, financial reports,\nfinancial statements, actuarial reports and actuarial memoranda. Such rate or\namount filing and such documents, materials and other information shall be\nposted on such web site not later than three business days after the\ndepartment receives such filing, and such posting shall be updated to include\nany correspondence between the department and such filer.\n\n(B) The department shall provide for a written public comment period of not\nless than thirty calendar days following the posting of such filing. The\ndepartment shall include in such posting the date such public comment period\ncloses and instructions for the public to submit comments to the department.\n\n(b) (1) The commissioner shall hold a public hearing for each rate or amount\nfiled under the provisions of subdivision (1) of subsection (a) of this\nsection. Not later than five business days after the posting of such rate or\namount filing on the department's Internet web site in accordance with the\nprovisions of subparagraph (A) of subdivision (3) of subsection (a) of this\nsection, the commissioner shall set a public hearing date for such rate or\namount filing and shall post the date, place and time of such public hearing\nin a conspicuous place on the department's Internet web site.\n\n(2) Such public hearing shall be (A) held after the end of the public comment\nperiod specified in subparagraph (B) of subdivision (3) of subsection (a) of\nthis section, but not later than prior to the proposed effective date of such\nrate or amount, at a place and time that is convenient to the public, and (B)\nconducted in accordance with the provisions of chapter 54 of the general\nstatutes, this section and section 16 of this act.\n\n(3) Upon setting the date, place and time of the public hearing for such rate\nor amount filing, the commissioner shall immediately notify the filer of such\nrate or amount filing of the date, place and time of the public hearing.\n\n(c) The commissioner shall not approve a rate or amount filing submitted in\naccordance with the provisions of this section if such rate or amount filing\nis excessive, inadequate, unfairly discriminatory or unaffordable. The\ncommissioner shall conduct an actuarial review to determine if the methodology\nand assumptions used to develop such rate or amount filing are actuarially\nsound and in compliance with the Actuarial Standards of Practice issued by the\nActuarial Standards Board.\n\n(1) Any rate or amount shall be considered excessive if it is unreasonably\nhigh for the insurance provided in relation to the underlying risks and costs\nafter due consideration of: (A) The experience of such filer; (B) such filer's\npast and projected costs, including amounts to be paid for commissions; (C)\nany transfers of funds to the holding or parent company, subsidiary or\naffiliate of such filer; (D) such filer's rate of return on assets or\nprofitability, as compared to similar filers; (E) a reasonable margin for\nprofit and contingencies; (F) any public comments received on such filing in\naccordance with the provisions of subparagraph (B) of subdivision (3) of\nsubsection (a) of this section; and (G) other factors the commissioner deems\nrelevant.\n\n(2) Any rate or amount shall be considered inadequate if such rate or amount\nis unreasonably low for the insurance provided in relation to the underlying\nrisks and costs and continued use of such rate or amount would endanger\nsolvency of such filer.\n\n(3) Any rate or amount shall be considered unfairly discriminatory if the\npremium charged for any classification is not reasonably related to the\nunderlying risks and costs, such that different premiums result for insureds\nwith similar risks and costs.\n\n(4) Any rate or amount shall be considered unaffordable if the commissioner\ndetermines such rate or amount is inconsistent with the inflation-adjusted\nConnecticut Health Affordability Index commissioned by the Office of Health\nStrategy and the Office of the State Comptroller, or another metric jointly\ndesignated by the commissioner and the Commissioner of Health Strategy.\n\n(d) Not later than thirty days after such public hearing held in accordance\nwith the provisions of subsection (b) of this section, the commissioner shall\nissue a written decision approving, disapproving or modifying such rate or\namount filing. Such decision shall specify all factors used to reach such\ndecision and shall be posted on the department's Internet web site not later\nthan two business days after the commissioner issues such decision.\n\nSec. 16. (NEW) (Effective January 1, 2026) (a) Notwithstanding sections 4-176\nand 4-177a of the general statutes, the Healthcare Advocate or the Attorney\nGeneral, or both, may be parties to any public hearing held in accordance with\nthe provisions of section 15 of this act.\n\n(b) Subject to the provisions of section 4-181 of the general statutes, (1)\nthe Healthcare Advocate or the Attorney General, or both, shall have access to\nthe records of the Insurance Department regarding any rate or amount filing\nmade in accordance with the provisions of section 15 of this act, and (2)\nattorneys, actuaries, accountants and other experts who are part of the\nInsurance Commissioner's staff and who review or assist in the determination\nof such filing pursuant to the provisions of section 15 of this act shall\ncooperate with the Healthcare Advocate or Attorney General, or both, to carry\nout the provisions of this section.\n\n(c) The Healthcare Advocate or the Attorney General, or both, may (1) summon\nand examine under oath such witnesses as the Healthcare Advocate or the\nAttorney General deems necessary for the review of a rate or amount filing\nmade in accordance with the provisions of section 15 of this act, and (2)\nrequire the filer or any holding or parent company or subsidiary of such filer\nto produce books, vouchers, memoranda, papers, letters, contracts and other\ndocuments, regardless of the format in which such materials are stored. Any\nsuch books, vouchers, memoranda, papers, letters, contracts or other documents\nshall be limited to such information or transactions between such filer and\nthe holding or parent company or subsidiary that are reasonably related to the\nsubject matter of the filing.\n\nSec. 17. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No individual health insurance policy providing coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes delivered, issued for delivery, renewed, amended or\ncontinued in this state on or after January 1, 2026, shall (1) if such policy\nprovides coverage for general anesthesia, (A) impose an arbitrary time limit\non reimbursement for general anesthesia provided during any medically\nnecessary procedure, or (B) deny, reduce, terminate or fail to provide such\nreimbursement, in whole or in part, for general anesthesia solely because the\nduration of care exceeded a predetermined time limit as determined by the\ninsurer, or (2) impose unilateral arbitrary limitations on reimbursement for\nmedically necessary ancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nSec. 18. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medical necessity\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No group health insurance policy providing coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general\nstatutes delivered, issued for delivery, renewed, amended or continued in this\nstate on or after January 1, 2026, shall (1) if such policy provides coverage\nfor general anesthesia, (A) impose an arbitrary time limit on reimbursement\nfor general anesthesia provided during any medically necessary procedure, or\n(B) deny, reduce, terminate or fail to provide such reimbursement, in whole or\nin part, for general anesthesia solely because the duration of care exceeded a\npredetermined time limit as determined by the insurer, or (2) impose\nunilateral arbitrary limitations on reimbursement for medically necessary\nancillary services.\n\n(c) The medical necessity for administering general anesthesia during any\nmedical procedure shall be determined by the attending board-certified\nanesthesiologist during such medical procedure.\n\nThis act shall take effect as follows and shall amend the following sections:  \n  \n---  \nSection 1 | October 1, 2025 | New section  \nSec. 2 | October 1, 2025 | 38a-477ee(c)  \nSec. 3 | from passage | New section  \nSec. 4 | October 1, 2025 | New section  \nSec. 5 | January 1, 2026 | 38a-591c(a) and (b)  \nSec. 6 | January 1, 2026 | 38a-591e(c)  \nSec. 7 | January 1, 2026 | 38a-510  \nSec. 8 | January 1, 2026 | 38a-544  \nSec. 9 | July 1, 2026 | New section  \nSec. 10 | January 1, 2026 | 38a-481(a) to (c)  \nSec. 11 | January 1, 2026 | 38a-513  \nSec. 12 | January 1, 2026 | 38a-183(a)(1)  \nSec. 13 | January 1, 2026 | 38a-208(a)  \nSec. 14 | January 1, 2026 | 38a-218(a)  \nSec. 15 | January 1, 2026 | New section  \nSec. 16 | January 1, 2026 | New section  \nSec. 17 | January 1, 2026 | New section  \nSec. 18 | January 1, 2026 | New section  \n  \n**Statement of Legislative Commissioners:**\n\nIn Section 6(c)(1)(C)(i), \"_subdivision (1)_ \" was changed to \"_subdivision\n(2)_ \" for accuracy, in Section 15(c)(4), \"executive director of the Office of\nHealth Strategy\" was changed to \"Commissioner of Health Strategy\" for\naccuracy, and in Section 16(b)(2), \"the provisions of\" was added after\n\"pursuant to\" for consistency.\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": false
    },
    {
      "date": "06/11/2025",
      "label": "Enrolled",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250611_0_ENR&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Enrolled</td></tr> <tr><td class=\"label\">Version Date:</td> <td>06/11/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">\n    <b>Substitute Senate Bill No. 10</b>\n   </p>\n   <p class=\"center\">\n    <b>Public Act No. 25-94</b>\n   </p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">\n    <b>AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</b>\n   </p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <p class=\"indent\">Section 1. (NEW) (Effective October 1, 2025) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;Health carrier&quot; has the same meaning as provided in section 38a-1080 of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Mental health and substance use disorder benefits&quot; has the same meaning as provided in section 38a-477ee of the general statutes, as amended by this act.</p>\n   <p class=\"indent\">(b) (1) Not later than March 1, 2026, and annually thereafter, each health carrier shall file a certification with the Insurance Commissioner for the immediately preceding calendar year, certifying that such health carrier completed a review of such health carrier&#39;s administrative practices for compliance with the state and federal mental health and substance use disorder benefit reporting requirements pursuant to sections 38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n   <p class=\"indent\">(2) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding.</p>\n   <p class=\"indent\">(3) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year fail to comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding and identify (A) each administrative practice of such health carrier not in compliance with such state and federal mental health and substance use disorder benefit reporting requirements, and (B) action that such health carrier will take to bring such health carrier&#39;s administrative practices into compliance with such state and federal mental health and substance use disorder benefit reporting requirements.</p>\n   <p class=\"indent\">Sec. 2. Subsection (c) of section 38a-477ee of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2025):</p>\n   <p class=\"indent\">(c) <strike class=\"amendmentDeletedText\">(1)</strike> Not later than April 15, 2021, and annually thereafter, the Insurance Commissioner shall submit each report that the commissioner received pursuant to subsection (b) of this section for the calendar year immediately preceding to:</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(A)</strike>\n    <u class=\"amendmentInsertedText\">(1)</u> The joint standing committee of the General Assembly having cognizance of matters relating to insurance, in accordance with section 11-4a; and</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(B)</strike>\n    <u class=\"amendmentInsertedText\">(2)</u> The Attorney General, Healthcare Advocate and Commissioner of Health Strategy.</p>\n   <p class=\"indent\">\n    <strike class=\"amendmentDeletedText\">(2) Notwithstanding subdivision (1) of this subsection, the commissioner shall not submit the name or identity of any health carrier or entity that has contracted with such health carrier, and such name or identity shall be given confidential treatment and not be made public by the commissioner.</strike>\n   </p>\n   <p class=\"indent\">Sec. 3. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after providing an opportunity for a hearing in accordance with chapter 54 of the general statutes, may impose a civil penalty on any health carrier of not more than one hundred dollars with respect to each participant or beneficiary covered under a health insurance policy of such health carrier, provided such penalty shall not exceed an aggregate amount of six hundred twenty-five thousand dollars annually, for such health carrier&#39;s failure to comply with (A) the certification requirements pursuant to the provisions of section 1 of this act, (B) the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act, or (C) any other requirement pursuant to sections 38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n   <p class=\"indent\">(2) The commissioner may order the payment of such reasonable expenses as may be necessary to compensate the commissioner in conjunction with any proceedings under this section, which shall be dedicated to the enforcement and implementation of the state and federal mental health parity laws and regulations adopted thereunder.</p>\n   <p class=\"indent\">(b) (1) If any health carrier fails to file any data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, or section 1 of this act, the commissioner shall impose a late fee on such health carrier of one hundred dollars per day from the due date of such filing of data, report, certification or information to the date such health carrier submits such filing to the commissioner, provided such late fee shall not exceed an aggregate amount of six hundred twenty-five thousand dollars.</p>\n   <p class=\"indent\">(2) For any health carrier that files any incomplete data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, and section 1 of this act, the commissioner shall provide notice to such health carrier of such incomplete filing that includes (A) a description of such data, report, certification or other information that is incomplete and any additional data that is needed to consider such filing complete, and (B) the date by which such health carrier is required to provide such data. The commissioner shall impose a late fee on such health carrier of one hundred dollars per day, commencing from the date identified by the commissioner pursuant to subparagraph (B) of this subdivision, provided such late fee shall not exceed an aggregate amount of six hundred twenty-five thousand dollars.</p>\n   <p class=\"indent\">(c) The commissioner may waive any civil penalty imposed pursuant to subsection (a) of this section if the commissioner determines that the violation was due to reasonable cause and was not due to wilful neglect, or if such violation is corrected not more than thirty days after the date that the health carrier filed a certification of noncompliance with the commissioner pursuant to section 1 of this act.</p>\n   <p class=\"indent\">(d) All civil penalties and late fees received by the commissioner pursuant to this section shall be deposited in the General Fund.</p>\n   <p class=\"indent\">(e) The commissioner may engage the services of any health policy research organization or any other independent expert as the commissioner deems necessary to assist the commissioner in the review of any violation of the nonquantitative treatment limitations requirements pursuant to section 38a-477ee of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n   <p class=\"indent\">Sec. 4. Section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than thirty days, (B) for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer<u class=\"amendmentInsertedText\">, multiple sclerosis or rheumatoid arthritis,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, or (C) <strike class=\"amendmentDeletedText\">for the period commencing January 1, 2024, and ending January 1, 2027, inclusive,</strike> for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in subparagraph (B) or (C) of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">thirty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive, or (2) affect the provisions of section 38a-492i.</p>\n   <p class=\"indent\">Sec. 5. Section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:</p>\n   <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n   <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than thirty days, (B) for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer<u class=\"amendmentInsertedText\">, multiple sclerosis or rheumatoid arthritis,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, or (C) <strike class=\"amendmentDeletedText\">for the period commencing January 1, 2024, and ending January 1, 2027, inclusive,</strike> for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;.</p>\n   <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in subparagraph (B) or (C) of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n   <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n    <u class=\"amendmentInsertedText\">thirty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n   <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n   <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive, or (2) affect the provisions of section 38a-518i.</p>\n   <p class=\"indent\">Sec. 6. Subsection (b) of section 38a-481 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2027):</p>\n   <p class=\"indent\">(b) No rate filed under the provisions of subsection (a) of this section shall be effective until it has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate or unfairly discriminatory. The commissioner may disapprove such rate if it fails to comply with such standards, except that no rate filed under the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with section 38a-474. <u class=\"amendmentInsertedText\">If the commissioner determines that a health carrier&#39;s average premium rate increase, as approved by the commissioner, exceeded the health care cost growth benchmark established pursuant to section 19a-754g for each of the two most recent plan years for which such health care cost growth benchmark data is available, the commissioner may reduce such health carrier&#39;s requested rate filed under the provisions of subsection (a) of this section by not more than two percentage points of such premium rate filed in addition to any other rate reductions authorized under this title.</u>\n   </p>\n   <p class=\"indent\">Sec. 7. Subsection (a) of section 38a-513 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2027):</p>\n   <p class=\"indent\">(a) (1) No group health insurance policy, as defined by the commissioner, or certificate shall be delivered or issued for delivery in this state unless a copy of the form for such policy or certificate has been submitted to and approved by the commissioner under the regulations adopted pursuant to this section. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, concerning the provisions, submission and approval of such policies and certificates and establishing a procedure for reviewing such policies and certificates. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such order.</p>\n   <p class=\"indent\">(2) No group health insurance policy or certificate for a small employer, as defined in section 38a-564, shall be delivered or issued for delivery in this state unless the premium rates have been submitted to and approved by the commissioner. <u class=\"amendmentInsertedText\">If the commissioner determines that any small group health insurance carrier&#39;s average premium rate increase, as approved by the commissioner, or certificate for a small employer, exceeded the health care cost growth benchmark established pursuant to section 19a-754g for each of the two most recent plan years for which such health care cost growth benchmark data is available, the commissioner may reduce such policy&#39;s or certificate&#39;s requested premium rate filing under the provisions of subsection (a) of this section by not more than two percentage points of such premium rate filed in addition to any other premium rate reductions authorized under this title.</u> Premium rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. As used in this subdivision, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   <p class=\"indent\">Sec. 8. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medically necessary&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall, if such policy provides coverage for general anesthesia, (1) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (2) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer.</p>\n   <p class=\"indent\">Sec. 9. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n   <p class=\"indent\">(2) &quot;Medically necessary&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n   <p class=\"indent\">(b) No group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall, if such policy provides coverage for general anesthesia, (1) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (2) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer.</p>\n   <p class=\"indent\">Sec. 10. Section 19a-508c of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <p class=\"indent\">(a) As used in this section:</p>\n   <p class=\"indent\">(1) &quot;Affiliated provider&quot; means a provider that is: (A) Employed by a hospital or health system, (B) under a professional services agreement with a hospital or health system that permits such hospital or health system to bill on behalf of such provider, or (C) a clinical faculty member of a medical school, as defined in section 33-182aa, that is affiliated with a hospital or health system in a manner that permits such hospital or health system to bill on behalf of such clinical faculty member;</p>\n   <p class=\"indent\">(2) &quot;Campus&quot; means: (A) The physical area immediately adjacent to a hospital&#39;s main buildings and other areas and structures that are not strictly contiguous to the main buildings but are located within two hundred fifty yards of the main buildings, or (B) any other area that has been determined on an individual case basis by the Centers for Medicare and Medicaid Services to be part of a hospital&#39;s campus;</p>\n   <p class=\"indent\">(3) &quot;Facility fee&quot; means any fee charged or billed by a hospital or health system for outpatient services provided in a hospital-based facility that is: (A) Intended to compensate the hospital or health system for the operational expenses of the hospital or health system, and (B) separate and distinct from a professional fee;</p>\n   <p class=\"indent\">(4) &quot;Health care provider&quot; means an individual, entity, corporation, person or organization, whether for-profit or nonprofit, that furnishes, bills or is paid for health care service delivery in the normal course of business, including, but not limited to, a health system, a hospital, a hospital-based facility, a freestanding emergency department and an urgent care center;</p>\n   <p class=\"indent\">(5) &quot;Health system&quot; means: (A) A parent corporation of one or more hospitals and any entity affiliated with such parent corporation through ownership, governance, membership or other means, or (B) a hospital and any entity affiliated with such hospital through ownership, governance, membership or other means;</p>\n   <p class=\"indent\">(6) &quot;Hospital&quot; has the same meaning as provided in section 19a-490;</p>\n   <p class=\"indent\">(7) &quot;Hospital-based facility&quot; means a facility that is owned or operated, in whole or in part, by a hospital or health system where hospital or professional medical services are provided;</p>\n   <p class=\"indent\">(8) &quot;Medicaid&quot; means the program operated by the Department of Social Services pursuant to section 17b-260 and authorized by Title XIX of the Social Security Act, as amended from time to time;</p>\n   <p class=\"indent\">(9) &quot;Observation&quot; means services furnished by a hospital on the hospital&#39;s campus, regardless of length of stay, including use of a bed and periodic monitoring by the hospital&#39;s nursing or other staff to evaluate an outpatient&#39;s condition or determine the need for admission to the hospital as an inpatient;</p>\n   <p class=\"indent\">(10) &quot;Payer mix&quot; means the proportion of different sources of payment received by a hospital or health system, including, but not limited to, Medicare, Medicaid, other government-provided insurance, private insurance and self-pay patients;</p>\n   <p class=\"indent\">(11) &quot;Professional fee&quot; means any fee charged or billed by a provider for professional medical services provided in a hospital-based facility;</p>\n   <p class=\"indent\">(12) &quot;Provider&quot; means an individual, entity, corporation or health care provider, whether for profit or nonprofit, whose primary purpose is to provide professional medical services; and</p>\n   <p class=\"indent\">(13) &quot;Tagline&quot; means a short statement written in a non-English language that indicates the availability of language assistance services free of charge.</p>\n   <p class=\"indent\">(b) If a hospital or health system charges a facility fee utilizing a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code for outpatient services provided at a hospital-based facility where a professional fee is also expected to be charged, the hospital or health system shall provide the patient with a written notice that includes the following information:</p>\n   <p class=\"indent\">(1) That the hospital-based facility is part of a hospital or health system and that the hospital or health system charges a facility fee that is in addition to and separate from the professional fee charged by the provider;</p>\n   <p class=\"indent\">(2) (A) The amount of the patient&#39;s potential financial liability, including any facility fee likely to be charged, and, where professional medical services are provided by an affiliated provider, any professional fee likely to be charged, or, if the exact type and extent of the professional medical services needed are not known or the terms of a patient&#39;s health insurance coverage are not known with reasonable certainty, an estimate of the patient&#39;s financial liability based on typical or average charges for visits to the hospital-based facility, including the facility fee, (B) a statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, (C) an explanation that the patient may incur financial liability that is greater than the patient would incur if the professional medical services were not provided by a hospital-based facility, and (D) a telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability, including an estimate of the facility fee likely to be charged based on the scheduled professional medical services; and</p>\n   <p class=\"indent\">(3) That a patient covered by a health insurance policy should contact the health insurer for additional information regarding the hospital&#39;s or health system&#39;s charges and fees, including the patient&#39;s potential financial liability, if any, for such charges and fees.</p>\n   <p class=\"indent\">(c) If a hospital or health system charges a facility fee without utilizing a current procedural terminology evaluation and management (CPT E/M) code for outpatient services provided at a hospital-based facility, located outside the hospital campus, the hospital or health system shall provide the patient with a written notice that includes the following information:</p>\n   <p class=\"indent\">(1) That the hospital-based facility is part of a hospital or health system and that the hospital or health system charges a facility fee that may be in addition to and separate from the professional fee charged by a provider;</p>\n   <p class=\"indent\">(2) (A) A statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, (B) an explanation that the patient may incur financial liability that is greater than the patient would incur if the hospital-based facility was not hospital-based, and (C) a telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability, including an estimate of the facility fee likely to be charged based on the scheduled professional medical services; and</p>\n   <p class=\"indent\">(3) That a patient covered by a health insurance policy should contact the health insurer for additional information regarding the hospital&#39;s or health system&#39;s charges and fees, including the patient&#39;s potential financial liability, if any, for such charges and fees.</p>\n   <p class=\"indent\">(d) Each initial billing statement that includes a facility fee shall: (1) Clearly identify the fee as a facility fee that is billed in addition to, or separately from, any professional fee billed by the provider; (2) provide the corresponding Medicare facility fee reimbursement rate for the same service as a comparison or, if there is no corresponding Medicare facility fee for such service, (A) the approximate amount Medicare would have paid the hospital for the facility fee on the billing statement, or (B) the percentage of the hospital&#39;s charges that Medicare would have paid the hospital for the facility fee; (3) include a statement that the facility fee is intended to cover the hospital&#39;s or health system&#39;s operational expenses; (4) inform the patient that the patient&#39;s financial liability may have been less if the services had been provided at a facility not owned or operated by the hospital or health system; and (5) include written notice of the patient&#39;s right to request a reduction in the facility fee or any other portion of the bill and a telephone number that the patient may use to request such a reduction without regard to whether such patient qualifies for, or is likely to be granted, any reduction. Not later than October 15, 2022, and annually thereafter, each hospital, health system and hospital-based facility shall submit to the Health Systems Planning Unit of the Office of Health Strategy a sample of a billing statement issued by such hospital, health system or hospital-based facility that complies with the provisions of this subsection and which represents the format of billing statements received by patients. Such billing statement shall not contain patient identifying information.</p>\n   <p class=\"indent\">(e) The written notice described in subsections (b) to (d), inclusive, and (h) to (j), inclusive, of this section shall be in plain language and in a form that may be reasonably understood by a patient who does not possess special knowledge regarding hospital or health system facility fee charges. On and after October 1, 2022, such notices shall include tag lines in at least the top fifteen languages spoken in the state indicating that the notice is available in each of those top fifteen languages. The fifteen languages shall be either the languages in the list published by the Department of Health and Human Services in connection with section 1557 of the Patient Protection and Affordable Care Act, P.L. 111-148, or, as determined by the hospital or health system, the top fifteen languages in the geographic area of the hospital-based facility.</p>\n   <p class=\"indent\">(f) (1) For nonemergency care, if a patient&#39;s appointment is scheduled to occur ten or more days after the appointment is made, such written notice shall be sent to the patient by first class mail, encrypted electronic mail or a secure patient Internet portal not less than three days after the appointment is made. If an appointment is scheduled to occur less than ten days after the appointment is made or if the patient arrives without an appointment, such notice shall be hand-delivered to the patient when the patient arrives at the hospital-based facility.</p>\n   <p class=\"indent\">(2) For emergency care, such written notice shall be provided to the patient as soon as practicable after the patient is stabilized in accordance with the federal Emergency Medical Treatment and Active Labor Act, 42 USC 1395dd, as amended from time to time, or is determined not to have an emergency medical condition and before the patient leaves the hospital-based facility. If the patient is unconscious, under great duress or for any other reason unable to read the notice and understand and act on his or her rights, the notice shall be provided to the patient&#39;s representative as soon as practicable.</p>\n   <p class=\"indent\">(g) Subsections (b) to (f), inclusive, and (l) of this section shall not apply if a patient is insured by Medicare or Medicaid or is receiving services under a workers&#39; compensation plan established to provide medical services pursuant to chapter 568.</p>\n   <p class=\"indent\">(h) A hospital-based facility shall prominently display written notice in locations that are readily accessible to and visible by patients, including patient waiting or appointment check-in areas, stating: (1) That the hospital-based facility is part of a hospital or health system, (2) the name of the hospital or health system, and (3) that if the hospital-based facility charges a facility fee, the patient may incur a financial liability greater than the patient would incur if the hospital-based facility was not hospital-based. On and after October 1, 2022, such notices shall include tag lines in at least the top fifteen languages spoken in the state indicating that the notice is available in each of those top fifteen languages. The fifteen languages shall be either the languages in the list published by the Department of Health and Human Services in connection with section 1557 of the Patient Protection and Affordable Care Act, P.L. 111-148, or, as determined by the hospital or health system, the top fifteen languages in the geographic area of the hospital-based facility. Not later than October 1, 2022, and annually thereafter, each hospital-based facility shall submit a copy of the written notice required by this subsection to the Health Systems Planning Unit of the Office of Health Strategy.</p>\n   <p class=\"indent\">(i) A hospital-based facility shall clearly hold itself out to the public and payers as being hospital-based, including, at a minimum, by stating the name of the hospital or health system in its signage, marketing materials, Internet web sites and stationery.</p>\n   <p class=\"indent\">(j) A hospital-based facility shall, when scheduling services for which a facility fee may be charged, inform the patient (1) that the hospital-based facility is part of a hospital or health system, (2) of the name of the hospital or health system, (3) that the hospital or health system may charge a facility fee in addition to and separate from the professional fee charged by the provider, and (4) of the telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability.</p>\n   <p class=\"indent\">(k) (1) If any transaction described in subsection (c) of section 19a-486i results in the establishment of a hospital-based facility at which facility fees may be billed, the hospital or health system, that is the purchaser in such transaction shall, not later than thirty days after such transaction, provide written notice, by first class mail, of the transaction to each patient served within the three years preceding the date of the transaction by the health care facility that has been purchased as part of such transaction.</p>\n   <p class=\"indent\">(2) Such notice shall include the following information:</p>\n   <p class=\"indent\">(A) A statement that the health care facility is now a hospital-based facility and is part of a hospital or health system, the health care facility&#39;s full legal and business name and the date of such facility&#39;s acquisition by a hospital or health system;</p>\n   <p class=\"indent\">(B) The name, business address and phone number of the hospital or health system that is the purchaser of the health care facility;</p>\n   <p class=\"indent\">(C) A statement that the hospital-based facility bills, or is likely to bill, patients a facility fee that may be in addition to, and separate from, any professional fee billed by a health care provider at the hospital-based facility;</p>\n   <p class=\"indent\">(D) (i) A statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, and (ii) an explanation that the patient may incur financial liability that is greater than the patient would incur if the hospital-based facility were not a hospital-based facility;</p>\n   <p class=\"indent\">(E) The estimated amount or range of amounts the hospital-based facility may bill for a facility fee or an example of the average facility fee billed at such hospital-based facility for the most common services provided at such hospital-based facility; and</p>\n   <p class=\"indent\">(F) A statement that, prior to seeking services at such hospital-based facility, a patient covered by a health insurance policy should contact the patient&#39;s health insurer for additional information regarding the hospital-based facility fees, including the patient&#39;s potential financial liability, if any, for such fees.</p>\n   <p class=\"indent\">(3) A copy of the written notice provided to patients in accordance with this subsection shall be filed with the Health Systems Planning Unit of the Office of Health Strategy, established under section 19a-612. Said unit shall post a link to such notice on its Internet web site.</p>\n   <p class=\"indent\">(4) A hospital, health system or hospital-based facility shall not collect a facility fee for services provided at a hospital-based facility that is subject to the provisions of this subsection from the date of the transaction until at least thirty days after the written notice required pursuant to this subsection is mailed to the patient or a copy of such notice is filed with the Health Systems Planning Unit of the Office of Health Strategy, whichever is later. A violation of this subsection shall be considered an unfair trade practice pursuant to section 42-110b.</p>\n   <p class=\"indent\">(5) Not later than July 1, 2023, and annually thereafter, each hospital-based facility that was the subject of a transaction, as described in subsection (c) of section 19a-486i, during the preceding calendar year shall report to the Health Systems Planning Unit of the Office of Health Strategy the number of patients served by such hospital-based facility in the preceding three years.</p>\n   <p class=\"indent\">(l) (1) Notwithstanding the provisions of this section, no hospital, health system or hospital-based facility shall collect a facility fee for (A) outpatient health care services that use a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code and are provided at a hospital-based facility located off-site from a hospital campus, or (B) outpatient health care services provided at a hospital-based facility located off-site from a hospital campus received by a patient who is uninsured of more than the Medicare rate.</p>\n   <p class=\"indent\">(2) Notwithstanding the provisions of this section, on and after July 1, 2024, no hospital or health system shall collect a facility fee for outpatient health care services that use a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code and are provided on the hospital campus. The provisions of this subdivision shall not apply to (A) an emergency department located on a hospital campus, or (B) observation stays on a hospital campus and (CPT E/M) and (CPT A/M) codes when billed for the following services: (i) Wound care, (ii) orthopedics, (iii) anticoagulation, (iv) oncology, (v) obstetrics, and (vi) solid organ transplant.</p>\n   <p class=\"indent\">(3) Notwithstanding the provisions of subdivisions (1) and (2) of this subsection, in circumstances when an insurance contract that is in effect on July 1, 2016, provides reimbursement for facility fees prohibited under the provisions of subdivision (1) of this subsection, and in circumstances when an insurance contract that is in effect on July 1, 2024, provides reimbursement for facility fees prohibited under the provisions of subdivision (2) of this subsection, a hospital or health system may continue to collect reimbursement from the health insurer for such facility fees until the applicable date of expiration, renewal or amendment of such contract, whichever such date is the earliest.</p>\n   <p class=\"indent\">(4) The provisions of this subsection shall not apply to a freestanding emergency department. As used in this subdivision, &quot;freestanding emergency department&quot; means a freestanding facility that (A) is structurally separate and distinct from a hospital, (B) provides emergency care, (C) is a department of a hospital licensed under chapter 368v, and (D) has been issued a certificate of need to operate as a freestanding emergency department pursuant to chapter 368z.</p>\n   <p class=\"indent\">(5) (A) On and after July 1, 2024, if the Commissioner of Health Strategy receives information and has a reasonable belief, after evaluating such information, that any hospital, health system or hospital-based facility charged facility fees, other than through isolated clerical or electronic billing errors, in violation of any provision of this section, or rule or regulation adopted thereunder, such hospital, health system or hospital-based facility shall be subject to a civil penalty of up to one thousand dollars. The commissioner may issue a notice of violation and civil penalty by first class mail or personal service. Such notice shall include: (i) A reference to the section of the general statutes, rule or section of the regulations of Connecticut state agencies believed or alleged to have been violated; (ii) a short and plain language statement of the matters asserted or charged; (iii) a description of the activity to cease; (iv) a statement of the amount of the civil penalty or penalties that may be imposed; (v) a statement concerning the right to a hearing; and (vi) a statement that such hospital, health system or hospital-based facility may, not later than ten business days after receipt of such notice, make a request for a hearing on the matters asserted.</p>\n   <p class=\"indent\">(B) The hospital, health system or hospital-based facility to whom such notice is provided pursuant to subparagraph (A) of this subdivision may, not later than ten business days after receipt of such notice, make written application to the Office of Health Strategy to request a hearing to demonstrate that such violation did not occur. The failure to make a timely request for a hearing shall result in the issuance of a cease and desist order or civil penalty. All hearings held under this subsection shall be conducted in accordance with the provisions of chapter 54.</p>\n   <p class=\"indent\">(C) Following any hearing before the Office of Health Strategy pursuant to this subdivision, if said office finds, by a preponderance of the evidence, that such hospital, health system or hospital-based facility violated or is violating any provision of this subsection, any rule or regulation adopted thereunder or any order issued by said office, said office shall issue a final cease and desist order in addition to any civil penalty said office imposes.</p>\n   <p class=\"indent\">\n    <u class=\"amendmentInsertedText\">(6) A violation of this subsection shall be considered an unfair trade practice pursuant to section 42-110b.</u>\n   </p>\n   <p class=\"indent\">(m) (1) Each hospital and health system shall report not later than October 1, 2023, and thereafter not later than July 1, 2024, and annually thereafter, to the Commissioner of Health Strategy, on a form prescribed by the commissioner, concerning facility fees charged or billed during the preceding calendar year. Such report shall include, but need not be limited to, (A) the name and address of each facility owned or operated by the hospital or health system that provides services for which a facility fee is charged or billed, and an indication as to whether each facility is located on or outside of the hospital or health system campus, (B) the number of patient visits at each such facility for which a facility fee was charged or billed, (C) the number, total amount and range of allowable facility fees paid at each such facility disaggregated by payer mix, (D) for each facility, the total amount of facility fees charged and the total amount of revenue received by the hospital or health system derived from facility fees, (E) the total amount of facility fees charged and the total amount of revenue received by the hospital or health system from all facilities derived from facility fees, (F) a description of the ten procedures or services that generated the greatest amount of facility fee gross revenue, disaggregated by current procedural terminology <u class=\"amendmentInsertedText\">(CPT)</u> category <strike class=\"amendmentDeletedText\">(CPT)</strike> code for each such procedure or service and, for each such procedure or service, patient volume and the total amount of gross and net revenue received by the hospital or health system derived from facility fees, disaggregated by on-campus and off-campus, and (G) the top ten procedures or services for which facility fees are charged based on patient volume and the gross and net revenue received by the hospital or health system for each such procedure or service, disaggregated by on-campus and off-campus. For purposes of this subsection, &quot;facility&quot; means a hospital-based facility that is located on a hospital campus or outside a hospital campus.</p>\n   <p class=\"indent\">(2) The commissioner shall publish the information reported pursuant to subdivision (1) of this subsection, or post a link to such information, on the Internet web site of the Office of Health Strategy.</p>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Enrolled  \nVersion Date: | 06/11/2025  \n  \n**STATE OF CONNECTICUT**\n\n**Substitute Senate Bill No. 10**\n\n**Public Act No. 25-94**\n\n**AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.**\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nSection 1. (NEW) (Effective October 1, 2025) (a) As used in this section:\n\n(1) \"Health carrier\" has the same meaning as provided in section 38a-1080 of\nthe general statutes; and\n\n(2) \"Mental health and substance use disorder benefits\" has the same meaning\nas provided in section 38a-477ee of the general statutes, as amended by this\nact.\n\n(b) (1) Not later than March 1, 2026, and annually thereafter, each health\ncarrier shall file a certification with the Insurance Commissioner for the\nimmediately preceding calendar year, certifying that such health carrier\ncompleted a review of such health carrier's administrative practices for\ncompliance with the state and federal mental health and substance use disorder\nbenefit reporting requirements pursuant to sections 38a-477ee, as amended by\nthis act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act,\n38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by\nthis act, and the provisions of the federal Paul Wellstone and Pete Domenici\nMental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as\namended from time to time, and regulations adopted thereunder.\n\n(2) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year comply\nwith the state and federal mental health and substance use disorder benefit\nreporting requirements identified in subdivision (1) of this subsection, such\ncertification filed pursuant to subdivision (1) of this subsection shall state\nsuch finding.\n\n(3) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year fail to\ncomply with the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of this\nsubsection, such certification filed pursuant to subdivision (1) of this\nsubsection shall state such finding and identify (A) each administrative\npractice of such health carrier not in compliance with such state and federal\nmental health and substance use disorder benefit reporting requirements, and\n(B) action that such health carrier will take to bring such health carrier's\nadministrative practices into compliance with such state and federal mental\nhealth and substance use disorder benefit reporting requirements.\n\nSec. 2. Subsection (c) of section 38a-477ee of the general statutes is\nrepealed and the following is substituted in lieu thereof (Effective October\n1, 2025):\n\n(c) ~~(1)~~ Not later than April 15, 2021, and annually thereafter, the\nInsurance Commissioner shall submit each report that the commissioner received\npursuant to subsection (b) of this section for the calendar year immediately\npreceding to:\n\n~~(A)~~ _(1)_ The joint standing committee of the General Assembly having\ncognizance of matters relating to insurance, in accordance with section 11-4a;\nand\n\n~~(B)~~ _(2)_ The Attorney General, Healthcare Advocate and Commissioner of\nHealth Strategy.\n\n~~(2) Notwithstanding subdivision (1) of this subsection, the commissioner\nshall not submit the name or identity of any health carrier or entity that has\ncontracted with such health carrier, and such name or identity shall be given\nconfidential treatment and not be made public by the commissioner.~~\n\nSec. 3. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after\nproviding an opportunity for a hearing in accordance with chapter 54 of the\ngeneral statutes, may impose a civil penalty on any health carrier of not more\nthan one hundred dollars with respect to each participant or beneficiary\ncovered under a health insurance policy of such health carrier, provided such\npenalty shall not exceed an aggregate amount of six hundred twenty-five\nthousand dollars annually, for such health carrier's failure to comply with\n(A) the certification requirements pursuant to the provisions of section 1 of\nthis act, (B) the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of subsection (b)\nof section 1 of this act, or (C) any other requirement pursuant to sections\n38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as\namended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general\nstatutes, as amended by this act, and the provisions of the federal Paul\nWellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of\n2008, P.L. 110-343, as amended from time to time, and regulations adopted\nthereunder.\n\n(2) The commissioner may order the payment of such reasonable expenses as may\nbe necessary to compensate the commissioner in conjunction with any\nproceedings under this section, which shall be dedicated to the enforcement\nand implementation of the state and federal mental health parity laws and\nregulations adopted thereunder.\n\n(b) (1) If any health carrier fails to file any data, report, certification or\nother information required by the provisions of section 38a-477ee of the\ngeneral statutes, as amended by this act, or section 1 of this act, the\ncommissioner shall impose a late fee on such health carrier of one hundred\ndollars per day from the due date of such filing of data, report,\ncertification or information to the date such health carrier submits such\nfiling to the commissioner, provided such late fee shall not exceed an\naggregate amount of six hundred twenty-five thousand dollars.\n\n(2) For any health carrier that files any incomplete data, report,\ncertification or other information required by the provisions of section\n38a-477ee of the general statutes, as amended by this act, and section 1 of\nthis act, the commissioner shall provide notice to such health carrier of such\nincomplete filing that includes (A) a description of such data, report,\ncertification or other information that is incomplete and any additional data\nthat is needed to consider such filing complete, and (B) the date by which\nsuch health carrier is required to provide such data. The commissioner shall\nimpose a late fee on such health carrier of one hundred dollars per day,\ncommencing from the date identified by the commissioner pursuant to\nsubparagraph (B) of this subdivision, provided such late fee shall not exceed\nan aggregate amount of six hundred twenty-five thousand dollars.\n\n(c) The commissioner may waive any civil penalty imposed pursuant to\nsubsection (a) of this section if the commissioner determines that the\nviolation was due to reasonable cause and was not due to wilful neglect, or if\nsuch violation is corrected not more than thirty days after the date that the\nhealth carrier filed a certification of noncompliance with the commissioner\npursuant to section 1 of this act.\n\n(d) All civil penalties and late fees received by the commissioner pursuant to\nthis section shall be deposited in the General Fund.\n\n(e) The commissioner may engage the services of any health policy research\norganization or any other independent expert as the commissioner deems\nnecessary to assist the commissioner in the review of any violation of the\nnonquantitative treatment limitations requirements pursuant to section\n38a-477ee of the general statutes, as amended by this act, and the provisions\nof the federal Paul Wellstone and Pete Domenici Mental Health Parity and\nAddiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and\nregulations adopted thereunder.\n\nSec. 4. Section 38a-510 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing an individual health insurance\npolicy or contract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan thirty days, (B) for a prescribed drug for cancer treatment for an\ninsured who has been diagnosed with stage IV metastatic cancer _, multiple\nsclerosis or rheumatoid arthritis,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications, or\n(C) ~~for the period commencing January 1, 2024, and ending January 1, 2027,\ninclusive,~~ for the treatment of schizophrenia, major depressive disorder or\nbipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\".\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\nsubparagraph (B) or (C) of subdivision (2) of this subsection, an insured's\ntreating health care provider may deem such step therapy drug regimen\nclinically ineffective for the insured, at which time the insurance company,\nhospital service corporation, medical service corporation, health care center\nor other entity shall authorize dispensation of and coverage for the drug\nprescribed by the insured's treating health care provider, provided such drug\nis a covered drug under such policy or contract. If such provider does not\ndeem such step therapy drug regimen clinically ineffective or has not\nrequested an override pursuant to subdivision (1) of subsection (b) of this\nsection, such drug regimen may be continued. For purposes of this section,\n\"step therapy\" means a protocol or program that establishes the specific\nsequence in which prescription drugs for a specified medical condition are to\nbe prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _thirty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive, or (2) affect the provisions of section 38a-492i.\n\nSec. 5. Section 38a-544 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing a group health insurance policy or\ncontract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan thirty days, (B) for a prescribed drug for cancer treatment for an\ninsured who has been diagnosed with stage IV metastatic cancer _, multiple\nsclerosis or rheumatoid arthritis,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications, or\n(C) ~~for the period commencing January 1, 2024, and ending January 1, 2027,\ninclusive,~~ for the treatment of schizophrenia, major depressive disorder or\nbipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\".\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\nsubparagraph (B) or (C) of subdivision (2) of this subsection, an insured's\ntreating health care provider may deem such step therapy drug regimen\nclinically ineffective for the insured, at which time the insurance company,\nhospital service corporation, medical service corporation, health care center\nor other entity shall authorize dispensation of and coverage for the drug\nprescribed by the insured's treating health care provider, provided such drug\nis a covered drug under such policy or contract. If such provider does not\ndeem such step therapy drug regimen clinically ineffective or has not\nrequested an override pursuant to subdivision (1) of subsection (b) of this\nsection, such drug regimen may be continued. For purposes of this section,\n\"step therapy\" means a protocol or program that establishes the specific\nsequence in which prescription drugs for a specified medical condition are to\nbe prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _thirty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive, or (2) affect the provisions of section 38a-518i.\n\nSec. 6. Subsection (b) of section 38a-481 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2027):\n\n(b) No rate filed under the provisions of subsection (a) of this section shall\nbe effective until it has been approved by the commissioner in accordance with\nregulations adopted pursuant to this subsection. The commissioner shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such rates shall not be excessive, inadequate or\nunfairly discriminatory. The commissioner may disapprove such rate if it fails\nto comply with such standards, except that no rate filed under the provisions\nof subsection (a) of this section for any Medicare supplement policy shall be\neffective unless approved in accordance with section 38a-474. _If the\ncommissioner determines that a health carrier 's average premium rate\nincrease, as approved by the commissioner, exceeded the health care cost\ngrowth benchmark established pursuant to section 19a-754g for each of the two\nmost recent plan years for which such health care cost growth benchmark data\nis available, the commissioner may reduce such health carrier's requested rate\nfiled under the provisions of subsection (a) of this section by not more than\ntwo percentage points of such premium rate filed in addition to any other rate\nreductions authorized under this title._\n\nSec. 7. Subsection (a) of section 38a-513 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2027):\n\n(a) (1) No group health insurance policy, as defined by the commissioner, or\ncertificate shall be delivered or issued for delivery in this state unless a\ncopy of the form for such policy or certificate has been submitted to and\napproved by the commissioner under the regulations adopted pursuant to this\nsection. The commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54, concerning the provisions, submission and approval\nof such policies and certificates and establishing a procedure for reviewing\nsuch policies and certificates. The commissioner shall disapprove the use of\nsuch form at any time if it does not comply with the requirements of law, or\nif it contains a provision or provisions that are unfair or deceptive or that\nencourage misrepresentation of the policy. The commissioner shall notify, in\nwriting, the insurer that has filed any such form of the commissioner's\ndisapproval, specifying the reasons for disapproval, and ordering that no such\ninsurer shall deliver or issue for delivery to any person in this state a\npolicy on or containing such form. The provisions of section 38a-19 shall\napply to such order.\n\n(2) No group health insurance policy or certificate for a small employer, as\ndefined in section 38a-564, shall be delivered or issued for delivery in this\nstate unless the premium rates have been submitted to and approved by the\ncommissioner. _If the commissioner determines that any small group health\ninsurance carrier 's average premium rate increase, as approved by the\ncommissioner, or certificate for a small employer, exceeded the health care\ncost growth benchmark established pursuant to section 19a-754g for each of the\ntwo most recent plan years for which such health care cost growth benchmark\ndata is available, the commissioner may reduce such policy's or certificate's\nrequested premium rate filing under the provisions of subsection (a) of this\nsection by not more than two percentage points of such premium rate filed in\naddition to any other premium rate reductions authorized under this title._\nPremium rate filings shall include the information and data required under\nsection 38a-479qqq if the policy is subject to said section, and an actuarial\nmemorandum that includes, but is not limited to, pricing assumptions and\nclaims experience, and premium rates and loss ratios from the inception of the\npolicy. Each premium rate filed on or after January 1, 2021, shall, if the\ninsurer intends to account for rebates, as defined in section 38a-479ooo in\nthe manner specified in section 38a-479rrr, account for such rebates in such\nmanner, if the policy is subject to section 38a-479rrr. As used in this\nsubdivision, \"loss ratio\" means the ratio of incurred claims to earned\npremiums by the number of years of policy duration for all combined durations.\n\nSec. 8. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medically necessary\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No individual health insurance policy providing coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes delivered, issued for delivery, renewed, amended or\ncontinued in this state on or after January 1, 2026, shall, if such policy\nprovides coverage for general anesthesia, (1) impose an arbitrary time limit\non reimbursement for general anesthesia provided during any medically\nnecessary procedure, or (2) deny, reduce, terminate or fail to provide such\nreimbursement, in whole or in part, for general anesthesia solely because the\nduration of care exceeded a predetermined time limit as determined by the\ninsurer.\n\nSec. 9. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medically necessary\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No group health insurance policy providing coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general\nstatutes delivered, issued for delivery, renewed, amended or continued in this\nstate on or after January 1, 2026, shall, if such policy provides coverage for\ngeneral anesthesia, (1) impose an arbitrary time limit on reimbursement for\ngeneral anesthesia provided during any medically necessary procedure, or (2)\ndeny, reduce, terminate or fail to provide such reimbursement, in whole or in\npart, for general anesthesia solely because the duration of care exceeded a\npredetermined time limit as determined by the insurer.\n\nSec. 10. Section 19a-508c of the general statutes is repealed and the\nfollowing is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) As used in this section:\n\n(1) \"Affiliated provider\" means a provider that is: (A) Employed by a hospital\nor health system, (B) under a professional services agreement with a hospital\nor health system that permits such hospital or health system to bill on behalf\nof such provider, or (C) a clinical faculty member of a medical school, as\ndefined in section 33-182aa, that is affiliated with a hospital or health\nsystem in a manner that permits such hospital or health system to bill on\nbehalf of such clinical faculty member;\n\n(2) \"Campus\" means: (A) The physical area immediately adjacent to a hospital's\nmain buildings and other areas and structures that are not strictly contiguous\nto the main buildings but are located within two hundred fifty yards of the\nmain buildings, or (B) any other area that has been determined on an\nindividual case basis by the Centers for Medicare and Medicaid Services to be\npart of a hospital's campus;\n\n(3) \"Facility fee\" means any fee charged or billed by a hospital or health\nsystem for outpatient services provided in a hospital-based facility that is:\n(A) Intended to compensate the hospital or health system for the operational\nexpenses of the hospital or health system, and (B) separate and distinct from\na professional fee;\n\n(4) \"Health care provider\" means an individual, entity, corporation, person or\norganization, whether for-profit or nonprofit, that furnishes, bills or is\npaid for health care service delivery in the normal course of business,\nincluding, but not limited to, a health system, a hospital, a hospital-based\nfacility, a freestanding emergency department and an urgent care center;\n\n(5) \"Health system\" means: (A) A parent corporation of one or more hospitals\nand any entity affiliated with such parent corporation through ownership,\ngovernance, membership or other means, or (B) a hospital and any entity\naffiliated with such hospital through ownership, governance, membership or\nother means;\n\n(6) \"Hospital\" has the same meaning as provided in section 19a-490;\n\n(7) \"Hospital-based facility\" means a facility that is owned or operated, in\nwhole or in part, by a hospital or health system where hospital or\nprofessional medical services are provided;\n\n(8) \"Medicaid\" means the program operated by the Department of Social Services\npursuant to section 17b-260 and authorized by Title XIX of the Social Security\nAct, as amended from time to time;\n\n(9) \"Observation\" means services furnished by a hospital on the hospital's\ncampus, regardless of length of stay, including use of a bed and periodic\nmonitoring by the hospital's nursing or other staff to evaluate an\noutpatient's condition or determine the need for admission to the hospital as\nan inpatient;\n\n(10) \"Payer mix\" means the proportion of different sources of payment received\nby a hospital or health system, including, but not limited to, Medicare,\nMedicaid, other government-provided insurance, private insurance and self-pay\npatients;\n\n(11) \"Professional fee\" means any fee charged or billed by a provider for\nprofessional medical services provided in a hospital-based facility;\n\n(12) \"Provider\" means an individual, entity, corporation or health care\nprovider, whether for profit or nonprofit, whose primary purpose is to provide\nprofessional medical services; and\n\n(13) \"Tagline\" means a short statement written in a non-English language that\nindicates the availability of language assistance services free of charge.\n\n(b) If a hospital or health system charges a facility fee utilizing a current\nprocedural terminology evaluation and management (CPT E/M) code or assessment\nand management (CPT A/M) code for outpatient services provided at a hospital-\nbased facility where a professional fee is also expected to be charged, the\nhospital or health system shall provide the patient with a written notice that\nincludes the following information:\n\n(1) That the hospital-based facility is part of a hospital or health system\nand that the hospital or health system charges a facility fee that is in\naddition to and separate from the professional fee charged by the provider;\n\n(2) (A) The amount of the patient's potential financial liability, including\nany facility fee likely to be charged, and, where professional medical\nservices are provided by an affiliated provider, any professional fee likely\nto be charged, or, if the exact type and extent of the professional medical\nservices needed are not known or the terms of a patient's health insurance\ncoverage are not known with reasonable certainty, an estimate of the patient's\nfinancial liability based on typical or average charges for visits to the\nhospital-based facility, including the facility fee, (B) a statement that the\npatient's actual financial liability will depend on the professional medical\nservices actually provided to the patient, (C) an explanation that the patient\nmay incur financial liability that is greater than the patient would incur if\nthe professional medical services were not provided by a hospital-based\nfacility, and (D) a telephone number the patient may call for additional\ninformation regarding such patient's potential financial liability, including\nan estimate of the facility fee likely to be charged based on the scheduled\nprofessional medical services; and\n\n(3) That a patient covered by a health insurance policy should contact the\nhealth insurer for additional information regarding the hospital's or health\nsystem's charges and fees, including the patient's potential financial\nliability, if any, for such charges and fees.\n\n(c) If a hospital or health system charges a facility fee without utilizing a\ncurrent procedural terminology evaluation and management (CPT E/M) code for\noutpatient services provided at a hospital-based facility, located outside the\nhospital campus, the hospital or health system shall provide the patient with\na written notice that includes the following information:\n\n(1) That the hospital-based facility is part of a hospital or health system\nand that the hospital or health system charges a facility fee that may be in\naddition to and separate from the professional fee charged by a provider;\n\n(2) (A) A statement that the patient's actual financial liability will depend\non the professional medical services actually provided to the patient, (B) an\nexplanation that the patient may incur financial liability that is greater\nthan the patient would incur if the hospital-based facility was not hospital-\nbased, and (C) a telephone number the patient may call for additional\ninformation regarding such patient's potential financial liability, including\nan estimate of the facility fee likely to be charged based on the scheduled\nprofessional medical services; and\n\n(3) That a patient covered by a health insurance policy should contact the\nhealth insurer for additional information regarding the hospital's or health\nsystem's charges and fees, including the patient's potential financial\nliability, if any, for such charges and fees.\n\n(d) Each initial billing statement that includes a facility fee shall: (1)\nClearly identify the fee as a facility fee that is billed in addition to, or\nseparately from, any professional fee billed by the provider; (2) provide the\ncorresponding Medicare facility fee reimbursement rate for the same service as\na comparison or, if there is no corresponding Medicare facility fee for such\nservice, (A) the approximate amount Medicare would have paid the hospital for\nthe facility fee on the billing statement, or (B) the percentage of the\nhospital's charges that Medicare would have paid the hospital for the facility\nfee; (3) include a statement that the facility fee is intended to cover the\nhospital's or health system's operational expenses; (4) inform the patient\nthat the patient's financial liability may have been less if the services had\nbeen provided at a facility not owned or operated by the hospital or health\nsystem; and (5) include written notice of the patient's right to request a\nreduction in the facility fee or any other portion of the bill and a telephone\nnumber that the patient may use to request such a reduction without regard to\nwhether such patient qualifies for, or is likely to be granted, any reduction.\nNot later than October 15, 2022, and annually thereafter, each hospital,\nhealth system and hospital-based facility shall submit to the Health Systems\nPlanning Unit of the Office of Health Strategy a sample of a billing statement\nissued by such hospital, health system or hospital-based facility that\ncomplies with the provisions of this subsection and which represents the\nformat of billing statements received by patients. Such billing statement\nshall not contain patient identifying information.\n\n(e) The written notice described in subsections (b) to (d), inclusive, and (h)\nto (j), inclusive, of this section shall be in plain language and in a form\nthat may be reasonably understood by a patient who does not possess special\nknowledge regarding hospital or health system facility fee charges. On and\nafter October 1, 2022, such notices shall include tag lines in at least the\ntop fifteen languages spoken in the state indicating that the notice is\navailable in each of those top fifteen languages. The fifteen languages shall\nbe either the languages in the list published by the Department of Health and\nHuman Services in connection with section 1557 of the Patient Protection and\nAffordable Care Act, P.L. 111-148, or, as determined by the hospital or health\nsystem, the top fifteen languages in the geographic area of the hospital-based\nfacility.\n\n(f) (1) For nonemergency care, if a patient's appointment is scheduled to\noccur ten or more days after the appointment is made, such written notice\nshall be sent to the patient by first class mail, encrypted electronic mail or\na secure patient Internet portal not less than three days after the\nappointment is made. If an appointment is scheduled to occur less than ten\ndays after the appointment is made or if the patient arrives without an\nappointment, such notice shall be hand-delivered to the patient when the\npatient arrives at the hospital-based facility.\n\n(2) For emergency care, such written notice shall be provided to the patient\nas soon as practicable after the patient is stabilized in accordance with the\nfederal Emergency Medical Treatment and Active Labor Act, 42 USC 1395dd, as\namended from time to time, or is determined not to have an emergency medical\ncondition and before the patient leaves the hospital-based facility. If the\npatient is unconscious, under great duress or for any other reason unable to\nread the notice and understand and act on his or her rights, the notice shall\nbe provided to the patient's representative as soon as practicable.\n\n(g) Subsections (b) to (f), inclusive, and (l) of this section shall not apply\nif a patient is insured by Medicare or Medicaid or is receiving services under\na workers' compensation plan established to provide medical services pursuant\nto chapter 568.\n\n(h) A hospital-based facility shall prominently display written notice in\nlocations that are readily accessible to and visible by patients, including\npatient waiting or appointment check-in areas, stating: (1) That the hospital-\nbased facility is part of a hospital or health system, (2) the name of the\nhospital or health system, and (3) that if the hospital-based facility charges\na facility fee, the patient may incur a financial liability greater than the\npatient would incur if the hospital-based facility was not hospital-based. On\nand after October 1, 2022, such notices shall include tag lines in at least\nthe top fifteen languages spoken in the state indicating that the notice is\navailable in each of those top fifteen languages. The fifteen languages shall\nbe either the languages in the list published by the Department of Health and\nHuman Services in connection with section 1557 of the Patient Protection and\nAffordable Care Act, P.L. 111-148, or, as determined by the hospital or health\nsystem, the top fifteen languages in the geographic area of the hospital-based\nfacility. Not later than October 1, 2022, and annually thereafter, each\nhospital-based facility shall submit a copy of the written notice required by\nthis subsection to the Health Systems Planning Unit of the Office of Health\nStrategy.\n\n(i) A hospital-based facility shall clearly hold itself out to the public and\npayers as being hospital-based, including, at a minimum, by stating the name\nof the hospital or health system in its signage, marketing materials, Internet\nweb sites and stationery.\n\n(j) A hospital-based facility shall, when scheduling services for which a\nfacility fee may be charged, inform the patient (1) that the hospital-based\nfacility is part of a hospital or health system, (2) of the name of the\nhospital or health system, (3) that the hospital or health system may charge a\nfacility fee in addition to and separate from the professional fee charged by\nthe provider, and (4) of the telephone number the patient may call for\nadditional information regarding such patient's potential financial liability.\n\n(k) (1) If any transaction described in subsection (c) of section 19a-486i\nresults in the establishment of a hospital-based facility at which facility\nfees may be billed, the hospital or health system, that is the purchaser in\nsuch transaction shall, not later than thirty days after such transaction,\nprovide written notice, by first class mail, of the transaction to each\npatient served within the three years preceding the date of the transaction by\nthe health care facility that has been purchased as part of such transaction.\n\n(2) Such notice shall include the following information:\n\n(A) A statement that the health care facility is now a hospital-based facility\nand is part of a hospital or health system, the health care facility's full\nlegal and business name and the date of such facility's acquisition by a\nhospital or health system;\n\n(B) The name, business address and phone number of the hospital or health\nsystem that is the purchaser of the health care facility;\n\n(C) A statement that the hospital-based facility bills, or is likely to bill,\npatients a facility fee that may be in addition to, and separate from, any\nprofessional fee billed by a health care provider at the hospital-based\nfacility;\n\n(D) (i) A statement that the patient's actual financial liability will depend\non the professional medical services actually provided to the patient, and\n(ii) an explanation that the patient may incur financial liability that is\ngreater than the patient would incur if the hospital-based facility were not a\nhospital-based facility;\n\n(E) The estimated amount or range of amounts the hospital-based facility may\nbill for a facility fee or an example of the average facility fee billed at\nsuch hospital-based facility for the most common services provided at such\nhospital-based facility; and\n\n(F) A statement that, prior to seeking services at such hospital-based\nfacility, a patient covered by a health insurance policy should contact the\npatient's health insurer for additional information regarding the hospital-\nbased facility fees, including the patient's potential financial liability, if\nany, for such fees.\n\n(3) A copy of the written notice provided to patients in accordance with this\nsubsection shall be filed with the Health Systems Planning Unit of the Office\nof Health Strategy, established under section 19a-612. Said unit shall post a\nlink to such notice on its Internet web site.\n\n(4) A hospital, health system or hospital-based facility shall not collect a\nfacility fee for services provided at a hospital-based facility that is\nsubject to the provisions of this subsection from the date of the transaction\nuntil at least thirty days after the written notice required pursuant to this\nsubsection is mailed to the patient or a copy of such notice is filed with the\nHealth Systems Planning Unit of the Office of Health Strategy, whichever is\nlater. A violation of this subsection shall be considered an unfair trade\npractice pursuant to section 42-110b.\n\n(5) Not later than July 1, 2023, and annually thereafter, each hospital-based\nfacility that was the subject of a transaction, as described in subsection (c)\nof section 19a-486i, during the preceding calendar year shall report to the\nHealth Systems Planning Unit of the Office of Health Strategy the number of\npatients served by such hospital-based facility in the preceding three years.\n\n(l) (1) Notwithstanding the provisions of this section, no hospital, health\nsystem or hospital-based facility shall collect a facility fee for (A)\noutpatient health care services that use a current procedural terminology\nevaluation and management (CPT E/M) code or assessment and management (CPT\nA/M) code and are provided at a hospital-based facility located off-site from\na hospital campus, or (B) outpatient health care services provided at a\nhospital-based facility located off-site from a hospital campus received by a\npatient who is uninsured of more than the Medicare rate.\n\n(2) Notwithstanding the provisions of this section, on and after July 1, 2024,\nno hospital or health system shall collect a facility fee for outpatient\nhealth care services that use a current procedural terminology evaluation and\nmanagement (CPT E/M) code or assessment and management (CPT A/M) code and are\nprovided on the hospital campus. The provisions of this subdivision shall not\napply to (A) an emergency department located on a hospital campus, or (B)\nobservation stays on a hospital campus and (CPT E/M) and (CPT A/M) codes when\nbilled for the following services: (i) Wound care, (ii) orthopedics, (iii)\nanticoagulation, (iv) oncology, (v) obstetrics, and (vi) solid organ\ntransplant.\n\n(3) Notwithstanding the provisions of subdivisions (1) and (2) of this\nsubsection, in circumstances when an insurance contract that is in effect on\nJuly 1, 2016, provides reimbursement for facility fees prohibited under the\nprovisions of subdivision (1) of this subsection, and in circumstances when an\ninsurance contract that is in effect on July 1, 2024, provides reimbursement\nfor facility fees prohibited under the provisions of subdivision (2) of this\nsubsection, a hospital or health system may continue to collect reimbursement\nfrom the health insurer for such facility fees until the applicable date of\nexpiration, renewal or amendment of such contract, whichever such date is the\nearliest.\n\n(4) The provisions of this subsection shall not apply to a freestanding\nemergency department. As used in this subdivision, \"freestanding emergency\ndepartment\" means a freestanding facility that (A) is structurally separate\nand distinct from a hospital, (B) provides emergency care, (C) is a department\nof a hospital licensed under chapter 368v, and (D) has been issued a\ncertificate of need to operate as a freestanding emergency department pursuant\nto chapter 368z.\n\n(5) (A) On and after July 1, 2024, if the Commissioner of Health Strategy\nreceives information and has a reasonable belief, after evaluating such\ninformation, that any hospital, health system or hospital-based facility\ncharged facility fees, other than through isolated clerical or electronic\nbilling errors, in violation of any provision of this section, or rule or\nregulation adopted thereunder, such hospital, health system or hospital-based\nfacility shall be subject to a civil penalty of up to one thousand dollars.\nThe commissioner may issue a notice of violation and civil penalty by first\nclass mail or personal service. Such notice shall include: (i) A reference to\nthe section of the general statutes, rule or section of the regulations of\nConnecticut state agencies believed or alleged to have been violated; (ii) a\nshort and plain language statement of the matters asserted or charged; (iii) a\ndescription of the activity to cease; (iv) a statement of the amount of the\ncivil penalty or penalties that may be imposed; (v) a statement concerning the\nright to a hearing; and (vi) a statement that such hospital, health system or\nhospital-based facility may, not later than ten business days after receipt of\nsuch notice, make a request for a hearing on the matters asserted.\n\n(B) The hospital, health system or hospital-based facility to whom such notice\nis provided pursuant to subparagraph (A) of this subdivision may, not later\nthan ten business days after receipt of such notice, make written application\nto the Office of Health Strategy to request a hearing to demonstrate that such\nviolation did not occur. The failure to make a timely request for a hearing\nshall result in the issuance of a cease and desist order or civil penalty. All\nhearings held under this subsection shall be conducted in accordance with the\nprovisions of chapter 54.\n\n(C) Following any hearing before the Office of Health Strategy pursuant to\nthis subdivision, if said office finds, by a preponderance of the evidence,\nthat such hospital, health system or hospital-based facility violated or is\nviolating any provision of this subsection, any rule or regulation adopted\nthereunder or any order issued by said office, said office shall issue a final\ncease and desist order in addition to any civil penalty said office imposes.\n\n_(6) A violation of this subsection shall be considered an unfair trade\npractice pursuant to section 42-110b._\n\n(m) (1) Each hospital and health system shall report not later than October 1,\n2023, and thereafter not later than July 1, 2024, and annually thereafter, to\nthe Commissioner of Health Strategy, on a form prescribed by the commissioner,\nconcerning facility fees charged or billed during the preceding calendar year.\nSuch report shall include, but need not be limited to, (A) the name and\naddress of each facility owned or operated by the hospital or health system\nthat provides services for which a facility fee is charged or billed, and an\nindication as to whether each facility is located on or outside of the\nhospital or health system campus, (B) the number of patient visits at each\nsuch facility for which a facility fee was charged or billed, (C) the number,\ntotal amount and range of allowable facility fees paid at each such facility\ndisaggregated by payer mix, (D) for each facility, the total amount of\nfacility fees charged and the total amount of revenue received by the hospital\nor health system derived from facility fees, (E) the total amount of facility\nfees charged and the total amount of revenue received by the hospital or\nhealth system from all facilities derived from facility fees, (F) a\ndescription of the ten procedures or services that generated the greatest\namount of facility fee gross revenue, disaggregated by current procedural\nterminology _(CPT)_ category ~~(CPT)~~ code for each such procedure or service\nand, for each such procedure or service, patient volume and the total amount\nof gross and net revenue received by the hospital or health system derived\nfrom facility fees, disaggregated by on-campus and off-campus, and (G) the top\nten procedures or services for which facility fees are charged based on\npatient volume and the gross and net revenue received by the hospital or\nhealth system for each such procedure or service, disaggregated by on-campus\nand off-campus. For purposes of this subsection, \"facility\" means a hospital-\nbased facility that is located on a hospital campus or outside a hospital\ncampus.\n\n(2) The commissioner shall publish the information reported pursuant to\nsubdivision (1) of this subsection, or post a link to such information, on the\nInternet web site of the Office of Health Strategy.\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": false
    },
    {
      "date": "06/24/2025",
      "label": "Enacted - Final",
      "url": "https://custom.statenet.com/public/resources.cgi?mode=show_text&id=ID:bill:CT2025000S10&verid=CT2025000S10_20250624_0_EF&",
      "raw_html": "<html>\n<head>\n<title>Bill Resource</title>\n\n<!--   <link href=\"https://custom.statenet.com/network/Common/css/extregtext.css\" rel=\"stylesheet\" type=\"text/css\" />-->\n   <link href=\"https://custom.statenet.com/network/Common/css/xmltext-2.0.css\" rel=\"stylesheet\" type=\"text/css\" />\n   <link href=\"https://custom.statenet.com/network/Common/css/additional-text.css\" rel=\"stylesheet\" type=\"text/css\" />\n\n\t<style type=\"text/css\">\n<!--\n\ntd, body {\n     background-color: white;\n\tfont-family: Verdana, Arial, Helvetica, sans-serif;\n\tfont-size: 12px;\n}\n\n.resourceContainer {\n   border: 1px solid black;\n}\n-->\n</style>\n</head>\n<body>\n\n    <div style=\"width: 750px; margin: auto\">\n       <div style=\"font-size: .8em;margin-bottom: 10px\"><table width=\"100%\"><tr><td align=\"left\" style=\"font-size: .8em;\"><div>The following has special meaning:</div>\n<div><u class=\"amendmentInsertedText\">green underline denotes added text</u></div>\n<div><strike class=\"amendmentDeletedText\">red struck out text denotes deleted text</strike></div></td> <td align=\"right\"><a href=\"https://www.lexisnexis.com/statenet/\"><img alt=\"Powered by State Net\" src=\"https://custom.statenet.com/network/poweredby.gif\" /></a></td></tr></table></div><table id=\"text-identifier\"><tr><td class=\"key\">2025 CT S 10</td> <td><table><tr><td class=\"label\">Author:</td> <td>Looney</td></tr> <tr><td class=\"label\">Version:</td> <td>Enacted - Final</td></tr> <tr><td class=\"label\">Version Date:</td> <td>06/24/2025</td></tr></table></td></tr></table><div class=\"documentBody\">\n  <a name=\"head_document_section\"></a><div class=\"head\">\n   <p class=\"center\">\n    <b>STATE OF CONNECTICUT</b>\n   </p>\n   <p class=\"center\">\n    <b>Substitute Senate Bill No. 10</b>\n   </p>\n   <p class=\"center\">\n    <b>Public Act No. 25-94</b>\n   </p>\n  </div>\n  <a name=\"title_document_section\"></a><div class=\"title\">\n   <p class=\"indent\">\n    <b>AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.</b>\n   </p>\n  </div>\n  <a name=\"text_document_section\"></a><div class=\"text\">\n   <span>\n    <p class=\"indent\">Be it enacted by the Senate and House of Representatives in General Assembly convened:</p>\n   </span>\n   <a name=\"section-Section 1-new\"></a><div title=\"Section: Section 1, Action: &quot;new&quot;, Title: &quot;25-94&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">Section 1. (NEW) (Effective October 1, 2025) (a) As used in this section:</p>\n    <p class=\"indent\">(1) &quot;Health carrier&quot; has the same meaning as provided in section 38a-1080 of the general statutes; and</p>\n    <p class=\"indent\">(2) &quot;Mental health and substance use disorder benefits&quot; has the same meaning as provided in section 38a-477ee of the general statutes, as amended by this act.</p>\n    <p class=\"indent\">(b) (1) Not later than March 1, 2026, and annually thereafter, each health carrier shall file a certification with the Insurance Commissioner for the immediately preceding calendar year, certifying that such health carrier completed a review of such health carrier&#39;s administrative practices for compliance with the state and federal mental health and substance use disorder benefit reporting requirements pursuant to sections 38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n    <p class=\"indent\">(2) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding.</p>\n    <p class=\"indent\">(3) If such health carrier determines that such health carrier&#39;s administrative practices for the immediately preceding calendar year fail to comply with the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of this subsection, such certification filed pursuant to subdivision (1) of this subsection shall state such finding and identify (A) each administrative practice of such health carrier not in compliance with such state and federal mental health and substance use disorder benefit reporting requirements, and (B) action that such health carrier will take to bring such health carrier&#39;s administrative practices into compliance with such state and federal mental health and substance use disorder benefit reporting requirements.</p>\n   </div>\n   <p class=\"indent\">Sec. 2. Subsection (c) of section 38a-477ee of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2025):</p>\n   <a name=\"section-38a-477ee(c)-amended\"></a><div class=\"sectionContent\" title=\"Section: 38a-477ee(c), Action: &quot;amended&quot;\">\n    <p class=\"indent\">(c) <strike class=\"amendmentDeletedText\">(1)</strike> Not later than April 15, 2021, and annually thereafter, the Insurance Commissioner shall submit each report that the commissioner received pursuant to subsection (b) of this section for the calendar year immediately preceding to:</p>\n    <p class=\"indent\">\n     <strike class=\"amendmentDeletedText\">(A)</strike>\n     <u class=\"amendmentInsertedText\">(1)</u> The joint standing committee of the General Assembly having cognizance of matters relating to insurance, in accordance with section 11-4a; and</p>\n    <p class=\"indent\">\n     <strike class=\"amendmentDeletedText\">(B)</strike>\n     <u class=\"amendmentInsertedText\">(2)</u> The Attorney General, Healthcare Advocate and Commissioner of Health Strategy.</p>\n    <p class=\"indent\">\n     <strike class=\"amendmentDeletedText\">(2) Notwithstanding subdivision (1) of this subsection, the commissioner shall not submit the name or identity of any health carrier or entity that has contracted with such health carrier, and such name or identity shall be given confidential treatment and not be made public by the commissioner.</strike>\n    </p>\n   </div>\n   <a name=\"section-Sec. 3-new\"></a><div title=\"Section: Sec. 3, Action: &quot;new&quot;, Title: &quot;25-94&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">Sec. 3. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after providing an opportunity for a hearing in accordance with chapter 54 of the general statutes, may impose a civil penalty on any health carrier of not more than one hundred dollars with respect to each participant or beneficiary covered under a health insurance policy of such health carrier, provided such penalty shall not exceed an aggregate amount of six hundred twenty-five thousand dollars annually, for such health carrier&#39;s failure to comply with (A) the certification requirements pursuant to the provisions of section 1 of this act, (B) the state and federal mental health and substance use disorder benefit reporting requirements identified in subdivision (1) of subsection (b) of section 1 of this act, or (C) any other requirement pursuant to sections 38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n    <p class=\"indent\">(2) The commissioner may order the payment of such reasonable expenses as may be necessary to compensate the commissioner in conjunction with any proceedings under this section, which shall be dedicated to the enforcement and implementation of the state and federal mental health parity laws and regulations adopted thereunder.</p>\n    <p class=\"indent\">(b) (1) If any health carrier fails to file any data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, or section 1 of this act, the commissioner shall impose a late fee on such health carrier of one hundred dollars per day from the due date of such filing of data, report, certification or information to the date such health carrier submits such filing to the commissioner, provided such late fee shall not exceed an aggregate amount of six hundred twenty-five thousand dollars.</p>\n    <p class=\"indent\">(2) For any health carrier that files any incomplete data, report, certification or other information required by the provisions of section 38a-477ee of the general statutes, as amended by this act, and section 1 of this act, the commissioner shall provide notice to such health carrier of such incomplete filing that includes (A) a description of such data, report, certification or other information that is incomplete and any additional data that is needed to consider such filing complete, and (B) the date by which such health carrier is required to provide such data. The commissioner shall impose a late fee on such health carrier of one hundred dollars per day, commencing from the date identified by the commissioner pursuant to subparagraph (B) of this subdivision, provided such late fee shall not exceed an aggregate amount of six hundred twenty-five thousand dollars.</p>\n    <p class=\"indent\">(c) The commissioner may waive any civil penalty imposed pursuant to subsection (a) of this section if the commissioner determines that the violation was due to reasonable cause and was not due to wilful neglect, or if such violation is corrected not more than thirty days after the date that the health carrier filed a certification of noncompliance with the commissioner pursuant to section 1 of this act.</p>\n    <p class=\"indent\">(d) All civil penalties and late fees received by the commissioner pursuant to this section shall be deposited in the General Fund.</p>\n    <p class=\"indent\">(e) The commissioner may engage the services of any health policy research organization or any other independent expert as the commissioner deems necessary to assist the commissioner in the review of any violation of the nonquantitative treatment limitations requirements pursuant to section 38a-477ee of the general statutes, as amended by this act, and the provisions of the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and regulations adopted thereunder.</p>\n   </div>\n   <p class=\"indent\">Sec. 4. Section 38a-510 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <a name=\"section-38a-510-amended\"></a><div title=\"Section: 38a-510, Action: &quot;amended&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing an individual health insurance policy or contract that provides coverage for prescription drugs may:</p>\n    <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n    <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than thirty days, (B) for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer<u class=\"amendmentInsertedText\">, multiple sclerosis or rheumatoid arthritis,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, or (C) <strike class=\"amendmentDeletedText\">for the period commencing January 1, 2024, and ending January 1, 2027, inclusive,</strike> for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;.</p>\n    <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in subparagraph (B) or (C) of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n    <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n     <u class=\"amendmentInsertedText\">thirty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n    <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n    <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive, or (2) affect the provisions of section 38a-492i.</p>\n   </div>\n   <p class=\"indent\">Sec. 5. Section 38a-544 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <a name=\"section-38a-544-amended\"></a><div class=\"sectionContent\" title=\"Section: 38a-544, Action: &quot;amended&quot;\">\n    <p class=\"indent\">(a) No insurance company, hospital service corporation, medical service corporation, health care center or other entity delivering, issuing for delivery, renewing, amending or continuing a group health insurance policy or contract that provides coverage for prescription drugs may:</p>\n    <p class=\"indent\">(1) Require any person covered under such policy or contract to obtain prescription drugs from a mail order pharmacy as a condition of obtaining benefits for such drugs; or</p>\n    <p class=\"indent\">(2) Require, if such insurance company, hospital service corporation, medical service corporation, health care center or other entity uses step therapy for such drugs, the use of step therapy (A) for any prescribed drug for longer than thirty days, (B) for a prescribed drug for cancer treatment for an insured who has been diagnosed with stage IV metastatic cancer<u class=\"amendmentInsertedText\">, multiple sclerosis or rheumatoid arthritis,</u> provided such prescribed drug is in compliance with approved federal Food and Drug Administration indications, or (C) <strike class=\"amendmentDeletedText\">for the period commencing January 1, 2024, and ending January 1, 2027, inclusive,</strike> for the treatment of schizophrenia, major depressive disorder or bipolar disorder, as defined in the most recent edition of the American Psychiatric Association&#39;s &quot;Diagnostic and Statistical Manual of Mental Disorders&quot;.</p>\n    <p class=\"indent\">(3) At the expiration of the time period specified in subparagraph (A) of subdivision (2) of this subsection or for a prescribed drug described in subparagraph (B) or (C) of subdivision (2) of this subsection, an insured&#39;s treating health care provider may deem such step therapy drug regimen clinically ineffective for the insured, at which time the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract. If such provider does not deem such step therapy drug regimen clinically ineffective or has not requested an override pursuant to subdivision (1) of subsection (b) of this section, such drug regimen may be continued. For purposes of this section, &quot;step therapy&quot; means a protocol or program that establishes the specific sequence in which prescription drugs for a specified medical condition are to be prescribed.</p>\n    <p class=\"indent\">(b) (1) Notwithstanding the <strike class=\"amendmentDeletedText\">sixty-day</strike>\n     <u class=\"amendmentInsertedText\">thirty-day</u> period set forth in <u class=\"amendmentInsertedText\">subparagraph (A) of</u> subdivision (2) of subsection (a) of this section, each insurance company, hospital service corporation, medical service corporation, health care center or other entity that uses step therapy for such prescription drugs shall establish and disclose to its health care providers a process by which an insured&#39;s treating health care provider may request at any time an override of the use of any step therapy drug regimen. Any such override process shall be convenient to use by health care providers and an override request shall be expeditiously granted when an insured&#39;s treating health care provider demonstrates that the drug regimen required under step therapy (A) has been ineffective in the past for treatment of the insured&#39;s medical condition, (B) is expected to be ineffective based on the known relevant physical or mental characteristics of the insured and the known characteristics of the drug regimen, (C) will cause or will likely cause an adverse reaction by or physical harm to the insured, or (D) is not in the best interest of the insured, based on medical necessity.</p>\n    <p class=\"indent\">(2) Upon the granting of an override request, the insurance company, hospital service corporation, medical service corporation, health care center or other entity shall authorize dispensation of and coverage for the drug prescribed by the insured&#39;s treating health care provider, provided such drug is a covered drug under such policy or contract.</p>\n    <p class=\"indent\">(c) Nothing in this section shall (1) preclude an insured or an insured&#39;s treating health care provider from requesting a review under sections 38a-591c to 38a-591g, inclusive, or (2) affect the provisions of section 38a-518i.</p>\n   </div>\n   <p class=\"indent\">Sec. 6. Subsection (b) of section 38a-481 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2027):</p>\n   <a name=\"section-38a-481(b)-amended\"></a><div title=\"Section: 38a-481(b), Action: &quot;amended&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">(b) No rate filed under the provisions of subsection (a) of this section shall be effective until it has been approved by the commissioner in accordance with regulations adopted pursuant to this subsection. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, to prescribe standards to ensure that such rates shall not be excessive, inadequate or unfairly discriminatory. The commissioner may disapprove such rate if it fails to comply with such standards, except that no rate filed under the provisions of subsection (a) of this section for any Medicare supplement policy shall be effective unless approved in accordance with section 38a-474. <u class=\"amendmentInsertedText\">If the commissioner determines that a health carrier&#39;s average premium rate increase, as approved by the commissioner, exceeded the health care cost growth benchmark established pursuant to section 19a-754g for each of the two most recent plan years for which such health care cost growth benchmark data is available, the commissioner may reduce such health carrier&#39;s requested rate filed under the provisions of subsection (a) of this section by not more than two percentage points of such premium rate filed in addition to any other rate reductions authorized under this title.</u>\n    </p>\n   </div>\n   <p class=\"indent\">Sec. 7. Subsection (a) of section 38a-513 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2027):</p>\n   <a name=\"section-38a-513(a)-amended\"></a><div title=\"Section: 38a-513(a), Action: &quot;amended&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">(a) (1) No group health insurance policy, as defined by the commissioner, or certificate shall be delivered or issued for delivery in this state unless a copy of the form for such policy or certificate has been submitted to and approved by the commissioner under the regulations adopted pursuant to this section. The commissioner shall adopt regulations, in accordance with the provisions of chapter 54, concerning the provisions, submission and approval of such policies and certificates and establishing a procedure for reviewing such policies and certificates. The commissioner shall disapprove the use of such form at any time if it does not comply with the requirements of law, or if it contains a provision or provisions that are unfair or deceptive or that encourage misrepresentation of the policy. The commissioner shall notify, in writing, the insurer that has filed any such form of the commissioner&#39;s disapproval, specifying the reasons for disapproval, and ordering that no such insurer shall deliver or issue for delivery to any person in this state a policy on or containing such form. The provisions of section 38a-19 shall apply to such order.</p>\n    <p class=\"indent\">(2) No group health insurance policy or certificate for a small employer, as defined in section 38a-564, shall be delivered or issued for delivery in this state unless the premium rates have been submitted to and approved by the commissioner. <u class=\"amendmentInsertedText\">If the commissioner determines that any small group health insurance carrier&#39;s average premium rate increase, as approved by the commissioner, or certificate for a small employer, exceeded the health care cost growth benchmark established pursuant to section 19a-754g for each of the two most recent plan years for which such health care cost growth benchmark data is available, the commissioner may reduce such policy&#39;s or certificate&#39;s requested premium rate filing under the provisions of subsection (a) of this section by not more than two percentage points of such premium rate filed in addition to any other premium rate reductions authorized under this title.</u> Premium rate filings shall include the information and data required under section 38a-479qqq if the policy is subject to said section, and an actuarial memorandum that includes, but is not limited to, pricing assumptions and claims experience, and premium rates and loss ratios from the inception of the policy. Each premium rate filed on or after January 1, 2021, shall, if the insurer intends to account for rebates, as defined in section 38a-479ooo in the manner specified in section 38a-479rrr, account for such rebates in such manner, if the policy is subject to section 38a-479rrr. As used in this subdivision, &quot;loss ratio&quot; means the ratio of incurred claims to earned premiums by the number of years of policy duration for all combined durations.</p>\n   </div>\n   <a name=\"section-Sec. 8-new\"></a><div class=\"sectionContent\" title=\"Section: Sec. 8, Action: &quot;new&quot;, Title: &quot;25-94&quot;\">\n    <p class=\"indent\">Sec. 8. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n    <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n    <p class=\"indent\">(2) &quot;Medically necessary&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n    <p class=\"indent\">(b) No individual health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall, if such policy provides coverage for general anesthesia, (1) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (2) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer.</p>\n   </div>\n   <a name=\"section-Sec. 9-new\"></a><div class=\"sectionContent\" title=\"Section: Sec. 9, Action: &quot;new&quot;, Title: &quot;25-94&quot;\">\n    <p class=\"indent\">Sec. 9. (NEW) (Effective January 1, 2026) (a) As used in this section:</p>\n    <p class=\"indent\">(1) &quot;General anesthesia&quot; has the same meaning as provided in section 20-123a of the general statutes; and</p>\n    <p class=\"indent\">(2) &quot;Medically necessary&quot; has the same meaning as provided in section 38a-482a of the general statutes.</p>\n    <p class=\"indent\">(b) No group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes delivered, issued for delivery, renewed, amended or continued in this state on or after January 1, 2026, shall, if such policy provides coverage for general anesthesia, (1) impose an arbitrary time limit on reimbursement for general anesthesia provided during any medically necessary procedure, or (2) deny, reduce, terminate or fail to provide such reimbursement, in whole or in part, for general anesthesia solely because the duration of care exceeded a predetermined time limit as determined by the insurer.</p>\n   </div>\n   <p class=\"indent\">Sec. 10. Section 19a-508c of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2026):</p>\n   <a name=\"section-19a-508c-amended\"></a><div title=\"Section: 19a-508c, Action: &quot;amended&quot;\" class=\"sectionContent\">\n    <p class=\"indent\">(a) As used in this section:</p>\n    <p class=\"indent\">(1) &quot;Affiliated provider&quot; means a provider that is: (A) Employed by a hospital or health system, (B) under a professional services agreement with a hospital or health system that permits such hospital or health system to bill on behalf of such provider, or (C) a clinical faculty member of a medical school, as defined in section 33-182aa, that is affiliated with a hospital or health system in a manner that permits such hospital or health system to bill on behalf of such clinical faculty member;</p>\n    <p class=\"indent\">(2) &quot;Campus&quot; means: (A) The physical area immediately adjacent to a hospital&#39;s main buildings and other areas and structures that are not strictly contiguous to the main buildings but are located within two hundred fifty yards of the main buildings, or (B) any other area that has been determined on an individual case basis by the Centers for Medicare and Medicaid Services to be part of a hospital&#39;s campus;</p>\n    <p class=\"indent\">(3) &quot;Facility fee&quot; means any fee charged or billed by a hospital or health system for outpatient services provided in a hospital-based facility that is: (A) Intended to compensate the hospital or health system for the operational expenses of the hospital or health system, and (B) separate and distinct from a professional fee;</p>\n    <p class=\"indent\">(4) &quot;Health care provider&quot; means an individual, entity, corporation, person or organization, whether for-profit or nonprofit, that furnishes, bills or is paid for health care service delivery in the normal course of business, including, but not limited to, a health system, a hospital, a hospital-based facility, a freestanding emergency department and an urgent care center;</p>\n    <p class=\"indent\">(5) &quot;Health system&quot; means: (A) A parent corporation of one or more hospitals and any entity affiliated with such parent corporation through ownership, governance, membership or other means, or (B) a hospital and any entity affiliated with such hospital through ownership, governance, membership or other means;</p>\n    <p class=\"indent\">(6) &quot;Hospital&quot; has the same meaning as provided in section 19a-490;</p>\n    <p class=\"indent\">(7) &quot;Hospital-based facility&quot; means a facility that is owned or operated, in whole or in part, by a hospital or health system where hospital or professional medical services are provided;</p>\n    <p class=\"indent\">(8) &quot;Medicaid&quot; means the program operated by the Department of Social Services pursuant to section 17b-260 and authorized by Title XIX of the Social Security Act, as amended from time to time;</p>\n    <p class=\"indent\">(9) &quot;Observation&quot; means services furnished by a hospital on the hospital&#39;s campus, regardless of length of stay, including use of a bed and periodic monitoring by the hospital&#39;s nursing or other staff to evaluate an outpatient&#39;s condition or determine the need for admission to the hospital as an inpatient;</p>\n    <p class=\"indent\">(10) &quot;Payer mix&quot; means the proportion of different sources of payment received by a hospital or health system, including, but not limited to, Medicare, Medicaid, other government-provided insurance, private insurance and self-pay patients;</p>\n    <p class=\"indent\">(11) &quot;Professional fee&quot; means any fee charged or billed by a provider for professional medical services provided in a hospital-based facility;</p>\n    <p class=\"indent\">(12) &quot;Provider&quot; means an individual, entity, corporation or health care provider, whether for profit or nonprofit, whose primary purpose is to provide professional medical services; and</p>\n    <p class=\"indent\">(13) &quot;Tagline&quot; means a short statement written in a non-English language that indicates the availability of language assistance services free of charge.</p>\n    <p class=\"indent\">(b) If a hospital or health system charges a facility fee utilizing a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code for outpatient services provided at a hospital-based facility where a professional fee is also expected to be charged, the hospital or health system shall provide the patient with a written notice that includes the following information:</p>\n    <p class=\"indent\">(1) That the hospital-based facility is part of a hospital or health system and that the hospital or health system charges a facility fee that is in addition to and separate from the professional fee charged by the provider;</p>\n    <p class=\"indent\">(2) (A) The amount of the patient&#39;s potential financial liability, including any facility fee likely to be charged, and, where professional medical services are provided by an affiliated provider, any professional fee likely to be charged, or, if the exact type and extent of the professional medical services needed are not known or the terms of a patient&#39;s health insurance coverage are not known with reasonable certainty, an estimate of the patient&#39;s financial liability based on typical or average charges for visits to the hospital-based facility, including the facility fee, (B) a statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, (C) an explanation that the patient may incur financial liability that is greater than the patient would incur if the professional medical services were not provided by a hospital-based facility, and (D) a telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability, including an estimate of the facility fee likely to be charged based on the scheduled professional medical services; and</p>\n    <p class=\"indent\">(3) That a patient covered by a health insurance policy should contact the health insurer for additional information regarding the hospital&#39;s or health system&#39;s charges and fees, including the patient&#39;s potential financial liability, if any, for such charges and fees.</p>\n    <p class=\"indent\">(c) If a hospital or health system charges a facility fee without utilizing a current procedural terminology evaluation and management (CPT E/M) code for outpatient services provided at a hospital-based facility, located outside the hospital campus, the hospital or health system shall provide the patient with a written notice that includes the following information:</p>\n    <p class=\"indent\">(1) That the hospital-based facility is part of a hospital or health system and that the hospital or health system charges a facility fee that may be in addition to and separate from the professional fee charged by a provider;</p>\n    <p class=\"indent\">(2) (A) A statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, (B) an explanation that the patient may incur financial liability that is greater than the patient would incur if the hospital-based facility was not hospital-based, and (C) a telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability, including an estimate of the facility fee likely to be charged based on the scheduled professional medical services; and</p>\n    <p class=\"indent\">(3) That a patient covered by a health insurance policy should contact the health insurer for additional information regarding the hospital&#39;s or health system&#39;s charges and fees, including the patient&#39;s potential financial liability, if any, for such charges and fees.</p>\n    <p class=\"indent\">(d) Each initial billing statement that includes a facility fee shall: (1) Clearly identify the fee as a facility fee that is billed in addition to, or separately from, any professional fee billed by the provider; (2) provide the corresponding Medicare facility fee reimbursement rate for the same service as a comparison or, if there is no corresponding Medicare facility fee for such service, (A) the approximate amount Medicare would have paid the hospital for the facility fee on the billing statement, or (B) the percentage of the hospital&#39;s charges that Medicare would have paid the hospital for the facility fee; (3) include a statement that the facility fee is intended to cover the hospital&#39;s or health system&#39;s operational expenses; (4) inform the patient that the patient&#39;s financial liability may have been less if the services had been provided at a facility not owned or operated by the hospital or health system; and (5) include written notice of the patient&#39;s right to request a reduction in the facility fee or any other portion of the bill and a telephone number that the patient may use to request such a reduction without regard to whether such patient qualifies for, or is likely to be granted, any reduction. Not later than October 15, 2022, and annually thereafter, each hospital, health system and hospital-based facility shall submit to the Health Systems Planning Unit of the Office of Health Strategy a sample of a billing statement issued by such hospital, health system or hospital-based facility that complies with the provisions of this subsection and which represents the format of billing statements received by patients. Such billing statement shall not contain patient identifying information.</p>\n    <p class=\"indent\">(e) The written notice described in subsections (b) to (d), inclusive, and (h) to (j), inclusive, of this section shall be in plain language and in a form that may be reasonably understood by a patient who does not possess special knowledge regarding hospital or health system facility fee charges. On and after October 1, 2022, such notices shall include tag lines in at least the top fifteen languages spoken in the state indicating that the notice is available in each of those top fifteen languages. The fifteen languages shall be either the languages in the list published by the Department of Health and Human Services in connection with section 1557 of the Patient Protection and Affordable Care Act, P.L. 111-148, or, as determined by the hospital or health system, the top fifteen languages in the geographic area of the hospital-based facility.</p>\n    <p class=\"indent\">(f) (1) For nonemergency care, if a patient&#39;s appointment is scheduled to occur ten or more days after the appointment is made, such written notice shall be sent to the patient by first class mail, encrypted electronic mail or a secure patient Internet portal not less than three days after the appointment is made. If an appointment is scheduled to occur less than ten days after the appointment is made or if the patient arrives without an appointment, such notice shall be hand-delivered to the patient when the patient arrives at the hospital-based facility.</p>\n    <p class=\"indent\">(2) For emergency care, such written notice shall be provided to the patient as soon as practicable after the patient is stabilized in accordance with the federal Emergency Medical Treatment and Active Labor Act, 42 USC 1395dd, as amended from time to time, or is determined not to have an emergency medical condition and before the patient leaves the hospital-based facility. If the patient is unconscious, under great duress or for any other reason unable to read the notice and understand and act on his or her rights, the notice shall be provided to the patient&#39;s representative as soon as practicable.</p>\n    <p class=\"indent\">(g) Subsections (b) to (f), inclusive, and (l) of this section shall not apply if a patient is insured by Medicare or Medicaid or is receiving services under a workers&#39; compensation plan established to provide medical services pursuant to chapter 568.</p>\n    <p class=\"indent\">(h) A hospital-based facility shall prominently display written notice in locations that are readily accessible to and visible by patients, including patient waiting or appointment check-in areas, stating: (1) That the hospital-based facility is part of a hospital or health system, (2) the name of the hospital or health system, and (3) that if the hospital-based facility charges a facility fee, the patient may incur a financial liability greater than the patient would incur if the hospital-based facility was not hospital-based. On and after October 1, 2022, such notices shall include tag lines in at least the top fifteen languages spoken in the state indicating that the notice is available in each of those top fifteen languages. The fifteen languages shall be either the languages in the list published by the Department of Health and Human Services in connection with section 1557 of the Patient Protection and Affordable Care Act, P.L. 111-148, or, as determined by the hospital or health system, the top fifteen languages in the geographic area of the hospital-based facility. Not later than October 1, 2022, and annually thereafter, each hospital-based facility shall submit a copy of the written notice required by this subsection to the Health Systems Planning Unit of the Office of Health Strategy.</p>\n    <p class=\"indent\">(i) A hospital-based facility shall clearly hold itself out to the public and payers as being hospital-based, including, at a minimum, by stating the name of the hospital or health system in its signage, marketing materials, Internet web sites and stationery.</p>\n    <p class=\"indent\">(j) A hospital-based facility shall, when scheduling services for which a facility fee may be charged, inform the patient (1) that the hospital-based facility is part of a hospital or health system, (2) of the name of the hospital or health system, (3) that the hospital or health system may charge a facility fee in addition to and separate from the professional fee charged by the provider, and (4) of the telephone number the patient may call for additional information regarding such patient&#39;s potential financial liability.</p>\n    <p class=\"indent\">(k) (1) If any transaction described in subsection (c) of section 19a-486i results in the establishment of a hospital-based facility at which facility fees may be billed, the hospital or health system, that is the purchaser in such transaction shall, not later than thirty days after such transaction, provide written notice, by first class mail, of the transaction to each patient served within the three years preceding the date of the transaction by the health care facility that has been purchased as part of such transaction.</p>\n    <p class=\"indent\">(2) Such notice shall include the following information:</p>\n    <p class=\"indent\">(A) A statement that the health care facility is now a hospital-based facility and is part of a hospital or health system, the health care facility&#39;s full legal and business name and the date of such facility&#39;s acquisition by a hospital or health system;</p>\n    <p class=\"indent\">(B) The name, business address and phone number of the hospital or health system that is the purchaser of the health care facility;</p>\n    <p class=\"indent\">(C) A statement that the hospital-based facility bills, or is likely to bill, patients a facility fee that may be in addition to, and separate from, any professional fee billed by a health care provider at the hospital-based facility;</p>\n    <p class=\"indent\">(D) (i) A statement that the patient&#39;s actual financial liability will depend on the professional medical services actually provided to the patient, and (ii) an explanation that the patient may incur financial liability that is greater than the patient would incur if the hospital-based facility were not a hospital-based facility;</p>\n    <p class=\"indent\">(E) The estimated amount or range of amounts the hospital-based facility may bill for a facility fee or an example of the average facility fee billed at such hospital-based facility for the most common services provided at such hospital-based facility; and</p>\n    <p class=\"indent\">(F) A statement that, prior to seeking services at such hospital-based facility, a patient covered by a health insurance policy should contact the patient&#39;s health insurer for additional information regarding the hospital-based facility fees, including the patient&#39;s potential financial liability, if any, for such fees.</p>\n    <p class=\"indent\">(3) A copy of the written notice provided to patients in accordance with this subsection shall be filed with the Health Systems Planning Unit of the Office of Health Strategy, established under section 19a-612. Said unit shall post a link to such notice on its Internet web site.</p>\n    <p class=\"indent\">(4) A hospital, health system or hospital-based facility shall not collect a facility fee for services provided at a hospital-based facility that is subject to the provisions of this subsection from the date of the transaction until at least thirty days after the written notice required pursuant to this subsection is mailed to the patient or a copy of such notice is filed with the Health Systems Planning Unit of the Office of Health Strategy, whichever is later. A violation of this subsection shall be considered an unfair trade practice pursuant to section 42-110b.</p>\n    <p class=\"indent\">(5) Not later than July 1, 2023, and annually thereafter, each hospital-based facility that was the subject of a transaction, as described in subsection (c) of section 19a-486i, during the preceding calendar year shall report to the Health Systems Planning Unit of the Office of Health Strategy the number of patients served by such hospital-based facility in the preceding three years.</p>\n    <p class=\"indent\">(l) (1) Notwithstanding the provisions of this section, no hospital, health system or hospital-based facility shall collect a facility fee for (A) outpatient health care services that use a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code and are provided at a hospital-based facility located off-site from a hospital campus, or (B) outpatient health care services provided at a hospital-based facility located off-site from a hospital campus received by a patient who is uninsured of more than the Medicare rate.</p>\n    <p class=\"indent\">(2) Notwithstanding the provisions of this section, on and after July 1, 2024, no hospital or health system shall collect a facility fee for outpatient health care services that use a current procedural terminology evaluation and management (CPT E/M) code or assessment and management (CPT A/M) code and are provided on the hospital campus. The provisions of this subdivision shall not apply to (A) an emergency department located on a hospital campus, or (B) observation stays on a hospital campus and (CPT E/M) and (CPT A/M) codes when billed for the following services: (i) Wound care, (ii) orthopedics, (iii) anticoagulation, (iv) oncology, (v) obstetrics, and (vi) solid organ transplant.</p>\n    <p class=\"indent\">(3) Notwithstanding the provisions of subdivisions (1) and (2) of this subsection, in circumstances when an insurance contract that is in effect on July 1, 2016, provides reimbursement for facility fees prohibited under the provisions of subdivision (1) of this subsection, and in circumstances when an insurance contract that is in effect on July 1, 2024, provides reimbursement for facility fees prohibited under the provisions of subdivision (2) of this subsection, a hospital or health system may continue to collect reimbursement from the health insurer for such facility fees until the applicable date of expiration, renewal or amendment of such contract, whichever such date is the earliest.</p>\n    <p class=\"indent\">(4) The provisions of this subsection shall not apply to a freestanding emergency department. As used in this subdivision, &quot;freestanding emergency department&quot; means a freestanding facility that (A) is structurally separate and distinct from a hospital, (B) provides emergency care, (C) is a department of a hospital licensed under chapter 368v, and (D) has been issued a certificate of need to operate as a freestanding emergency department pursuant to chapter 368z.</p>\n    <p class=\"indent\">(5) (A) On and after July 1, 2024, if the Commissioner of Health Strategy receives information and has a reasonable belief, after evaluating such information, that any hospital, health system or hospital-based facility charged facility fees, other than through isolated clerical or electronic billing errors, in violation of any provision of this section, or rule or regulation adopted thereunder, such hospital, health system or hospital-based facility shall be subject to a civil penalty of up to one thousand dollars. The commissioner may issue a notice of violation and civil penalty by first class mail or personal service. Such notice shall include: (i) A reference to the section of the general statutes, rule or section of the regulations of Connecticut state agencies believed or alleged to have been violated; (ii) a short and plain language statement of the matters asserted or charged; (iii) a description of the activity to cease; (iv) a statement of the amount of the civil penalty or penalties that may be imposed; (v) a statement concerning the right to a hearing; and (vi) a statement that such hospital, health system or hospital-based facility may, not later than ten business days after receipt of such notice, make a request for a hearing on the matters asserted.</p>\n    <p class=\"indent\">(B) The hospital, health system or hospital-based facility to whom such notice is provided pursuant to subparagraph (A) of this subdivision may, not later than ten business days after receipt of such notice, make written application to the Office of Health Strategy to request a hearing to demonstrate that such violation did not occur. The failure to make a timely request for a hearing shall result in the issuance of a cease and desist order or civil penalty. All hearings held under this subsection shall be conducted in accordance with the provisions of chapter 54.</p>\n    <p class=\"indent\">(C) Following any hearing before the Office of Health Strategy pursuant to this subdivision, if said office finds, by a preponderance of the evidence, that such hospital, health system or hospital-based facility violated or is violating any provision of this subsection, any rule or regulation adopted thereunder or any order issued by said office, said office shall issue a final cease and desist order in addition to any civil penalty said office imposes.</p>\n    <p class=\"indent\">\n     <u class=\"amendmentInsertedText\">(6) A violation of this subsection shall be considered an unfair trade practice pursuant to section 42-110b.</u>\n    </p>\n    <p class=\"indent\">(m) (1) Each hospital and health system shall report not later than October 1, 2023, and thereafter not later than July 1, 2024, and annually thereafter, to the Commissioner of Health Strategy, on a form prescribed by the commissioner, concerning facility fees charged or billed during the preceding calendar year. Such report shall include, but need not be limited to, (A) the name and address of each facility owned or operated by the hospital or health system that provides services for which a facility fee is charged or billed, and an indication as to whether each facility is located on or outside of the hospital or health system campus, (B) the number of patient visits at each such facility for which a facility fee was charged or billed, (C) the number, total amount and range of allowable facility fees paid at each such facility disaggregated by payer mix, (D) for each facility, the total amount of facility fees charged and the total amount of revenue received by the hospital or health system derived from facility fees, (E) the total amount of facility fees charged and the total amount of revenue received by the hospital or health system from all facilities derived from facility fees, (F) a description of the ten procedures or services that generated the greatest amount of facility fee gross revenue, disaggregated by current procedural terminology <u class=\"amendmentInsertedText\">(CPT)</u> category <strike class=\"amendmentDeletedText\">(CPT)</strike> code for each such procedure or service and, for each such procedure or service, patient volume and the total amount of gross and net revenue received by the hospital or health system derived from facility fees, disaggregated by on-campus and off-campus, and (G) the top ten procedures or services for which facility fees are charged based on patient volume and the gross and net revenue received by the hospital or health system for each such procedure or service, disaggregated by on-campus and off-campus. For purposes of this subsection, &quot;facility&quot; means a hospital-based facility that is located on a hospital campus or outside a hospital campus.</p>\n    <p class=\"indent\">(2) The commissioner shall publish the information reported pursuant to subdivision (1) of this subsection, or post a link to such information, on the Internet web site of the Office of Health Strategy.</p>\n   </div>\n  </div>\n </div>\n    </div>\t\n<table cellpadding=0 cellspacing=0 width=\"100%\">\n   <tr>\n      <td>\n          Copyright &copy; 2025 State Net\n      </td>\n<BR>\n<!--???MOVED INTO resources.cgi      <td align=\"right\">\n          <img src=\"https://custom.statenet.com/network/poweredby.gif\" alt=\"Powered by State Net\">\n      </td>-->\n\n    </tr>\n</table>\n</body></html>\n",
      "markdown": "The following has special meaning: _green underline denotes added text_ ~~red struck out text denotes deleted text~~ | [![Powered by State Net](https://custom.statenet.com/network/poweredby.gif)](https://www.lexisnexis.com/statenet/)  \n---|---  \n  \n2025 CT S 10 | | Author: | Looney  \n---|---  \nVersion: | Enacted - Final  \nVersion Date: | 06/24/2025  \n  \n**STATE OF CONNECTICUT**\n\n**Substitute Senate Bill No. 10**\n\n**Public Act No. 25-94**\n\n**AN ACT CONCERNING HEALTH INSURANCE AND PATIENT PROTECTION.**\n\nBe it enacted by the Senate and House of Representatives in General Assembly\nconvened:\n\nSection 1. (NEW) (Effective October 1, 2025) (a) As used in this section:\n\n(1) \"Health carrier\" has the same meaning as provided in section 38a-1080 of\nthe general statutes; and\n\n(2) \"Mental health and substance use disorder benefits\" has the same meaning\nas provided in section 38a-477ee of the general statutes, as amended by this\nact.\n\n(b) (1) Not later than March 1, 2026, and annually thereafter, each health\ncarrier shall file a certification with the Insurance Commissioner for the\nimmediately preceding calendar year, certifying that such health carrier\ncompleted a review of such health carrier's administrative practices for\ncompliance with the state and federal mental health and substance use disorder\nbenefit reporting requirements pursuant to sections 38a-477ee, as amended by\nthis act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as amended by this act,\n38a-514, 38a-514c, 38a-514d and 38a-544 of the general statutes, as amended by\nthis act, and the provisions of the federal Paul Wellstone and Pete Domenici\nMental Health Parity and Addiction Equity Act of 2008, P.L. 110-343, as\namended from time to time, and regulations adopted thereunder.\n\n(2) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year comply\nwith the state and federal mental health and substance use disorder benefit\nreporting requirements identified in subdivision (1) of this subsection, such\ncertification filed pursuant to subdivision (1) of this subsection shall state\nsuch finding.\n\n(3) If such health carrier determines that such health carrier's\nadministrative practices for the immediately preceding calendar year fail to\ncomply with the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of this\nsubsection, such certification filed pursuant to subdivision (1) of this\nsubsection shall state such finding and identify (A) each administrative\npractice of such health carrier not in compliance with such state and federal\nmental health and substance use disorder benefit reporting requirements, and\n(B) action that such health carrier will take to bring such health carrier's\nadministrative practices into compliance with such state and federal mental\nhealth and substance use disorder benefit reporting requirements.\n\nSec. 2. Subsection (c) of section 38a-477ee of the general statutes is\nrepealed and the following is substituted in lieu thereof (Effective October\n1, 2025):\n\n(c) ~~(1)~~ Not later than April 15, 2021, and annually thereafter, the\nInsurance Commissioner shall submit each report that the commissioner received\npursuant to subsection (b) of this section for the calendar year immediately\npreceding to:\n\n~~(A)~~ _(1)_ The joint standing committee of the General Assembly having\ncognizance of matters relating to insurance, in accordance with section 11-4a;\nand\n\n~~(B)~~ _(2)_ The Attorney General, Healthcare Advocate and Commissioner of\nHealth Strategy.\n\n~~(2) Notwithstanding subdivision (1) of this subsection, the commissioner\nshall not submit the name or identity of any health carrier or entity that has\ncontracted with such health carrier, and such name or identity shall be given\nconfidential treatment and not be made public by the commissioner.~~\n\nSec. 3. (NEW) (Effective October 1, 2025) (a) (1) The commissioner, after\nproviding an opportunity for a hearing in accordance with chapter 54 of the\ngeneral statutes, may impose a civil penalty on any health carrier of not more\nthan one hundred dollars with respect to each participant or beneficiary\ncovered under a health insurance policy of such health carrier, provided such\npenalty shall not exceed an aggregate amount of six hundred twenty-five\nthousand dollars annually, for such health carrier's failure to comply with\n(A) the certification requirements pursuant to the provisions of section 1 of\nthis act, (B) the state and federal mental health and substance use disorder\nbenefit reporting requirements identified in subdivision (1) of subsection (b)\nof section 1 of this act, or (C) any other requirement pursuant to sections\n38a-477ee, as amended by this act, 38a-488a, 38a-488c, 38a-488d, 38a-510, as\namended by this act, 38a-514, 38a-514c, 38a-514d and 38a-544 of the general\nstatutes, as amended by this act, and the provisions of the federal Paul\nWellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of\n2008, P.L. 110-343, as amended from time to time, and regulations adopted\nthereunder.\n\n(2) The commissioner may order the payment of such reasonable expenses as may\nbe necessary to compensate the commissioner in conjunction with any\nproceedings under this section, which shall be dedicated to the enforcement\nand implementation of the state and federal mental health parity laws and\nregulations adopted thereunder.\n\n(b) (1) If any health carrier fails to file any data, report, certification or\nother information required by the provisions of section 38a-477ee of the\ngeneral statutes, as amended by this act, or section 1 of this act, the\ncommissioner shall impose a late fee on such health carrier of one hundred\ndollars per day from the due date of such filing of data, report,\ncertification or information to the date such health carrier submits such\nfiling to the commissioner, provided such late fee shall not exceed an\naggregate amount of six hundred twenty-five thousand dollars.\n\n(2) For any health carrier that files any incomplete data, report,\ncertification or other information required by the provisions of section\n38a-477ee of the general statutes, as amended by this act, and section 1 of\nthis act, the commissioner shall provide notice to such health carrier of such\nincomplete filing that includes (A) a description of such data, report,\ncertification or other information that is incomplete and any additional data\nthat is needed to consider such filing complete, and (B) the date by which\nsuch health carrier is required to provide such data. The commissioner shall\nimpose a late fee on such health carrier of one hundred dollars per day,\ncommencing from the date identified by the commissioner pursuant to\nsubparagraph (B) of this subdivision, provided such late fee shall not exceed\nan aggregate amount of six hundred twenty-five thousand dollars.\n\n(c) The commissioner may waive any civil penalty imposed pursuant to\nsubsection (a) of this section if the commissioner determines that the\nviolation was due to reasonable cause and was not due to wilful neglect, or if\nsuch violation is corrected not more than thirty days after the date that the\nhealth carrier filed a certification of noncompliance with the commissioner\npursuant to section 1 of this act.\n\n(d) All civil penalties and late fees received by the commissioner pursuant to\nthis section shall be deposited in the General Fund.\n\n(e) The commissioner may engage the services of any health policy research\norganization or any other independent expert as the commissioner deems\nnecessary to assist the commissioner in the review of any violation of the\nnonquantitative treatment limitations requirements pursuant to section\n38a-477ee of the general statutes, as amended by this act, and the provisions\nof the federal Paul Wellstone and Pete Domenici Mental Health Parity and\nAddiction Equity Act of 2008, P.L. 110-343, as amended from time to time, and\nregulations adopted thereunder.\n\nSec. 4. Section 38a-510 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing an individual health insurance\npolicy or contract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan thirty days, (B) for a prescribed drug for cancer treatment for an\ninsured who has been diagnosed with stage IV metastatic cancer _, multiple\nsclerosis or rheumatoid arthritis,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications, or\n(C) ~~for the period commencing January 1, 2024, and ending January 1, 2027,\ninclusive,~~ for the treatment of schizophrenia, major depressive disorder or\nbipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\".\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\nsubparagraph (B) or (C) of subdivision (2) of this subsection, an insured's\ntreating health care provider may deem such step therapy drug regimen\nclinically ineffective for the insured, at which time the insurance company,\nhospital service corporation, medical service corporation, health care center\nor other entity shall authorize dispensation of and coverage for the drug\nprescribed by the insured's treating health care provider, provided such drug\nis a covered drug under such policy or contract. If such provider does not\ndeem such step therapy drug regimen clinically ineffective or has not\nrequested an override pursuant to subdivision (1) of subsection (b) of this\nsection, such drug regimen may be continued. For purposes of this section,\n\"step therapy\" means a protocol or program that establishes the specific\nsequence in which prescription drugs for a specified medical condition are to\nbe prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _thirty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive, or (2) affect the provisions of section 38a-492i.\n\nSec. 5. Section 38a-544 of the general statutes is repealed and the following\nis substituted in lieu thereof (Effective January 1, 2026):\n\n(a) No insurance company, hospital service corporation, medical service\ncorporation, health care center or other entity delivering, issuing for\ndelivery, renewing, amending or continuing a group health insurance policy or\ncontract that provides coverage for prescription drugs may:\n\n(1) Require any person covered under such policy or contract to obtain\nprescription drugs from a mail order pharmacy as a condition of obtaining\nbenefits for such drugs; or\n\n(2) Require, if such insurance company, hospital service corporation, medical\nservice corporation, health care center or other entity uses step therapy for\nsuch drugs, the use of step therapy (A) for any prescribed drug for longer\nthan thirty days, (B) for a prescribed drug for cancer treatment for an\ninsured who has been diagnosed with stage IV metastatic cancer _, multiple\nsclerosis or rheumatoid arthritis,_ provided such prescribed drug is in\ncompliance with approved federal Food and Drug Administration indications, or\n(C) ~~for the period commencing January 1, 2024, and ending January 1, 2027,\ninclusive,~~ for the treatment of schizophrenia, major depressive disorder or\nbipolar disorder, as defined in the most recent edition of the American\nPsychiatric Association's \"Diagnostic and Statistical Manual of Mental\nDisorders\".\n\n(3) At the expiration of the time period specified in subparagraph (A) of\nsubdivision (2) of this subsection or for a prescribed drug described in\nsubparagraph (B) or (C) of subdivision (2) of this subsection, an insured's\ntreating health care provider may deem such step therapy drug regimen\nclinically ineffective for the insured, at which time the insurance company,\nhospital service corporation, medical service corporation, health care center\nor other entity shall authorize dispensation of and coverage for the drug\nprescribed by the insured's treating health care provider, provided such drug\nis a covered drug under such policy or contract. If such provider does not\ndeem such step therapy drug regimen clinically ineffective or has not\nrequested an override pursuant to subdivision (1) of subsection (b) of this\nsection, such drug regimen may be continued. For purposes of this section,\n\"step therapy\" means a protocol or program that establishes the specific\nsequence in which prescription drugs for a specified medical condition are to\nbe prescribed.\n\n(b) (1) Notwithstanding the ~~sixty-day~~ _thirty-day_ period set forth in\n_subparagraph (A) of_ subdivision (2) of subsection (a) of this section, each\ninsurance company, hospital service corporation, medical service corporation,\nhealth care center or other entity that uses step therapy for such\nprescription drugs shall establish and disclose to its health care providers a\nprocess by which an insured's treating health care provider may request at any\ntime an override of the use of any step therapy drug regimen. Any such\noverride process shall be convenient to use by health care providers and an\noverride request shall be expeditiously granted when an insured's treating\nhealth care provider demonstrates that the drug regimen required under step\ntherapy (A) has been ineffective in the past for treatment of the insured's\nmedical condition, (B) is expected to be ineffective based on the known\nrelevant physical or mental characteristics of the insured and the known\ncharacteristics of the drug regimen, (C) will cause or will likely cause an\nadverse reaction by or physical harm to the insured, or (D) is not in the best\ninterest of the insured, based on medical necessity.\n\n(2) Upon the granting of an override request, the insurance company, hospital\nservice corporation, medical service corporation, health care center or other\nentity shall authorize dispensation of and coverage for the drug prescribed by\nthe insured's treating health care provider, provided such drug is a covered\ndrug under such policy or contract.\n\n(c) Nothing in this section shall (1) preclude an insured or an insured's\ntreating health care provider from requesting a review under sections 38a-591c\nto 38a-591g, inclusive, or (2) affect the provisions of section 38a-518i.\n\nSec. 6. Subsection (b) of section 38a-481 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2027):\n\n(b) No rate filed under the provisions of subsection (a) of this section shall\nbe effective until it has been approved by the commissioner in accordance with\nregulations adopted pursuant to this subsection. The commissioner shall adopt\nregulations, in accordance with the provisions of chapter 54, to prescribe\nstandards to ensure that such rates shall not be excessive, inadequate or\nunfairly discriminatory. The commissioner may disapprove such rate if it fails\nto comply with such standards, except that no rate filed under the provisions\nof subsection (a) of this section for any Medicare supplement policy shall be\neffective unless approved in accordance with section 38a-474. _If the\ncommissioner determines that a health carrier 's average premium rate\nincrease, as approved by the commissioner, exceeded the health care cost\ngrowth benchmark established pursuant to section 19a-754g for each of the two\nmost recent plan years for which such health care cost growth benchmark data\nis available, the commissioner may reduce such health carrier's requested rate\nfiled under the provisions of subsection (a) of this section by not more than\ntwo percentage points of such premium rate filed in addition to any other rate\nreductions authorized under this title._\n\nSec. 7. Subsection (a) of section 38a-513 of the general statutes is repealed\nand the following is substituted in lieu thereof (Effective January 1, 2027):\n\n(a) (1) No group health insurance policy, as defined by the commissioner, or\ncertificate shall be delivered or issued for delivery in this state unless a\ncopy of the form for such policy or certificate has been submitted to and\napproved by the commissioner under the regulations adopted pursuant to this\nsection. The commissioner shall adopt regulations, in accordance with the\nprovisions of chapter 54, concerning the provisions, submission and approval\nof such policies and certificates and establishing a procedure for reviewing\nsuch policies and certificates. The commissioner shall disapprove the use of\nsuch form at any time if it does not comply with the requirements of law, or\nif it contains a provision or provisions that are unfair or deceptive or that\nencourage misrepresentation of the policy. The commissioner shall notify, in\nwriting, the insurer that has filed any such form of the commissioner's\ndisapproval, specifying the reasons for disapproval, and ordering that no such\ninsurer shall deliver or issue for delivery to any person in this state a\npolicy on or containing such form. The provisions of section 38a-19 shall\napply to such order.\n\n(2) No group health insurance policy or certificate for a small employer, as\ndefined in section 38a-564, shall be delivered or issued for delivery in this\nstate unless the premium rates have been submitted to and approved by the\ncommissioner. _If the commissioner determines that any small group health\ninsurance carrier 's average premium rate increase, as approved by the\ncommissioner, or certificate for a small employer, exceeded the health care\ncost growth benchmark established pursuant to section 19a-754g for each of the\ntwo most recent plan years for which such health care cost growth benchmark\ndata is available, the commissioner may reduce such policy's or certificate's\nrequested premium rate filing under the provisions of subsection (a) of this\nsection by not more than two percentage points of such premium rate filed in\naddition to any other premium rate reductions authorized under this title._\nPremium rate filings shall include the information and data required under\nsection 38a-479qqq if the policy is subject to said section, and an actuarial\nmemorandum that includes, but is not limited to, pricing assumptions and\nclaims experience, and premium rates and loss ratios from the inception of the\npolicy. Each premium rate filed on or after January 1, 2021, shall, if the\ninsurer intends to account for rebates, as defined in section 38a-479ooo in\nthe manner specified in section 38a-479rrr, account for such rebates in such\nmanner, if the policy is subject to section 38a-479rrr. As used in this\nsubdivision, \"loss ratio\" means the ratio of incurred claims to earned\npremiums by the number of years of policy duration for all combined durations.\n\nSec. 8. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medically necessary\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No individual health insurance policy providing coverage of the type\nspecified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of\nthe general statutes delivered, issued for delivery, renewed, amended or\ncontinued in this state on or after January 1, 2026, shall, if such policy\nprovides coverage for general anesthesia, (1) impose an arbitrary time limit\non reimbursement for general anesthesia provided during any medically\nnecessary procedure, or (2) deny, reduce, terminate or fail to provide such\nreimbursement, in whole or in part, for general anesthesia solely because the\nduration of care exceeded a predetermined time limit as determined by the\ninsurer.\n\nSec. 9. (NEW) (Effective January 1, 2026) (a) As used in this section:\n\n(1) \"General anesthesia\" has the same meaning as provided in section 20-123a\nof the general statutes; and\n\n(2) \"Medically necessary\" has the same meaning as provided in section 38a-482a\nof the general statutes.\n\n(b) No group health insurance policy providing coverage of the type specified\nin subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general\nstatutes delivered, issued for delivery, renewed, amended or continued in this\nstate on or after January 1, 2026, shall, if such policy provides coverage for\ngeneral anesthesia, (1) impose an arbitrary time limit on reimbursement for\ngeneral anesthesia provided during any medically necessary procedure, or (2)\ndeny, reduce, terminate or fail to provide such reimbursement, in whole or in\npart, for general anesthesia solely because the duration of care exceeded a\npredetermined time limit as determined by the insurer.\n\nSec. 10. Section 19a-508c of the general statutes is repealed and the\nfollowing is substituted in lieu thereof (Effective January 1, 2026):\n\n(a) As used in this section:\n\n(1) \"Affiliated provider\" means a provider that is: (A) Employed by a hospital\nor health system, (B) under a professional services agreement with a hospital\nor health system that permits such hospital or health system to bill on behalf\nof such provider, or (C) a clinical faculty member of a medical school, as\ndefined in section 33-182aa, that is affiliated with a hospital or health\nsystem in a manner that permits such hospital or health system to bill on\nbehalf of such clinical faculty member;\n\n(2) \"Campus\" means: (A) The physical area immediately adjacent to a hospital's\nmain buildings and other areas and structures that are not strictly contiguous\nto the main buildings but are located within two hundred fifty yards of the\nmain buildings, or (B) any other area that has been determined on an\nindividual case basis by the Centers for Medicare and Medicaid Services to be\npart of a hospital's campus;\n\n(3) \"Facility fee\" means any fee charged or billed by a hospital or health\nsystem for outpatient services provided in a hospital-based facility that is:\n(A) Intended to compensate the hospital or health system for the operational\nexpenses of the hospital or health system, and (B) separate and distinct from\na professional fee;\n\n(4) \"Health care provider\" means an individual, entity, corporation, person or\norganization, whether for-profit or nonprofit, that furnishes, bills or is\npaid for health care service delivery in the normal course of business,\nincluding, but not limited to, a health system, a hospital, a hospital-based\nfacility, a freestanding emergency department and an urgent care center;\n\n(5) \"Health system\" means: (A) A parent corporation of one or more hospitals\nand any entity affiliated with such parent corporation through ownership,\ngovernance, membership or other means, or (B) a hospital and any entity\naffiliated with such hospital through ownership, governance, membership or\nother means;\n\n(6) \"Hospital\" has the same meaning as provided in section 19a-490;\n\n(7) \"Hospital-based facility\" means a facility that is owned or operated, in\nwhole or in part, by a hospital or health system where hospital or\nprofessional medical services are provided;\n\n(8) \"Medicaid\" means the program operated by the Department of Social Services\npursuant to section 17b-260 and authorized by Title XIX of the Social Security\nAct, as amended from time to time;\n\n(9) \"Observation\" means services furnished by a hospital on the hospital's\ncampus, regardless of length of stay, including use of a bed and periodic\nmonitoring by the hospital's nursing or other staff to evaluate an\noutpatient's condition or determine the need for admission to the hospital as\nan inpatient;\n\n(10) \"Payer mix\" means the proportion of different sources of payment received\nby a hospital or health system, including, but not limited to, Medicare,\nMedicaid, other government-provided insurance, private insurance and self-pay\npatients;\n\n(11) \"Professional fee\" means any fee charged or billed by a provider for\nprofessional medical services provided in a hospital-based facility;\n\n(12) \"Provider\" means an individual, entity, corporation or health care\nprovider, whether for profit or nonprofit, whose primary purpose is to provide\nprofessional medical services; and\n\n(13) \"Tagline\" means a short statement written in a non-English language that\nindicates the availability of language assistance services free of charge.\n\n(b) If a hospital or health system charges a facility fee utilizing a current\nprocedural terminology evaluation and management (CPT E/M) code or assessment\nand management (CPT A/M) code for outpatient services provided at a hospital-\nbased facility where a professional fee is also expected to be charged, the\nhospital or health system shall provide the patient with a written notice that\nincludes the following information:\n\n(1) That the hospital-based facility is part of a hospital or health system\nand that the hospital or health system charges a facility fee that is in\naddition to and separate from the professional fee charged by the provider;\n\n(2) (A) The amount of the patient's potential financial liability, including\nany facility fee likely to be charged, and, where professional medical\nservices are provided by an affiliated provider, any professional fee likely\nto be charged, or, if the exact type and extent of the professional medical\nservices needed are not known or the terms of a patient's health insurance\ncoverage are not known with reasonable certainty, an estimate of the patient's\nfinancial liability based on typical or average charges for visits to the\nhospital-based facility, including the facility fee, (B) a statement that the\npatient's actual financial liability will depend on the professional medical\nservices actually provided to the patient, (C) an explanation that the patient\nmay incur financial liability that is greater than the patient would incur if\nthe professional medical services were not provided by a hospital-based\nfacility, and (D) a telephone number the patient may call for additional\ninformation regarding such patient's potential financial liability, including\nan estimate of the facility fee likely to be charged based on the scheduled\nprofessional medical services; and\n\n(3) That a patient covered by a health insurance policy should contact the\nhealth insurer for additional information regarding the hospital's or health\nsystem's charges and fees, including the patient's potential financial\nliability, if any, for such charges and fees.\n\n(c) If a hospital or health system charges a facility fee without utilizing a\ncurrent procedural terminology evaluation and management (CPT E/M) code for\noutpatient services provided at a hospital-based facility, located outside the\nhospital campus, the hospital or health system shall provide the patient with\na written notice that includes the following information:\n\n(1) That the hospital-based facility is part of a hospital or health system\nand that the hospital or health system charges a facility fee that may be in\naddition to and separate from the professional fee charged by a provider;\n\n(2) (A) A statement that the patient's actual financial liability will depend\non the professional medical services actually provided to the patient, (B) an\nexplanation that the patient may incur financial liability that is greater\nthan the patient would incur if the hospital-based facility was not hospital-\nbased, and (C) a telephone number the patient may call for additional\ninformation regarding such patient's potential financial liability, including\nan estimate of the facility fee likely to be charged based on the scheduled\nprofessional medical services; and\n\n(3) That a patient covered by a health insurance policy should contact the\nhealth insurer for additional information regarding the hospital's or health\nsystem's charges and fees, including the patient's potential financial\nliability, if any, for such charges and fees.\n\n(d) Each initial billing statement that includes a facility fee shall: (1)\nClearly identify the fee as a facility fee that is billed in addition to, or\nseparately from, any professional fee billed by the provider; (2) provide the\ncorresponding Medicare facility fee reimbursement rate for the same service as\na comparison or, if there is no corresponding Medicare facility fee for such\nservice, (A) the approximate amount Medicare would have paid the hospital for\nthe facility fee on the billing statement, or (B) the percentage of the\nhospital's charges that Medicare would have paid the hospital for the facility\nfee; (3) include a statement that the facility fee is intended to cover the\nhospital's or health system's operational expenses; (4) inform the patient\nthat the patient's financial liability may have been less if the services had\nbeen provided at a facility not owned or operated by the hospital or health\nsystem; and (5) include written notice of the patient's right to request a\nreduction in the facility fee or any other portion of the bill and a telephone\nnumber that the patient may use to request such a reduction without regard to\nwhether such patient qualifies for, or is likely to be granted, any reduction.\nNot later than October 15, 2022, and annually thereafter, each hospital,\nhealth system and hospital-based facility shall submit to the Health Systems\nPlanning Unit of the Office of Health Strategy a sample of a billing statement\nissued by such hospital, health system or hospital-based facility that\ncomplies with the provisions of this subsection and which represents the\nformat of billing statements received by patients. Such billing statement\nshall not contain patient identifying information.\n\n(e) The written notice described in subsections (b) to (d), inclusive, and (h)\nto (j), inclusive, of this section shall be in plain language and in a form\nthat may be reasonably understood by a patient who does not possess special\nknowledge regarding hospital or health system facility fee charges. On and\nafter October 1, 2022, such notices shall include tag lines in at least the\ntop fifteen languages spoken in the state indicating that the notice is\navailable in each of those top fifteen languages. The fifteen languages shall\nbe either the languages in the list published by the Department of Health and\nHuman Services in connection with section 1557 of the Patient Protection and\nAffordable Care Act, P.L. 111-148, or, as determined by the hospital or health\nsystem, the top fifteen languages in the geographic area of the hospital-based\nfacility.\n\n(f) (1) For nonemergency care, if a patient's appointment is scheduled to\noccur ten or more days after the appointment is made, such written notice\nshall be sent to the patient by first class mail, encrypted electronic mail or\na secure patient Internet portal not less than three days after the\nappointment is made. If an appointment is scheduled to occur less than ten\ndays after the appointment is made or if the patient arrives without an\nappointment, such notice shall be hand-delivered to the patient when the\npatient arrives at the hospital-based facility.\n\n(2) For emergency care, such written notice shall be provided to the patient\nas soon as practicable after the patient is stabilized in accordance with the\nfederal Emergency Medical Treatment and Active Labor Act, 42 USC 1395dd, as\namended from time to time, or is determined not to have an emergency medical\ncondition and before the patient leaves the hospital-based facility. If the\npatient is unconscious, under great duress or for any other reason unable to\nread the notice and understand and act on his or her rights, the notice shall\nbe provided to the patient's representative as soon as practicable.\n\n(g) Subsections (b) to (f), inclusive, and (l) of this section shall not apply\nif a patient is insured by Medicare or Medicaid or is receiving services under\na workers' compensation plan established to provide medical services pursuant\nto chapter 568.\n\n(h) A hospital-based facility shall prominently display written notice in\nlocations that are readily accessible to and visible by patients, including\npatient waiting or appointment check-in areas, stating: (1) That the hospital-\nbased facility is part of a hospital or health system, (2) the name of the\nhospital or health system, and (3) that if the hospital-based facility charges\na facility fee, the patient may incur a financial liability greater than the\npatient would incur if the hospital-based facility was not hospital-based. On\nand after October 1, 2022, such notices shall include tag lines in at least\nthe top fifteen languages spoken in the state indicating that the notice is\navailable in each of those top fifteen languages. The fifteen languages shall\nbe either the languages in the list published by the Department of Health and\nHuman Services in connection with section 1557 of the Patient Protection and\nAffordable Care Act, P.L. 111-148, or, as determined by the hospital or health\nsystem, the top fifteen languages in the geographic area of the hospital-based\nfacility. Not later than October 1, 2022, and annually thereafter, each\nhospital-based facility shall submit a copy of the written notice required by\nthis subsection to the Health Systems Planning Unit of the Office of Health\nStrategy.\n\n(i) A hospital-based facility shall clearly hold itself out to the public and\npayers as being hospital-based, including, at a minimum, by stating the name\nof the hospital or health system in its signage, marketing materials, Internet\nweb sites and stationery.\n\n(j) A hospital-based facility shall, when scheduling services for which a\nfacility fee may be charged, inform the patient (1) that the hospital-based\nfacility is part of a hospital or health system, (2) of the name of the\nhospital or health system, (3) that the hospital or health system may charge a\nfacility fee in addition to and separate from the professional fee charged by\nthe provider, and (4) of the telephone number the patient may call for\nadditional information regarding such patient's potential financial liability.\n\n(k) (1) If any transaction described in subsection (c) of section 19a-486i\nresults in the establishment of a hospital-based facility at which facility\nfees may be billed, the hospital or health system, that is the purchaser in\nsuch transaction shall, not later than thirty days after such transaction,\nprovide written notice, by first class mail, of the transaction to each\npatient served within the three years preceding the date of the transaction by\nthe health care facility that has been purchased as part of such transaction.\n\n(2) Such notice shall include the following information:\n\n(A) A statement that the health care facility is now a hospital-based facility\nand is part of a hospital or health system, the health care facility's full\nlegal and business name and the date of such facility's acquisition by a\nhospital or health system;\n\n(B) The name, business address and phone number of the hospital or health\nsystem that is the purchaser of the health care facility;\n\n(C) A statement that the hospital-based facility bills, or is likely to bill,\npatients a facility fee that may be in addition to, and separate from, any\nprofessional fee billed by a health care provider at the hospital-based\nfacility;\n\n(D) (i) A statement that the patient's actual financial liability will depend\non the professional medical services actually provided to the patient, and\n(ii) an explanation that the patient may incur financial liability that is\ngreater than the patient would incur if the hospital-based facility were not a\nhospital-based facility;\n\n(E) The estimated amount or range of amounts the hospital-based facility may\nbill for a facility fee or an example of the average facility fee billed at\nsuch hospital-based facility for the most common services provided at such\nhospital-based facility; and\n\n(F) A statement that, prior to seeking services at such hospital-based\nfacility, a patient covered by a health insurance policy should contact the\npatient's health insurer for additional information regarding the hospital-\nbased facility fees, including the patient's potential financial liability, if\nany, for such fees.\n\n(3) A copy of the written notice provided to patients in accordance with this\nsubsection shall be filed with the Health Systems Planning Unit of the Office\nof Health Strategy, established under section 19a-612. Said unit shall post a\nlink to such notice on its Internet web site.\n\n(4) A hospital, health system or hospital-based facility shall not collect a\nfacility fee for services provided at a hospital-based facility that is\nsubject to the provisions of this subsection from the date of the transaction\nuntil at least thirty days after the written notice required pursuant to this\nsubsection is mailed to the patient or a copy of such notice is filed with the\nHealth Systems Planning Unit of the Office of Health Strategy, whichever is\nlater. A violation of this subsection shall be considered an unfair trade\npractice pursuant to section 42-110b.\n\n(5) Not later than July 1, 2023, and annually thereafter, each hospital-based\nfacility that was the subject of a transaction, as described in subsection (c)\nof section 19a-486i, during the preceding calendar year shall report to the\nHealth Systems Planning Unit of the Office of Health Strategy the number of\npatients served by such hospital-based facility in the preceding three years.\n\n(l) (1) Notwithstanding the provisions of this section, no hospital, health\nsystem or hospital-based facility shall collect a facility fee for (A)\noutpatient health care services that use a current procedural terminology\nevaluation and management (CPT E/M) code or assessment and management (CPT\nA/M) code and are provided at a hospital-based facility located off-site from\na hospital campus, or (B) outpatient health care services provided at a\nhospital-based facility located off-site from a hospital campus received by a\npatient who is uninsured of more than the Medicare rate.\n\n(2) Notwithstanding the provisions of this section, on and after July 1, 2024,\nno hospital or health system shall collect a facility fee for outpatient\nhealth care services that use a current procedural terminology evaluation and\nmanagement (CPT E/M) code or assessment and management (CPT A/M) code and are\nprovided on the hospital campus. The provisions of this subdivision shall not\napply to (A) an emergency department located on a hospital campus, or (B)\nobservation stays on a hospital campus and (CPT E/M) and (CPT A/M) codes when\nbilled for the following services: (i) Wound care, (ii) orthopedics, (iii)\nanticoagulation, (iv) oncology, (v) obstetrics, and (vi) solid organ\ntransplant.\n\n(3) Notwithstanding the provisions of subdivisions (1) and (2) of this\nsubsection, in circumstances when an insurance contract that is in effect on\nJuly 1, 2016, provides reimbursement for facility fees prohibited under the\nprovisions of subdivision (1) of this subsection, and in circumstances when an\ninsurance contract that is in effect on July 1, 2024, provides reimbursement\nfor facility fees prohibited under the provisions of subdivision (2) of this\nsubsection, a hospital or health system may continue to collect reimbursement\nfrom the health insurer for such facility fees until the applicable date of\nexpiration, renewal or amendment of such contract, whichever such date is the\nearliest.\n\n(4) The provisions of this subsection shall not apply to a freestanding\nemergency department. As used in this subdivision, \"freestanding emergency\ndepartment\" means a freestanding facility that (A) is structurally separate\nand distinct from a hospital, (B) provides emergency care, (C) is a department\nof a hospital licensed under chapter 368v, and (D) has been issued a\ncertificate of need to operate as a freestanding emergency department pursuant\nto chapter 368z.\n\n(5) (A) On and after July 1, 2024, if the Commissioner of Health Strategy\nreceives information and has a reasonable belief, after evaluating such\ninformation, that any hospital, health system or hospital-based facility\ncharged facility fees, other than through isolated clerical or electronic\nbilling errors, in violation of any provision of this section, or rule or\nregulation adopted thereunder, such hospital, health system or hospital-based\nfacility shall be subject to a civil penalty of up to one thousand dollars.\nThe commissioner may issue a notice of violation and civil penalty by first\nclass mail or personal service. Such notice shall include: (i) A reference to\nthe section of the general statutes, rule or section of the regulations of\nConnecticut state agencies believed or alleged to have been violated; (ii) a\nshort and plain language statement of the matters asserted or charged; (iii) a\ndescription of the activity to cease; (iv) a statement of the amount of the\ncivil penalty or penalties that may be imposed; (v) a statement concerning the\nright to a hearing; and (vi) a statement that such hospital, health system or\nhospital-based facility may, not later than ten business days after receipt of\nsuch notice, make a request for a hearing on the matters asserted.\n\n(B) The hospital, health system or hospital-based facility to whom such notice\nis provided pursuant to subparagraph (A) of this subdivision may, not later\nthan ten business days after receipt of such notice, make written application\nto the Office of Health Strategy to request a hearing to demonstrate that such\nviolation did not occur. The failure to make a timely request for a hearing\nshall result in the issuance of a cease and desist order or civil penalty. All\nhearings held under this subsection shall be conducted in accordance with the\nprovisions of chapter 54.\n\n(C) Following any hearing before the Office of Health Strategy pursuant to\nthis subdivision, if said office finds, by a preponderance of the evidence,\nthat such hospital, health system or hospital-based facility violated or is\nviolating any provision of this subsection, any rule or regulation adopted\nthereunder or any order issued by said office, said office shall issue a final\ncease and desist order in addition to any civil penalty said office imposes.\n\n_(6) A violation of this subsection shall be considered an unfair trade\npractice pursuant to section 42-110b._\n\n(m) (1) Each hospital and health system shall report not later than October 1,\n2023, and thereafter not later than July 1, 2024, and annually thereafter, to\nthe Commissioner of Health Strategy, on a form prescribed by the commissioner,\nconcerning facility fees charged or billed during the preceding calendar year.\nSuch report shall include, but need not be limited to, (A) the name and\naddress of each facility owned or operated by the hospital or health system\nthat provides services for which a facility fee is charged or billed, and an\nindication as to whether each facility is located on or outside of the\nhospital or health system campus, (B) the number of patient visits at each\nsuch facility for which a facility fee was charged or billed, (C) the number,\ntotal amount and range of allowable facility fees paid at each such facility\ndisaggregated by payer mix, (D) for each facility, the total amount of\nfacility fees charged and the total amount of revenue received by the hospital\nor health system derived from facility fees, (E) the total amount of facility\nfees charged and the total amount of revenue received by the hospital or\nhealth system from all facilities derived from facility fees, (F) a\ndescription of the ten procedures or services that generated the greatest\namount of facility fee gross revenue, disaggregated by current procedural\nterminology _(CPT)_ category ~~(CPT)~~ code for each such procedure or service\nand, for each such procedure or service, patient volume and the total amount\nof gross and net revenue received by the hospital or health system derived\nfrom facility fees, disaggregated by on-campus and off-campus, and (G) the top\nten procedures or services for which facility fees are charged based on\npatient volume and the gross and net revenue received by the hospital or\nhealth system for each such procedure or service, disaggregated by on-campus\nand off-campus. For purposes of this subsection, \"facility\" means a hospital-\nbased facility that is located on a hospital campus or outside a hospital\ncampus.\n\n(2) The commissioner shall publish the information reported pursuant to\nsubdivision (1) of this subsection, or post a link to such information, on the\nInternet web site of the Office of Health Strategy.\n\nCopyright (C) 2025 State Net  \n  \n---\n\n",
      "latest_version": true
    }
  ]
}